Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 6/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2467692 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL27918671 | 0.94 | ALDH1A1 (0.53) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL249847 | 0.94 | ALDH1A1 (0.52) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL5157555 | 0.83 | RELA (0.53) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL5157560 | 0.83 | RELA (0.53) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL8651744 | 0.83 | NPC1 (0.59) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217829 | 0.82 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL1405466 | 0.82 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217840 | 0.82 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217836 | 0.82 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1151 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059144-A1 | DYNAMIC NANOMECHANICAL AMPLIFICATION ANTENNA AND USES | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2025-03-20 | — | — | WO | claimed |
| US-20240383170-A1 | FLEXIBLE AND SMART WOOD WITH RESPONSIVE FUNCTION, PREPARATION METHOD THEREOF AND ACTUATOR | NANJING FORESTRY UNIVERSITY (CN) | 2024-11-21 | — | — | US | claimed |
| EP-4355908-A1 | A METHOD TO AMPLIFY AND DETECT TARGET NUCLEIC ACIDS WITH VERY HIGH SPECIFICITY AND SENSITIVITY | Obront Biotech Private Limited (IN) | 2024-04-24 | — | — | EP | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| US-11725227-B2 | Devices and methods for examining drug effects on microorganisms | ESSENLIX CORPORATION (US) | 2023-08-15 | — | — | US | claimed |
| CN-116373056-A | Flexible intelligent wood with responsiveness function, actuator and preparation method | 南京林业大学 | 2023-07-04 | — | — | CN | claimed |
| WO-2022264174-A1 | A METHOD TO AMPLIFY AND DETECT TARGET NUCLEIC ACIDS WITH VERY HIGH SPECIFICITY AND SENSITIVITY | ISLAM AMIRUL (IN) | 2022-12-22 | — | — | WO | claimed |
| CN-112592494-B | Preparation method of targeted colon part antibacterial imaging nano material based on dendritic cationic polyamide and tetraphenylethylene | 天津理工大学 | 2022-08-02 | — | — | CN | claimed |
| WO-2022159439-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2022-07-28 | — | — | WO | claimed |
| US-20220237930-A1 | CELL AGE CLASSIFICATION AND DRUG SCREENING | FOUNTAIN THERAPEUTICS INC (US) | 2022-07-28 | — | — | US | claimed |
| US-11359136-B2 | Colorimetric indicators for photocurable sealants | THE BOEING COMPANY (US) | 2022-06-14 | — | — | US | claimed |
| EP-2368558-A1 | Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates | Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch (DE) | 2011-09-28 | — | — | EP | claimed |
| EP-1451366-B1 | MOLECULAR DETECTION SYSTEMS UTILIZING REITERATIVE OLIGONUCLEOTIDE SYNTHESIS | RIBOMED BIOTECHNOLOGIES INC (US) | 2010-03-10 | — | — | EP | claimed |
| US-20020160525-A1 | IMMUNOASSAY DEVICES AND MATERIALS | PRINCETON BIOMEDITECH CORPORATION | 2002-10-31 | — | — | US | claimed |
| EP-0620822-A4 | HYBRIDIZATION OF POLYNUCLEOTIDES CONJUGATED WITH CHROMOPHORES AND FLUOROPHORES TO GENERATE DONOR-TO-DONOR ENERGY TRANSFER SYSTEM. | NANOTRONICS INC (US) | 1996-01-10 | — | — | EP | claimed |
| EP-0389437-B1 | Luciferin derivatives | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1995-05-24 | — | — | EP | claimed |
| EP-0620822-A1 | HYBRIDIZATION OF POLYNUCLEOTIDES CONJUGATED WITH CHROMOPHORES AND FLUOROPHORES TO GENERATE DONOR-TO-DONOR ENERGY TRANSFER SYSTEM | NANOTRONICS, INC. (US) | 1994-10-26 | — | — | EP | claimed |
| WO-1993009128-A1 | HYBRIDIZATION OF POLYNUCLEOTIDES CONJUGATED WITH CHROMOPHORES AND FLUOROPHORES TO GENERATE DONOR-TO-DONOR ENERGY TRANSFER SYSTEM | NANOTRONICS, INC. (US) | 1993-05-13 | — | — | WO | claimed |
| US-20260140039-A1 | METHODS FOR MONITORING FLOW RATE OF A FLOW STREAM AND SYSTEMS FOR SAME | BECTON DICKINSON AND CO (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4745556-A2 | METHODS FOR ASSESSING A FLUOROCHROME PANEL FOR USE IN ANALYSIS OF FLOW CYTOMETRY DATA AND SYSTEMS FOR SAME | BECTON, DICKINSON AND COMPANY (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12631645-B2 | Detection of BCL-2 family heterodimer complexes and use thereof | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2026-05-19 | — | — | US | disclosed |
| US-12631545-B2 | Method and systems for determining drop delay using scatter signals across spatially separated lasers | BECTON, DICKINSON AND COMPANY (US) | 2026-05-19 | — | — | US | disclosed |
| CN-122042510-A | Method for evaluating a fluorescent pigment panel for flow cytometry data analysis and system therefor | 贝克顿·迪金森公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260133126-A1 | METHODS FOR ASSESSING A FLUOROCHROME PANEL FOR USE IN ANALYSIS OF FLOW CYTOMETRY DATA AND SYSTEMS FOR SAME | BECTON DICKINSON AND CO (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4455309-B1 | METHODS FOR ANALYSING NUCLEIC ACID SEQUENCE INFORMATION USING GC BIAS, OPTIONALLY FOR DETECTING FETAL NUCLEIC ACID ABNORMALITIES | SEQUENOM INC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12624391-B2 | Cyanine dyes | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260118250-A1 | METHODS FOR ASSESSING COLLINEARITY OF MULTI-AUTOFLUORESCENCE SPECTRA OF A SAMPLE AND SYSTEMS FOR SAME | BECTON DICKINSON CO (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260117283-A1 | DIGITAL ANALYTE ANALYSIS | BIO RAD LABORATORIES INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260117301-A1 | REFERENCE STANDARDS FOR PLASMID DNA CONFORMATION ASSESSMENT AND SIZING ANALYSIS | REVVITY HEALTH SCIENCES, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4733742-A1 | METHODS FOR ASSESSING COLLINEARITY OF MULTI-AUTOFLUORESCENCE SPECTRA OF A SAMPLE AND SYSTEMS FOR SAME | Becton, Dickinson and Company (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4077464-B1 | FREE RADICAL POLYMERIZABLE ADHESION-PROMOTING INTERLAYER COMPOSITIONS AND METHODS OF USE | PRC DESOTO INT INC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260108464-A1 | Systems for Vacuum Mediated Liposome Preparation, and Methods for Using the Same | BECTON DICKINSON CO (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260109757-A1 | COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION | SCHOLAR ROCK INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4726060-A2 | METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4726362-A1 | METHODS FOR MONITORING FLOW RATE OF A FLOW STREAM AND SYSTEMS FOR SAME | Becton Dickinson and Company (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-3906415-B1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER | INST NAT SANTE RECH MED (FR) | 2026-04-15 | — | — | EP | disclosed |
| EP-4722387-A2 | METHODS FOR ANALYSING NUCLEIC ACID SEQUENCE INFORMATION USING GC BIAS, OPTIONALLY FOR DETECTING FETAL NUCLEIC ACID ABNORMALITIES | Sequenom, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12595517-B2 | Method to treat and stratify a patient suffering from a cancer | INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2026-04-07 | — | — | US | disclosed |
| US-20260092283-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF COMPLICATIONS AND DISORDERS RELATING TO VON WILLEBRAND FACTOR | BAND THERAPEUTICS LLC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260092336-A1 | AMPLICON-DEPLETED CRISPR/CAS-REGULATED ISOTHERMAL MOLECULAR ASSAY AT SKIN TEMPERATURE ENABLING MULTI-LEVEL, EQUIPMENT-FREE, HOME-BASED SELF-TESTING OF VIRAL INFECTIONS | UNIV HONG KONG SCIENCE & TECH (CN) | 2026-04-02 | — | — | US | disclosed |
| US-20260091104-A1 | NUCLEIC ACID VACCINES | MODERNATX, INC. (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4718056-A1 | METHODS FOR DETECTOR GAIN MODULATION AND SYSTEMS FOR SAME | Becton Dickinson and Company (US) | 2026-04-01 | — | — | EP | disclosed |
| US-20260086018-A1 | METHODS FOR DETECTOR GAIN MODULATION AND SYSTEMS FOR SAME | BECTON DICKINSON CO (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260085366-A1 | PSILOCYBE ASSAY | MEDICINAL GENOMICS CORP (US) | 2026-03-26 | — | — | US | disclosed |
| EP-2699693-B1 | METHODS FOR ISOLATING A TARGET ANALYTE FROM A HETEROGENEOUS SAMPLE | DNAE GROUP HOLDINGS LTD (GB) | 2026-03-18 | — | — | EP | disclosed |
| EP-4709877-A2 | METHODS AND KITS FOR DETECTING ENDOTOXIN | Life Technologies Corporation (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12578345-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-03-17 | — | — | US | disclosed |
| US-12577296-B2 | Compositions and methods for growth factor modulation | SCHOLAR ROCK, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12578341-B2 | Iterative fluorescence imaging | Universität Zürich (CH) | 2026-03-17 | — | — | US | disclosed |
| US-20260069717-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | MODERNATX INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260063530-A1 | METHODS AND COMPOSITIONS FOR FLOW CYTOMETER CALIBRATION | BECTON DICKINSON CO (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4703707-A1 | METHODS AND COMPOSITIONS FOR FLOW CYTOMETER CALIBRATION | Becton Dickinson and Company (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-3918096-B1 | METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS | US HEALTH (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-4700129-A2 | METHOD TO DETECT REPEAT SEQUENCE MOTIFS IN NUCLEIC ACID | Quest Diagnostics Investments Incorporated (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12559593-B2 | Dual cure sealants | PRC-DESOTO INTERNATIONAL, INC. (CA) | 2026-02-24 | — | — | US | disclosed |
| EP-4116431-B1 | DETECTION OF ATYPICAL PNEUMONIA | QUEST DIAGNOSTICS INVEST INC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260035471-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER | INST NAT SANTE RECH MED (FR) | 2026-02-05 | — | — | US | disclosed |
| US-20260036574-A1 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | BIO-RAD LABORATORIES, INC. | 2026-02-05 | — | — | US | disclosed |
| US-20260036577-A1 | SANDWICH ASSAYS IN DROPLETS | BIO-RAD LABORATORIES, INC. | 2026-02-05 | — | — | US | disclosed |
| EP-4685240-A2 | REFERENCE BEADS FOR LINKING IMAGING AND SEQUENCING READOUTS WITH SINGLE-CELL RESOLUTION | Becton, Dickinson and Company (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12529097-B2 | Digital analyte analysis | BIO-RAD LABORATORIES, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-12529092-B2 | In-situ spatial transcriptomics | THE BROAD INSTITUTE, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-12527743-B2 | Systems for vacuum mediated liposome preparation, and methods for using the same | BECTON, DICKINSON AND COMPANY (US) | 2026-01-20 | — | — | US | disclosed |
| US-20260016475-A1 | MATERIALS AND METHODS FOR EVALUATION OF ANTIGEN PRESENTATION MACHINERY COMPONENTS AND USES THEREOF | VENTANA MED SYST INC (US) | 2026-01-15 | — | — | US | disclosed |
| EP-4679088-A2 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | Becton, Dickinson and Company (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4674866-A2 | COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION | Scholar Rock, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-4673559-A1 | DUAL INDEXING PARTICLE LABELS FOR OBTAINING LINKED SINGLE CELL CYTOMETRIC AND SEQUENCE DATA | Becton, Dickinson and Company (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-4673560-A1 | DUAL INDEXING SPECIFIC BINDING MEMBERS FOR OBTAINING LINKED SINGLE CELL CYTOMETRIC AND SEQUENCE DATA | Becton, Dickinson and Company (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-4673160-A1 | NON-COVALENT BINDING PEPTIDE AND CARRIER COMPLEX COMPRISING IT | Consejo Superior de Investigaciones Cientificas M.P. (ES) | 2026-01-07 | — | — | EP | disclosed |
| US-12516390-B2 | Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cells | INCELLDX, INC. (US) | 2026-01-06 | — | — | US | disclosed |
| US-20260001866-A1 | QUENCHER AND USES THEREOF | SFC CO., LTD. (KR) | 2026-01-01 | — | — | US | disclosed |
| US-20260002864-A1 | METHODS FOR DETERMINING POSITIONAL FLOW STREAM VELOCITY AND SYSTEMS FOR SAME | BECTON DICKINSON CO (US) | 2026-01-01 | — | — | US | disclosed |
| US-20260002904-A1 | MICROFLUIDIC ELECTROPHORESIS-MEDIATED CHARACTERIZATION OF PLASMID DNA ISOFORMS | REVVITY HEALTH SCIENCES INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250388981-A1 | SYSTEMS AND METHODS FOR ULTRA-SPECIFIC AND ULTRA-SENSITIVE NUCLEIC ACID DETECTION | UNIV WAYNE STATE (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250387396-A1 | TREATING EXTRAPYRAMIDAL SYNDROME USING TRAPIDIL | SINOPIA BIOSCIENCES INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12503479-B2 | Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy | CELLECTAR BIOSCIENCES, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-12496346-B2 | Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy | CELLECTAR BIOSCIENCES, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250375442-A1 | COMBINATION THERAPY WITH CLK/DYRK INHIBITORS AND BCL2 INHIBITORS TO TREAT LEUKEMIA | TENARX, INC. | 2025-12-11 | — | — | US | disclosed |
| EP-4658815-A1 | METHODS AND COMPOSITIONS FOR OBTAINING LINKED FUNCTIONAL AND SEQUENCE DATA FOR SINGLE CELLS | Becton, Dickinson and Company (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250354218-A1 | METHODS FOR DETECTING ACUTE MYELOID LEUKEMIA | CORNELL UNIVERSITY (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250352547-A1 | Cancer Diagnostic and Treatment | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250354204-A1 | AUTOMATED RNA DETECTION USING LABELED 2'-O-METHYL RNA OLIGONUCLEOTIDE PROBES AND SIGNAL AMPLIFICATION SYSTEMS | VENTANA MED SYST INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250353014-A1 | DEVICES AND METHODS FOR PLATELET ASSAY | ESSENLIX CORPORATION (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250353001-A1 | Containing a Liquid Sample | ESSENLIX CORP (US) | 2025-11-20 | — | — | US | disclosed |
| WO-2025233323-A1 | DETECTION OF PATHOGENIC E. COLI STRAINS | Universität Bern (CH) | 2025-11-13 | — | — | WO | disclosed |
| US-20250345796-A1 | DIGITAL CHROMATOGRAPHY MICROFLUIDIC BIOCHIP AND METHODS OF USE THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2025-11-13 | — | — | US | disclosed |
| WO-2025235642-A1 | METHODS FOR TREATMENT AND ASSESSMENT OF MULTIPLE MYELOMA OR PRECURSORS THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| US-12467846-B2 | Methods for array binning flow cytometry data and systems for same | BECTON, DICKINSON AND COMPANY (US) | 2025-11-11 | — | — | US | disclosed |
| US-12466859-B2 | Desmoglein 2 (DSG2) binding proteins and uses therefor | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250340957-A1 | Assays for the Detection of SARS-CoV2 Mutants | PROCOMCURE BIOTECH GMBH (AT) | 2025-11-06 | — | — | US | disclosed |
| EP-4296370-B1 | METHOD TO DETECT REPEAT SEQUENCE MOTIFS IN NUCLEIC ACID | QUEST DIAGNOSTICS INVEST INC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12460252-B2 | MLH1 methylation assay | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12461094-B2 | Compositions and methods for molecular labeling | BIO-RAD LABORATORIES, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-4639170-A1 | MATERIALS AND METHODS FOR EVALUATION OF ANTIGEN PRESENTATION MACHINERY COMPONENTS AND USES THEREOF | Ventana Medical Systems, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4211273-B1 | METHOD TO TREAT AND STRATIFICATE A PATIENT SUFFERING FROM A CANCER | INST NAT SANTE RECH MED (FR) | 2025-10-29 | — | — | EP | disclosed |
| EP-4476336-B1 | REFERENCE BEADS FOR LINKING IMAGING AND SEQUENCING READOUTS WITH SINGLE-CELL RESOLUTION | BECTON DICKINSON CO (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4399327-B1 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | BECTON DICKINSON CO (US) | 2025-10-29 | — | — | EP | disclosed |
| US-12454718-B2 | Digital analyte analysis | BIO-RAD LABORATORIES, INC. (US) | 2025-10-28 | — | — | US | disclosed |
| US-12454570-B2 | Compositions and methods for growth factor modulation | SCHOLAR ROCK, INC. (US) | 2025-10-28 | — | — | US | disclosed |
| US-20250322927-A1 | MODELS FOR PREDICTING MUTANT P53 FITNESS AND THEIR IMPLICATIONS IN CANCER THERAPY | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2025-10-16 | — | — | US | disclosed |
| US-12442047-B2 | Methods for detecting Bordetella | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2025-10-14 | — | — | US | disclosed |
| US-12436083-B2 | Systems for detecting light by birefringent Fourier transform interferometry and methods for using same | BECTON, DICKINSON AND COMPANY (US) | 2025-10-07 | — | — | US | disclosed |
| US-12435064-B2 | Quencher and uses thereof | SFC CO., LTD. (KR) | 2025-10-07 | — | — | US | disclosed |
| US-20250297942-A1 | OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN | ESSENLIX CORPORATION (US) | 2025-09-25 | — | — | US | disclosed |
| US-12421560-B2 | Assays for the detection of SARS-CoV-2 mutants | PROCOMCURE BIOTECH GMBH (AT) | 2025-09-23 | — | — | US | disclosed |
| US-20250290920-A1 | TAG/ANTI-TAG SYSTEM FOR SIGNAL AMPLIFICATION IN IMMUNOASSAYS | Bender MedSystems GmbH (AT) | 2025-09-18 | — | — | US | disclosed |
| US-20250290139-A1 | DIAGNOSIS AND PROGNOSIS OF RICHTER'S SYNDROME | THE BROAD INSTITUTE, INC. (US) | 2025-09-18 | — | — | US | disclosed |
| US-20250290124-A1 | ULTRA RAPID DROPLET DIGITAL POLYMERASE CHAIN REACTION | NEW YORK UNIVERSITY | 2025-09-18 | — | — | US | disclosed |
| EP-4615445-A2 | METHODS FOR PREDICTING CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM USING CIRCULATING TUMOR DNA | Memorial Sloan-Kettering Cancer Center (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250283819-A1 | RAPID PATHOLOGY/CYTOLOGY WITHOUT WASH | ESSENLIX CORPORATION (US) | 2025-09-11 | — | — | US | disclosed |
| US-20250285767-A1 | ASSESSING RISK FOR MULTIPLE MYELOMA PRECURSOR DISEASE PROGRESSION | THE BROAD INSTITUTE, INC. (US) | 2025-09-11 | — | — | US | disclosed |
| US-20250281926-A1 | SAMPLE MANIPULATION AND ASSAY WITH RAPID TEMPERATURE CHANGE | ESSENLIX CORPORATION (US) | 2025-09-11 | — | — | US | disclosed |
| US-20250283817-A1 | MULTI-MODE ILLUMINATION SYSTEM | ESSENLIX CORPORATION (US) | 2025-09-11 | — | — | US | disclosed |
| EP-3791863-B1 | PROCESS FOR THE PRODUCTION OF HYBRIDOSOMES | ANJARIUM BIOSCIENCES AG (CH) | 2025-09-10 | — | — | EP | disclosed |
| US-12410463-B2 | Molecular beacons | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-09-09 | — | — | US | disclosed |
| EP-3692152-B1 | METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS | BROAD INST INC (US) | 2025-09-03 | — | — | EP | disclosed |
| US-12403177-B2 | Silk-based product formulations and methods of use | COCOON BIOTECH INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-12403465-B2 | Containing a liquid sample | ESSENLIX CORPORATION (US) | 2025-09-02 | — | — | US | disclosed |
| US-12405216-B2 | Rapid pathology/cytology without wash | ESSENLIX CORPORATION (US) | 2025-09-02 | — | — | US | disclosed |
| US-12399177-B2 | Combination treponemal and non-treponemal syphilis test | BIO-RAD LABORATORIES, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-12398419-B2 | Automated RNA detection using labeled 2′-O-methyl RNA oligonucleotide probes and signal amplification systems | VENTANA MEDICAL SYSTEMS, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-20250255889-A1 | METHODS FOR TREATMENT SELECTION FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | THE BROAD INSTITUTE, INC. (US) | 2025-08-14 | — | — | US | disclosed |
| US-20250257412-A1 | METHODS FOR DETECTING BORDETELLA | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2025-08-14 | — | — | US | disclosed |
| US-12385104-B2 | Methods and compositions for detecting transfusion-transmitted pathogens | The United States of America, as represented by the Secretary, Department of Health Human Services (US) | 2025-08-12 | — | — | US | disclosed |
| EP-3350333-B2 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | MODERNATX INC (US) | 2025-08-06 | — | — | EP | disclosed |
| EP-3965738-B1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIV DO MINHO (PT) | 2025-08-06 | — | — | EP | disclosed |
| US-12378598-B2 | Digital analyte analysis | BIO-RAD LABORATORIES, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-12379381-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250244320-A1 | Device and system for analyzing a sample, particularly blood, as well as methods of using the same | ESSENLIX CORPORATION (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4591867-A2 | METHODS FOR DETECTING BORDETELLA | Quest Diagnostics Investments LLC (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4031143-B1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4587594-A1 | <SMALLCAPSILOCYBE ASSAY | Medicinal Genomics Corporation (US) | 2025-07-23 | — | — | EP | disclosed |
| EP-3442538-B1 | TREATING LEVODOPA-INDUCED DYSKINESIA USING TRAPIDIL | SINOPIA BIOSCIENCES INC (US) | 2025-07-23 | — | — | EP | disclosed |
| US-12366520-B2 | Optical transmission sample holder and analysis, particularly for hemoglobin | ESSENLIX CORPORATION (US) | 2025-07-22 | — | — | US | disclosed |
| WO-2025151764-A1 | ACOUSTIC MICROFLUIDICS ENABLED PORTABLE PCR | TRANSFORMATIVE BIOTECH, LLC (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20250229269-A1 | ACOUSTIC MICROFLUIDICS ENABLED PORTABLE PCR | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2025-07-17 | — | — | US | disclosed |
| US-20250224397-A1 | BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR | BIO RAD LABORATORIES INC (US) | 2025-07-10 | — | — | US | disclosed |
| US-12351860-B2 | Digital analyte analysis | BIO-RAD LABORATORIES, INC. (US) | 2025-07-08 | — | — | US | disclosed |
| US-20250216383-A1 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | BIO-RAD LABORATORIES, INC. | 2025-07-03 | — | — | US | disclosed |
| US-20250216301-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II) | ESSENLIX CORPORATION (US) | 2025-07-03 | — | — | US | disclosed |
| EP-3463305-B1 | METHODS FOR LIPOSOME PREPARATION BY CENTRIFUGATION | BECTON DICKINSON CO (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025134126-A1 | METHOD OF RESOLVING DYNAMICS OF CELLULAR TRANSITIONS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2025-06-26 | — | — | WO | disclosed |
| EP-3335042-B1 | BIO/CHEMICAL ASSAY DEVICES AND METHODS FOR SIMPLIFIED STEPS, SMALL SAMPLES, ACCELERATED SPEED, AND EASE-OF-USE | ESSENLIX CORP (US) | 2025-06-25 | — | — | EP | disclosed |
| US-12339216-B2 | Linear variable optical filter systems for flow cytometry and methods for using the same | BECTON, DICKINSON AND COMPANY (US) | 2025-06-24 | — | — | US | disclosed |
| WO-2025090132-A9 | METHODS AND KITS FOR DETECTING ENDOTOXIN | LIFE TECHNOLOHGIES CORPORATION (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128693-A1 | AN ENGINEERED MAMMALIAN NUCLEASE FOR IMPROVED MAPPING OF 3-D GENOME ARCHITECTURE FROM NUCLEOSOME TO CHROMOSOME SCALE | THE ROCKEFELLER UNIVERSITY (US) | 2025-06-19 | — | — | WO | disclosed |
| CN-112218939-B | Rapid change in sample temperature for assay | 上海宜晟生物科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20250186624-A1 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | ARES CAPITAL CORPORATION, AS AGENT | 2025-06-12 | — | — | US | disclosed |
| WO-2025120184-A1 | T CELL SPECIFIC DISPERSION CANCER BIOMARKER | Universität Zürich (CH) | 2025-06-12 | — | — | WO | disclosed |
| US-20250189529-A1 | HIGH RISK BIOMARKERS FOR MYELOMA PRECURSOR DISEASE PROGRESSION AND METHODS OF USE THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-06-12 | — | — | US | disclosed |
| EP-3710820-B1 | DEVICES FOR SAMPLE ANALYSIS USING EPITACHOPHORESIS | HOFFMANN LA ROCHE (CH) | 2025-06-11 | — | — | EP | disclosed |
| EP-4565867-A1 | METHODS FOR DETERMINING PARTICLE POSITIONAL INFORMATION IN A FLOW CYTOMETER CORE STREAM AND SYSTEMS FOR SAME | Becton, Dickinson and Company (US) | 2025-06-11 | — | — | EP | disclosed |
| EP-4566715-A2 | SYSTEMS AND METHODS FOR HANDLING MICROFLUIDIC DROPLETS | Bio-Rad Laboratories, Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| US-12326396-B2 | Optical transmission sample holder and analysis, particularly for hemoglobin | ESSENLIX CORPORATION (US) | 2025-06-10 | — | — | US | disclosed |
| US-12320749-B2 | Multi-mode illumination system | ESSENLIX CORPORATION (US) | 2025-06-03 | — | — | US | disclosed |
| WO-2025109147-A1 | METHOD TO PREDICT THE RISK OF A CARDIOVASCULAR EVENT IN A PATIENT WITH TYPE 2 DIABETES | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-05-30 | — | — | WO | disclosed |
| US-20250171756-A1 | NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-05-29 | — | — | US | disclosed |
| US-20250171721-A1 | METHOD AND DEVICE FOR EARLY CANCER SCREENING | UNIV CALIFORNIA (US) | 2025-05-29 | — | — | US | disclosed |
| US-20250170228-A1 | TERMINALLY MODIFIED RNA | ARES CAPITAL CORPORATION, AS AGENT | 2025-05-29 | — | — | US | disclosed |
| US-12311357-B2 | Devices for sample analysis using epitachophoresis | Roche Sequencing Solutions, Inc. (US) | 2025-05-27 | — | — | US | disclosed |
| US-12313524-B2 | Systems for detecting light by spectral discrimination and methods for using same | BECTON, DICKINSON AND COMPANY (US) | 2025-05-27 | — | — | US | disclosed |
| CN-109219436-B | Modified wound dressing | 康沃特克科技公司 | 2025-05-23 | — | — | CN | disclosed |
| WO-2025106804-A1 | COMPOSITIONS AND METHODS FOR CHARACTERIZING HEPATOCYTE STRESS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-05-22 | — | — | WO | disclosed |
| US-20250161411-A1 | TUMOR MHC CLASS I EXPRESSION IS ASSOCIATED WITH INTERLEUKIN-2 RESPONSE IN MELANOMA | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2025-05-22 | — | — | US | disclosed |
| US-12306177-B2 | Blood based controls for complex panel | BECTON, DICKINSON AND COMPANY (US) | 2025-05-20 | — | — | US | disclosed |
| WO-2025101689-A1 | INFLUENZA NEURAMINIDASE ACTIVE SITE PROXIMITY ASSAY (NASPA) FOR RAPID PROFILING OF INHIBITORY ANTIBODIES AND ANTIGENIC DRIFT | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-05-15 | — | — | WO | disclosed |
| WO-2025101438-A1 | METHODS FOR DETECTING RHD INCOMPATIBILTY IN PREGNANT BLOOD AND PLASMA SAMPLES | NATERA, INC. (US) | 2025-05-15 | — | — | WO | disclosed |
| EP-4551926-A2 | TISSUE PROCESSING | Applikate Technologies, Inc. (US) | 2025-05-14 | — | — | EP | disclosed |
| US-12297426-B2 | DNA damage response signature guided rational design of CRISPR-based systems and therapies | THE BROAD INSTITUTE, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-12298309-B2 | Methods of assaying neoplastic and neoplasia-related cells and uses thereof | INCELLDX, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| CN-114599366-B | Therapeutic conjugates | 托特斯医药公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20250147026-A1 | BCR-ABL VARIANTS | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2025-05-08 | — | — | US | disclosed |
| EP-4144867-B1 | METHODS FOR DETECTING BORDETELLA | QUEST DIAGNOSTICS INVEST LLC (US) | 2025-05-07 | — | — | EP | disclosed |
| EP-4291901-B1 | USE OF MARKERS FOUND ON LYMPH NODE METASTATIC SAMPLES FOR THE PROGNOSIS OF BREAST CANCER | UNIV ZUERICH (CH) | 2025-05-07 | — | — | EP | disclosed |
| US-12291752-B2 | Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2025-05-06 | — | — | US | disclosed |
| US-12292440-B2 | Sandwich assays in droplets | BIO-RAD LABORATORIES, INC. (US) | 2025-05-06 | — | — | US | disclosed |
| US-20250136972-A1 | MODIFIED FLOW PROXY ASSAY PRIOR TO SINGLE-CELL CITE-SEQ | BECTON, DICKINSON AND COMPANY | 2025-05-01 | — | — | US | disclosed |
| US-20250138020-A1 | Simultaneous Cell Tagging Methods | NARWHAL BIO, INC. (US) | 2025-05-01 | — | — | US | disclosed |
| WO-2025090132-A2 | METHODS AND KITS FOR DETECTING ENDOTOXIN | LIFE TECHNOLOHGIES CORPORATION (US) | 2025-05-01 | — | — | WO | disclosed |
| EP-3443001-B1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS INC (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119907908-A | Method for determining particle location information in a flow cytometer core stream and system therefor | 贝克顿·迪金森公司 | 2025-04-29 | — | — | CN | disclosed |
| US-20250129405-A1 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | BECTON, DICKINSON AND COMPANY | 2025-04-24 | — | — | US | disclosed |
| CN-119845853-A | Improved light-transmissive sample holder and analysis, in particular for haemoglobin | 上海宜晟生物科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025080282-A1 | COMBINATION THERAPY WITH CLK/DYRK INHIBITORS AND BCL2 INHIBITORS TO TREAT LEUKEMIA | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2025-04-17 | — | — | WO | disclosed |
| WO-2025078632-A1 | METHODS OF PROGNOSIS AND TREATMENT OF PATIENTS SUFFERING FROM CANCER | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-04-17 | — | — | WO | disclosed |
| EP-4536405-A1 | SYSTEMS FOR RECONSTITUTING DRIED REAGENT COMPOSITIONS AND METHODS FOR USING THE SAME | Becton, Dickinson and Company (US) | 2025-04-16 | — | — | EP | disclosed |
| US-12274743-B2 | Nucleic acid vaccines | MODERNATX, INC. (US) | 2025-04-15 | — | — | US | disclosed |
| US-12276660-B2 | Device and system for analyzing a sample, particularly blood, as well as methods of using the same | ESSENLIX CORPORATION (US) | 2025-04-15 | — | — | US | disclosed |
| WO-2025073765-A1 | METHODS OF PROGNOSIS AND TREATMENT OF PATIENTS SUFFERING FROM MELANOMA | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-04-10 | — | — | WO | disclosed |
| US-20250114454-A1 | MODIFIED IMMUNE CELLS AND METHODS FOR USE THEREOF | THE BROAD INSTITUTE, INC. | 2025-04-10 | — | — | US | disclosed |
| WO-2025076128-A1 | ADAPTORS FOR ADOPTIVE CELL THERAPY AND COMPOUNDS FOR PREPARING SAME | UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-04-10 | — | — | WO | disclosed |
| EP-4532714-A1 | RIBOZYME-ASSISTED CIRCULAR RNAS AND COMPOSITIONS AND METHODS OF USE THERE OF | The Broad Institute, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-4533065-A1 | LINEAR VARIABLE OPTICAL FILTER SYSTEMS FOR FLOW CYTOMETRY AND METHODS FOR USING SAME | Becton, Dickinson and Company (US) | 2025-04-09 | — | — | EP | disclosed |
| CN-119790293-A | Tissue treatment | 艾普利凯特科技股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-12268691-B2 | Treating extrapyramidal syndrome using trapidil | SINOPIA BIOSCIENCES, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| WO-2025068340-A1 | METHOD TO PREDICT AML OUTCOME | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-04-03 | — | — | WO | disclosed |
| US-20250108137-A1 | APTAMERS SPECIFIC TO EBV-ASSOCIATED MALIGNANCIES AND THEIR APPLICATIONS IN CANCER IMAGING AND THERAPIES | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-04-03 | — | — | US | disclosed |
| US-12264369-B2 | Real-time PCR for the detection of pathogens | The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services (US) | 2025-04-01 | — | — | US | disclosed |
| US-20250099965-A1 | RAPID SAMPLE TEMPERATURE CHANGING FOR ASSAYING | ESSENLIX CORPORATION (US) | 2025-03-27 | — | — | US | disclosed |
| US-20250101400-A1 | NOVEL CRISPR ENZYMES AND SYSTEMS | THE BROAD INSTITUTE, INC. | 2025-03-27 | — | — | US | disclosed |
| US-12257323-B2 | Modified wound dressings | CONVATEC TECHNOLOGIES INC. (US) | 2025-03-25 | — | — | US | disclosed |
| WO-2025059144-A1 | DYNAMIC NANOMECHANICAL AMPLIFICATION ANTENNA AND USES | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2025-03-20 | — | — | WO | disclosed |
| US-20250092397-A1 | RIBOZYME-ASSISTED CIRCULAR RNAS AND COMPOSITIONS AND METHODS OF USE THEREOF | THE BROAD INSTITUTE, INC. (US) | 2025-03-20 | — | — | US | disclosed |
| EP-4522319-A1 | SYSTEMS FOR VACUUM MEDIATED LIPOSOME PREPARATION, AND METHODS FOR USING THE SAME | Becton, Dickinson and Company (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119614728-A | Method for detecting Legionella | 奎斯特诊断投资有限责任公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20250084491-A1 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A COMPLEX BIOLOGICAL SAMPLE | THE BROAD INSTITUTE, INC. (US) | 2025-03-13 | — | — | US | disclosed |
| US-20250076293-A1 | Homogeneous Assay | ESSENLIX CORPORATION (US) | 2025-03-06 | — | — | US | disclosed |
| US-20250074962-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES | ARES CAPITAL CORPORATION, AS AGENT | 2025-03-06 | — | — | US | disclosed |
| WO-2025045894-A1 | METHODS AND KITS FOR DIAGNOSING CAUSE OF NEPHROTIC SYNDROME AND GUIDING THERAPY | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-03-06 | — | — | WO | disclosed |
| WO-2025049359-A2 | METHODS OF GUIDING TREATMENT USING A NETWORK OF BIOMARKERS | SAPERE BIO, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| EP-3074754-B1 | MICROIMAGER ANALYSIS SYSTEM COMPRISING OPTICS AND METHODS OF USE THEREOF | BECTON DICKINSON CO (US) | 2025-03-05 | — | — | EP | disclosed |
| US-12241116-B2 | Digital analyte analysis | BIO-RAD LABORATORIES, INC. (US) | 2025-03-04 | — | — | US | disclosed |
| US-12239646-B2 | Cancer diagnostic and treatment | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-03-04 | — | — | US | disclosed |
| US-20250066761-A1 | REFERENCE BEADS FOR LINKING IMAGING AND SEQUENCING READOUTS WITH SINGLE-CELL RESOLUTION | BECTON, DICKINSON AND COMPANY | 2025-02-27 | — | — | US | disclosed |
| US-20250066843-A1 | SORTING OF MRNA AND/OR ABSEQ CONTAINING BARCODED BEADS BY FLOW | BECTON, DICKINSON AND COMPANY | 2025-02-27 | — | — | US | disclosed |
| US-20250067745-A1 | CD38 AS A BIOMARKER AND BIOTARGET IN T-CELL LYMPHOMAS | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-02-27 | — | — | US | disclosed |
| EP-4511633-A1 | HIGH-THROUGHPUT FLOW CYTOMETRY ANALYSIS OF HIGHLY MULTIPLEXED SAMPLES USING SAMPLE INDEXING WITH SPECIFIC BINDING MEMBER-FLUOR CONJUGATES | Becton, Dickinson and Company (US) | 2025-02-26 | — | — | EP | disclosed |
| WO-2025036992-A1 | RNA CONJUGATES | CureVac SE (DE) | 2025-02-20 | — | — | WO | disclosed |
| CN-119486812-A | System for reconstituting dry reagent compositions and methods of use thereof | 贝克顿·迪金森公司 | 2025-02-18 | — | — | CN | disclosed |
| US-12226769-B2 | Sample manipulation and assay with rapid temperature change | ESSENLIX CORPORATION (US) | 2025-02-18 | — | — | US | disclosed |
| US-12228580-B2 | Methods of assigning a COVID pathological type based on a cytokine/chemokine panel | INCELLDX, INC. (US) | 2025-02-18 | — | — | US | disclosed |
| EP-3956663-B1 | A METHOD OF PROFILING THE ENERGETIC METABOLISM OF A POPULATION OF CELLS | INST NAT SANTE RECH MED (FR) | 2025-02-12 | — | — | EP | disclosed |
| CN-119422050-A | Flow cytometry linear variable optical filter system and method of use thereof | 贝克顿·迪金森公司 | 2025-02-11 | — | — | CN | disclosed |
| US-12221720-B2 | Methods for determining spatial and temporal gene expression dynamics during adult neurogenesis in single cells | THE BROAD INSTITUTE, INC. (US) | 2025-02-11 | — | — | US | disclosed |
| CN-114761389-B | Phospholipid-FLAVAGLINE conjugates and methods for their use in targeted cancer therapy | 塞勒科塔生物科学公司 | 2025-02-07 | — | — | CN | disclosed |
| WO-2025027127-A1 | NEW PROGNOSTIC METHOD OF KIDNEY FAILURE | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-02-06 | — | — | WO | disclosed |
| WO-2025029797-A1 | METHODS OF ASSIGNING A COVID PATHOLOGICAL TYPE AND COMPOSITIONS FOR PRACTICING THE SAME, AND METHODS OF TREATING A SUBJECT FOR CHRONIC COVID-19 | INCELLDX, INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| WO-2025029844-A1 | DETECTION OF A MODIFICATION TO A POLYNUCLEOTIDE THROUGH PROXIMITY ASSAYS | BIO-RAD LABORATORIES, INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| EP-2981349-B1 | SYSTEMS FOR HANDLING MICROFLUIDIC DROPLETS | BIO RAD LABORATORIES INC (US) | 2025-02-05 | — | — | EP | disclosed |
| EP-4501318-A2 | NUCLEIC ACID VACCINES | ModernaTX, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| US-20250034662-A1 | PSILOCYBE ASSAY | Medicinal Genomics Corporation (US) | 2025-01-30 | — | — | US | disclosed |
| EP-3730943-B1 | B-CELL ANTIGEN PRESENTING CELL ASSAY | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2025-01-29 | — | — | EP | disclosed |
| CN-119384312-A | System for vacuum-mediated liposome preparation and method of use thereof | 贝克顿·迪金森公司 | 2025-01-28 | — | — | CN | disclosed |
| US-12209292-B2 | Nucleic acid amplification assays for detection of pathogens | THE BROAD INSTITUTE, INC. (US) | 2025-01-28 | — | — | US | disclosed |
| US-20250018062-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE | MODERNA TX INC (US) | 2025-01-16 | — | — | US | disclosed |
| EP-4490315-A1 | MODIFIED FLOW PROXY ASSAY PRIOR TO SINGLE-CELL CITE-SEQ | Becton, Dickinson and Company (US) | 2025-01-15 | — | — | EP | disclosed |
| CN-119317830-A | High throughput flow cytometry analysis of highly multiplexed samples using sample index with specific binding member-fluorescent conjugates | 贝克顿·迪金森公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-113646444-B | Method for detecting Legionella | 奎斯特诊断投资有限责任公司 | 2025-01-14 | — | — | CN | disclosed |
| US-12196746-B2 | Enhanced chemiluminescent enzyme-linked immunosorbent assay for detection of antibodies against Babesia microti | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-01-14 | — | — | US | disclosed |
| CN-119301272-A | Electrophoresis mediated characterization of the DNA content of adeno-associated viral capsids | 瑞孚迪健康科学公司 | 2025-01-10 | — | — | CN | disclosed |
| US-12188931-B2 | Borrelia immunoassays and materials therefor | BIO-RAD LABORATORIES, INC. (US) | 2025-01-07 | — | — | US | disclosed |
| US-12187992-B2 | Method and device for early cancer screening | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-07 | — | — | US | disclosed |
| US-12188925-B2 | Multi-stage, multiplexed target isolation and processing from heterogeneous populations | THE BROAD INSTITUTE, INC. (US) | 2025-01-07 | — | — | US | disclosed |
| CN-112752763-B | Kit for screening colorectal cancer and advanced adenoma and application thereof | 杭州诺辉健康科技有限公司 | 2025-01-03 | — | — | CN | disclosed |
| US-20250002999-A1 | COVID BIOASSAY TO DETERMINE DISEASE SEVERITY AND THERAPY | VDS723, LLC | 2025-01-02 | — | — | US | disclosed |
| US-20250000829-A1 | PHENYLBUTYRATE COMPOSITIONS FOR TREATING DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY (“DEE”), AND STXBP1 DISORDERS | CORNELL UNIVERSITY (US) | 2025-01-02 | — | — | US | disclosed |
| US-20250002970-A1 | AMPLIFIABLE METABOLIC LABELING FOR DETECTION OF BACTERIAL VIABILITY, GROWTH AND ANTIBIOTIC SUSCEPTIBILITY | UNIVERSITY OF MASSACHUSETTS | 2025-01-02 | — | — | US | disclosed |
| EP-3468590-B1 | NUCLEIC ACIDS ENCODING ZIKA VIRUS-LIKE PARTICLES AND THEIR USE IN ZIKA VIRUS VACCINES AND DIAGNOSTIC ASSAYS | US HEALTH (US) | 2025-01-01 | — | — | EP | disclosed |
| EP-4484577-A2 | DIGITAL ANALYTE ANALYSIS | Bio-Rad Laboratories, Inc. (US) | 2025-01-01 | — | — | EP | disclosed |
| US-12180546-B2 | Methods for identifying and modulating co-occurant cellular phenotypes | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-12-31 | — | — | US | disclosed |
| US-12181472-B2 | Homogeneous assay | ESSENLIX CORPORATION (US) | 2024-12-31 | — | — | US | disclosed |
| US-20240425914-A1 | EPITRANSCRIPTOME EVALUATION | HTG MOLECULAR DIAGNOSTICS, INC. (US) | 2024-12-26 | — | — | US | disclosed |
| US-20240425903-A1 | ENGINEERED GYRI-LIKE MUTEIN APTAMERS, AND RELATED METHODS | CROSSLIFE TECH INC (US) | 2024-12-26 | — | — | US | disclosed |
| WO-2024263528-A2 | PROTEOMIC BIOMARKERS FOR PREDICTING CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-12-26 | — | — | WO | disclosed |
| US-20240425922-A1 | METHODS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY | VDS723, LLC | 2024-12-26 | — | — | US | disclosed |
| EP-4479729-A2 | SIMULTANEOUS CELL TAGGING METHODS | Narwhal Bio, Inc. (US) | 2024-12-25 | — | — | EP | disclosed |
| EP-4476337-A1 | SORTING OF MRNA AND ABSEQ CONTAINING BARCODED BEADS BY FLOW | Becton, Dickinson and Company (US) | 2024-12-18 | — | — | EP | disclosed |
| EP-4476336-A1 | REFERENCE BEADS FOR LINKING IMAGING AND SEQUENCING READOUTS WITH SINGLE-CELL RESOLUTION | Becton, Dickinson and Company (US) | 2024-12-18 | — | — | EP | disclosed |
| EP-4476345-A1 | APTAMERS SPECIFIC TO EBV-ASSOCIATED MALIGNANCIES AND THEIR APPLICATIONS IN CANCER IMAGING AND THERAPIES | The Chinese University Of Hong Kong (HK) | 2024-12-18 | — | — | EP | disclosed |
| US-12169167-B2 | Devices and methods for tissue and cell staining (II) | ESSENLIX CORPORATION (US) | 2024-12-17 | — | — | US | disclosed |
| CN-112912002-B | Improved light-transmissive sample holder and analysis, in particular for haemoglobin | 上海宜晟生物科技有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240408191-A1 | NUCLEIC ACID VACCINES | MODERNATX, INC. (US) | 2024-12-12 | — | — | US | disclosed |
| US-20240410019-A1 | CLUSTERED MUTATIONS FOR THE TREATMENT OF CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-12-12 | — | — | US | disclosed |
| US-20240409597-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS | ARES CAPITAL CORPORATION, AS AGENT | 2024-12-12 | — | — | US | disclosed |
| US-20240410892-A1 | PHOTOSTABLE DETECTABLE COMPOUNDS | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-12-12 | — | — | US | disclosed |
| EP-4472740-A1 | CD38 AS A BIOMARKER AND BIOTARGET IN T-CELL LYMPHOMAS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2024-12-11 | — | — | EP | disclosed |
| US-12165743-B2 | Compressed sensing for screening and tissue imaging | THE BROAD INSTITUTE, INC. | 2024-12-10 | — | — | US | disclosed |
| WO-2024245951-A1 | COMBINATION OF SLC8A1 INHIBITOR AND MITOCHONDRIA-TARGETED ANTIOXIDANT FOR TREATING MELANOMA | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024249690-A1 | HIGH-RESOLUTION EXTRACELLULAR VESICLE MRNA ANALYSIS | BECTON, DICKINSON AND COMPANY (US) | 2024-12-05 | — | — | WO | disclosed |
| US-20240398927-A9 | NUCLEIC ACID VACCINES | MODERNATX, INC. (US) | 2024-12-05 | — | — | US | disclosed |
| WO-2024249362-A1 | RARE ANTIBODY PHAGE ISOLATION AND DISCRIMINATION (RAPID) BIOLOGICAL PANNING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-12-05 | — | — | WO | disclosed |
| US-20240390480-A1 | NUCLEIC ACID VACCINES | MODERNATX, INC. (US) | 2024-11-28 | — | — | US | disclosed |
| US-12153049-B2 | BCR-ABL variants | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-11-26 | — | — | US | disclosed |
| CN-119000153-A | Sample analysis device and use thereof | 上海宜晟生物科技有限公司 | 2024-11-22 | — | — | CN | disclosed |
| WO-2024238249-A1 | EXTRACELLULAR VESICLE PROTEIN AND NUCLEIC ACID ANALYSIS | Life Technologies Corporation (US) | 2024-11-21 | — | — | WO | disclosed |
| US-20240383170-A1 | FLEXIBLE AND SMART WOOD WITH RESPONSIVE FUNCTION, PREPARATION METHOD THEREOF AND ACTUATOR | NANJING FORESTRY UNIVERSITY (CN) | 2024-11-21 | — | — | US | disclosed |
| WO-2024236574-A1 | ESCALATING HIGH DIMENSIONAL IMAGING USING CHANNEL MULTIPLEXING AND DEEP LEARNING | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-11-21 | — | — | WO | disclosed |
| WO-2024236131-A1 | STRATIFICATE AND METHOD TO TREAT A PATIENT SUFFERING FROM A CANCER | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-11-21 | — | — | WO | disclosed |
| US-12146199-B2 | Methods and compositions for influenza a virus subtyping | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-11-19 | — | — | US | disclosed |
| US-20240377289-A1 | Rapid Bio/Chemical Assay | ESSENLIX CORPORATION (US) | 2024-11-14 | — | — | US | disclosed |
| EP-3049867-B1 | PRODUCING A SEPARATION MEDIUM USING GRAYSCALE MASK | UNIV CALIFORNIA (US) | 2024-11-13 | — | — | EP | disclosed |
| US-12140591-B2 | Compositions and methods for molecular labeling | BIO-RAD LABORATORIES, INC. (US) | 2024-11-12 | — | — | US | disclosed |
| CN-104870022-B | In vivo production of proteins | 现代泰克斯公司 | 2024-11-12 | — | — | CN | disclosed |
| US-12140590-B2 | Compositions and methods for molecular labeling | BIO-RAD LABORATORIES, INC. (US) | 2024-11-12 | — | — | US | disclosed |
| CN-118922554-A | Improved flow agent assay prior to single cell CITE-SEQ | 贝克顿迪金森公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118922544-A | EBV-associated malignancy-specific aptamer and use thereof in cancer imaging and treatment | 香港中文大学 | 2024-11-08 | — | — | CN | disclosed |
| US-20240366771-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2024-11-07 | — | — | US | disclosed |
| US-20240368261-A1 | COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION | SCHOLAR ROCK, INC. | 2024-11-07 | — | — | US | disclosed |
| US-20240369545-A1 | MULTIPLEXED PROTEOMICS ANALYSIS USING OLIGONUCLEOTIDE-CONJUGATED ANTIBODIES | BECTON, DICKINSON AND COMPANY | 2024-11-07 | — | — | US | disclosed |
| US-12135272-B2 | Multi-color flow cytometric analysis of samples with low cell numbers | BECTON, DICKINSON AND COMPANY (US) | 2024-11-05 | — | — | US | disclosed |
| US-20240359185-A1 | Dried Reagent Strainers and Methods for Making and Using the Same | BECTON, DICKINSON AND COMPANY | 2024-10-31 | — | — | US | disclosed |
| US-20240361247-A1 | ASSAY WITH AMPLIFICATION | ESSENLIX CORPORATION (US) | 2024-10-31 | — | — | US | disclosed |
| EP-4455309-A2 | METHODS FOR ANALYSING NUCLEIC ACID SEQUENCE INFORMATION USING GC BIAS, OPTIONALLY FOR DETECTING FETAL NUCLEIC ACID ABNORMALITIES | Sequenom, Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| WO-2024220380-A2 | PI3K ASSAYS AND PROBE COMPOUNDS THEREIN | TOTUS MEDICINES INC. (US) | 2024-10-24 | — | — | WO | disclosed |
| US-20240353403-A1 | Electrophoretic Bar Code Assay Devices and Methods for Making and Using the Same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-10-24 | — | — | US | disclosed |
| US-20240352079-A1 | Silk-Based Products, Formulations, and Methods of Use | COCOON BIOTECH INC. | 2024-10-24 | — | — | US | disclosed |
| EP-4448800-A1 | CLUSTERED MUTATIONS FOR THE TREATMENT OF CANCER | The Regents of the University of California (US) | 2024-10-23 | — | — | EP | disclosed |
| US-20240343826-A1 | Compositions and Methods for Targeting Cancer Stem Cells | SEAGEN INC. (US) | 2024-10-17 | — | — | US | disclosed |
| US-20240343834-A1 | Compositions and Methods for Targeting Cancer Stem Cells | SEAGEN INC. (US) | 2024-10-17 | — | — | US | disclosed |
| US-20240342279-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2024-10-17 | — | — | US | disclosed |
| EP-3495817-B1 | MOLECULAR DIAGNOSTIC SCREENING ASSAY | BIO RAD LABORATORIES INC (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-118772376-A | Radically polymerizable adhesion-promoting interlayer compositions and methods of use | PRC-迪索托国际公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-118765322-A | Reference beads for linking imaging readout and sequencing readout at single cell resolution | 贝克顿迪金森公司 | 2024-10-11 | — | — | CN | disclosed |
| US-20240336981-A1 | PANELS AND METHODS FOR DIAGNOSING AND TREATING LUNG CANCER | THE BROAD INSTITUTE, INC. (US) | 2024-10-10 | — | — | US | disclosed |
| EP-3636776-B1 | METHODS FOR ANALYSING NUCLEIC ACID SEQUENCE INFORMATION USING GC BIAS, OPTIONALLY FOR DETECTING FETAL NUCLEIC ACID ABNORMALITIES | SEQUENOM INC (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-4441252-A1 | PSILOCYBE ASSAY | Medicinal Genomics Corporation (US) | 2024-10-09 | — | — | EP | disclosed |
| US-12109274-B2 | Polynucleotides containing a stabilizing tail region | MODERNATX, INC. (US) | 2024-10-08 | — | — | US | disclosed |
| US-20240327476-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE | ARES CAPITAL CORPORATION, AS AGENT | 2024-10-03 | — | — | US | disclosed |
| US-20240327925-A1 | DETECTION OF GENE FUSIONS BY INTRAGENIC DIFFERENTIAL EXPRESSION (IDE) USING AVERAGE CYCLE THRESHOLDS | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-10-03 | — | — | US | disclosed |
| US-20240325545-A1 | Phospholipid-Flavagline Conjugates and Methods of Using the Same for Targeted Cancer Therapy | CELLECTAR BIOSCIENCES, INC. | 2024-10-03 | — | — | US | disclosed |
| EP-4437324-A1 | INTEGRATED FLOW CYTOMETRY DATA QUALITY CONTROL | Becton, Dickinson and Company (US) | 2024-10-02 | — | — | EP | disclosed |
| US-12105101-B2 | Assay for the detection of alpha-synuclein seeding activity associated with synucleinopathies | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-10-01 | — | — | US | disclosed |
| US-12104201-B2 | Engineered gyri-like mutein aptamers, and related methods | CROSSLIFE TECHNOLOGIES INC. (US) | 2024-10-01 | — | — | US | disclosed |
| US-20240316005-A1 | GENE SIGNATURES FOR PREDICTING SURVIVAL TIME IN PATIENTS SUFFERING FROM RENAL CELL CARCINOMA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2024-09-26 | — | — | US | disclosed |
| EP-4435111-A1 | DIGITAL ANALYTE ANALYSIS | Bio-Rad Laboratories, Inc. (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-3700420-B1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING | ESSENLIX CORP (US) | 2024-09-25 | — | — | EP | disclosed |
| CN-118667923-A | Universal compositions and methods for multiplex genotyping | 香港科技大学 | 2024-09-20 | — | — | CN | disclosed |
| US-20240310378-A1 | USE OF MARKERS FOUND ON LYMPH NODE METASTATIC SAMPLES FOR THE PROGNOSIS OF BREAST CANCER | Universität Zürich (CH) | 2024-09-19 | — | — | US | disclosed |
| US-20240309430-A1 | UNIVERSAL COMPOSITIONS AND METHODS FOR MULTIPLEX GENOTYPING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-09-19 | — | — | US | disclosed |
| WO-2024191684-A1 | DETECTION OF HEPATITIS C VIRUS RIBONUCLEIC ACID FROM WHOLE BLOOD USING REVERSE TRANSCRIPTION LOOP-MEDIATED ISOTHERMAL AMPLIFICATION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-09-19 | — | — | WO | disclosed |
| US-20240309369-A1 | OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN | ESSENLIX CORPORATION (US) | 2024-09-19 | — | — | US | disclosed |
| WO-2024191942-A1 | CULTURE PLATE HOLDERS AND METHODS OF USE | ONCOPRECISION CORPORATION (US) | 2024-09-19 | — | — | WO | disclosed |
| US-12091710-B2 | Systems and methods for handling microfluidic droplets | BIO-RAD LABORATORIES, INC. (US) | 2024-09-17 | — | — | US | disclosed |
| CN-118647719-A | Barcoded beads containing mRNA and ABSEQ were sorted by flow | 贝克顿迪金森公司 | 2024-09-13 | — | — | CN | disclosed |
| US-20240301508-A1 | METHODS OF DETECTING MLH1 METHYLATION | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-09-12 | — | — | US | disclosed |
| US-20240301497-A1 | METHODS FOR DIAGNOSING NASAL INTESTINAL TYPE ADENOCARCINOMAS | CENTRE HOSPITALIER ET UNIVERSITAIRE DE NANCY (CHU) (FR) | 2024-09-12 | — | — | US | disclosed |
| US-20240302380-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-09-12 | — | — | US | disclosed |
| WO-2024182293-A1 | DUAL INDEXING SPECIFIC BINDING MEMBERS FOR OBTAINING LINKED SINGLE CELL CYTOMETRIC AND SEQUENCE DATA | BECTON, DICKINSON AND COMPANY (US) | 2024-09-06 | — | — | WO | disclosed |
| WO-2024179980-A1 | NON-COVALENT BINDING PEPTIDE AND CARRIER COMPLEX COMPRISING IT | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2024-09-06 | — | — | WO | disclosed |
| WO-2024182184-A1 | DUAL INDEXING PARTICLE LABELS FOR OBTAINING LINKED SINGLE CELL CYTOMETRIC AND SEQUENCE DATA | BECTON, DICKINSON AND COMPANY (US) | 2024-09-06 | — | — | WO | disclosed |
| US-12077830-B2 | Methods for detecting norovirus | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-09-03 | — | — | US | disclosed |
| EP-4420670-A1 | NON-COVALENT BINDING PEPTIDE AND CARRIER COMPLEX COMPRISING IT | Consejo Superior De Investigaciones Científicas (ES) | 2024-08-28 | — | — | EP | disclosed |
| US-12071663-B2 | Semi-permeable arrays for analyzing biological systems and methods of using same | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-08-27 | — | — | US | disclosed |
| US-12071620-B2 | Polynucleotides containing a morpholino linker | MODERNATX, INC. (US) | 2024-08-27 | — | — | US | disclosed |
| US-20240279726-A1 | A METHOD TO AMPLIFY AND DETECT TARGET NUCLEIC ACIDS WITH VERY HIGH SPECIFICITY AND SENSITIVITY | Obront Biotech Private Limited (IN) | 2024-08-22 | — | — | US | disclosed |
| US-20240280569-A1 | SANDWICH ASSAYS IN DROPLETS | BIO-RAD LABORATORIES, INC. | 2024-08-22 | — | — | US | disclosed |
| US-12064771-B2 | Rapid sample temperature changing for assaying | ESSENLIX CORPORATION (US) | 2024-08-20 | — | — | US | disclosed |
| CN-110998325-B | Amplification assay | 上海宜晟生物科技有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-117243963-B | Use of Remodelin and Venetoclax in the treatment of cancer | 深圳大学 | 2024-08-13 | — | — | CN | disclosed |
| US-12060412-B2 | Methods for determining spatial and temporal gene expression dynamics in single cells | THE BROAD INSTITUTE, INC. (US) | 2024-08-13 | — | — | US | disclosed |
| CN-113677992-B | Method for analyzing energy metabolism of cell population | INSERM(法国国家健康医学研究院) | 2024-08-09 | — | — | CN | disclosed |
| WO-2024163290-A1 | METHODS AND COMPOSITIONS FOR OBTAINING LINKED FUNCTIONAL AND SEQUENCE DATA FOR SINGLE CELLS | BECTON, DICKINSON AND COMPANY (US) | 2024-08-08 | — | — | WO | disclosed |
| US-12054764-B2 | High-throughput screens for exploring biological functions of microscale biological systems | THE BROAD INSTITUTE, INC. (US) | 2024-08-06 | — | — | US | disclosed |
| US-20240254564-A1 | METHODS FOR PREDICTING AND TREATING CHEMORESISTANCE IN SMALL CELL LUNG CANCER PATIENTS | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-08-01 | — | — | US | disclosed |
| US-20240253049-A1 | ASSAY USING DIFFERENT SPACING HEIGHTS | ESSENLIX CORPORATION (US) | 2024-08-01 | — | — | US | disclosed |
| EP-4406001-A1 | BASELINE RESTORATION CIRCUIT | Becton, Dickinson and Company (US) | 2024-07-31 | — | — | EP | disclosed |
| CN-116430055-B | T cell immunological state marker combination for evaluating chronic pathological state of T lymphocyte of disease and application thereof | 中南大学湘雅二医院 | 2024-07-30 | — | — | CN | disclosed |
| US-12048710-B2 | Compositions and methods for modification of biomolecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-30 | — | — | US | disclosed |
| US-20240248086-A1 | COMBINATION TREPONEMAL AND NON-TREPONEMAL SYPHILIS TEST | BIO RAD LABORATORIES INC (US) | 2024-07-25 | — | — | US | disclosed |
| US-12044603-B2 | Rapid bio/chemical assay | ESSENLIX CORPORATION (US) | 2024-07-23 | — | — | US | disclosed |
| US-20240240253-A1 | METHODS, KITS, AND SYSTEMS FOR MODULATING AND PREDICTING CHANGES IN P16, SENESCENCE, AND PHYSIOLOGICAL RESERVE | SAPERE BIO INC (US) | 2024-07-18 | — | — | US | disclosed |
| EP-4399327-A1 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | Becton, Dickinson and Company (US) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024148227-A2 | LAMP DETECTION OF AFRICAN SWINE FEVER VIRUS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2024-07-11 | — | — | WO | disclosed |
| US-20240228500-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2024-07-11 | — | — | US | disclosed |
| US-20240229137-A9 | Oligonucleotide-Comprising Cellular Component-Binding Reagents and Methods of Using the Same | BECTON, DICKINSON AND COMPANY | 2024-07-11 | — | — | US | disclosed |
| US-20240229117-A1 | MULTIPLEXED PROTEIN AND NUCLEIC ACID DETECTION METHOD WITH ROLLING CIRCLE AMPLIFICATION (RCA) ASSISTED COLOR COMBINATORIAL AND SEQUENTIAL FLUORESCENCE IN SITU HYBRIDIZATION (CCS-FISH) | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-07-11 | — | — | US | disclosed |
| EP-4396581-A1 | MULTIPLEXED PROTEOMICS ANALYSIS USING OLIGONUCLEOTIDE-CONJUGATED ANTIBODIES | Becton, Dickinson and Company (US) | 2024-07-10 | — | — | EP | disclosed |
| EP-4395657-A1 | TREATMENTS FOR ATOPIC DERMATITIS | Galderma Holding SA (CH) | 2024-07-10 | — | — | EP | disclosed |
| US-12031175-B2 | Digital analyte analysis | BIO-RAD LABORATORIES, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-12029791-B2 | Therapeutic conjugates | TOTUS MEDICINES INC. (US) | 2024-07-09 | — | — | US | disclosed |
| CN-118311267-A | Multiplex protein and nucleic acid detection methods using Rolling Circle Amplification (RCA) -assisted color combining and sequential fluorescent in situ hybridization (CCS-FISH) | 香港科技大学 | 2024-07-09 | — | — | CN | disclosed |
| US-20240218430-A1 | MLH1 METHYLATION ASSAY | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240219403-A1 | METHODS FOR INHIBITING KRAS ONCOPROTEIN THROUGH ENHANCED GTPASE ACTIVITY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-07-04 | — | — | US | disclosed |
| CN-118284952-A | Baseline restoration circuit | 贝克顿·迪金森公司 | 2024-07-02 | — | — | CN | disclosed |
| US-12023371-B2 | Terminally modified RNA | MODERNATX, INC. (US) | 2024-07-02 | — | — | US | disclosed |
| US-20240210288-A1 | Representative Diagnostics | VENTANA MED SYST INC (US) | 2024-06-27 | — | — | US | disclosed |
| WO-2024137817-A1 | MATERIALS AND METHODS FOR EVALUATION OF ANTIGEN PRESENTATION MACHINERY COMPONENTS AND USES THEREOF | VENTANA MEDICAL SYSTEMS, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| US-12018402-B2 | Methods for detecting intracranial neoplasms | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240199911-A1 | HYBRID DUAL CURE COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2024-06-20 | — | — | US | disclosed |
| CN-115244102-B | Radically polymerizable adhesion-promoting interlayer compositions and methods of use | PRC-迪索托国际公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-109804082-B | Method for detecting intracranial tumors | 奎斯特诊断投资有限责任公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20240192137-A1 | MULTI-MODE ILLUMINATION SYSTEM | ESSENLIX CORPORATION (US) | 2024-06-13 | — | — | US | disclosed |
| US-12007315-B2 | Sample collection and handling for delayed analysis | ESSENLIX CORPORATION (US) | 2024-06-11 | — | — | US | disclosed |
| CN-114058680-B | Detection of analytes by enzyme-mediated strand displacement reactions | 香港科技大学 | 2024-06-11 | — | — | CN | disclosed |
| CN-112462055-B | Device and system for analyzing a sample, in particular blood, and method for using same | 上海宜晟生物科技有限公司 | 2024-06-07 | — | — | CN | disclosed |
| WO-2024115935-A1 | METHODS FOR THE TREATMENT OF B-CELL LYMPHOMA USING CD39 INHIBITORS | INSERM (FR) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024118504-A1 | ASSESSING RISK FOR MULTIPLE MYELOMA PRECURSOR DISEASE PROGRESSION | THE BROAD INSTITUTE, INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| US-20240185950-A1 | DIGITAL ANALYSIS OF NUCLEIC ACID MODIFICATION | BIO-RAD LABORATORIES, INC. | 2024-06-06 | — | — | US | disclosed |
| EP-4377473-A2 | DETECTION OF GENETIC VARIANTS | Bio-Rad Laboratories, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| US-12000836-B2 | Methods for quantitating extra-cellular vesicle surface markers, and compositions for practicing the same | BECTON, DICKINSON AND COMPANY (US) | 2024-06-04 | — | — | US | disclosed |
| CN-118140146-A | Multi-sample analysis device | ESSENLIX 公司 | 2024-06-04 | — | — | CN | disclosed |
| US-20240175801-A1 | OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN | ESSENLIX CORPORATION (US) | 2024-05-30 | — | — | US | disclosed |
| EP-3580565-B1 | ASSAY USING DIFFERENT SPACING HEIGHTS | ESSENLIX CORP (US) | 2024-05-29 | — | — | EP | disclosed |
| US-11993820-B2 | Methods of detecting MLH1 methylation | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-05-28 | — | — | US | disclosed |
| US-11996168-B2 | Systems and methods for determining relative abundances of biomolecules | THE BROAD INSTITUTE, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-11992844-B2 | Dried reagent strainers and methods for making and using the same | BECTON, DICKINSON AND COMPANY (US) | 2024-05-28 | — | — | US | disclosed |
| CN-111433606-B | Determination with different pitch heights | 上海宜晟生物科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-113767315-B | Multi-mode lighting system | 上海宜晟生物科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20240165267-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | ARES CAPITAL CORPORATION, AS AGENT | 2024-05-23 | — | — | US | disclosed |
| EP-4370900-A1 | METHODS FOR DETERMINING A PHOTODETECTOR GAIN CORRECTION FACTOR FOR OPTICAL SIGNALS IN A FLOW CYTOMETER | Becton, Dickinson and Company (US) | 2024-05-22 | — | — | EP | disclosed |
| US-11988658-B2 | Methods of assessing cellular breast samples and compositions for use in practicing the same | INCELLDX, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-20240159760-A1 | METHOD FOR DIAGNOSING PANCREATIC CANCER | INST NAT SANTE RECH MED (FR) | 2024-05-16 | — | — | US | disclosed |
| US-20240156945-A1 | HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIGENS AND EPITOPES AND PROTEINS THAT BIND THERETO | COTROPIA JOSEPH (US) | 2024-05-16 | — | — | US | disclosed |
| US-20240159999-A1 | Optics, Device, and System for Assaying and Imaging | ESSENLIX CORPORATION (US) | 2024-05-16 | — | — | US | disclosed |
| US-20240158861-A1 | METHODS AND COMPOSITIONS FOR TREATING CELL SENESCENCE ACCUMULATION RELATED DISEASE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-05-16 | — | — | US | disclosed |
| WO-2024103018-A2 | METHODS FOR PREDICTING CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM USING CIRCULATING TUMOR DNA | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-05-16 | — | — | WO | disclosed |
| EP-4367269-A1 | GENE SIGNATURES FOR PREDICTING SURVIVAL TIME IN PATIENTS SUFFERING FROM RENAL CELL CARCINOMA | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2024-05-15 | — | — | EP | disclosed |
| CN-113736858-B | Real-time monitoring method for nucleic acid amplicon mediated by cyclic oligonucleotide probe | 香港科技大学 | 2024-05-10 | — | — | CN | disclosed |
| US-20240150813-A1 | MANIPULATING DROPLET SIZE | BIO-RAD LABORATORIES, INC. | 2024-05-09 | — | — | US | disclosed |
| US-20240150839-A1 | METHODS FOR PREDICTING RESPONSIVENESS OF PROSTATE CANCER PATIENTS TO PARP INHIBITORS | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-05-09 | — | — | US | disclosed |
| US-20240151736-A1 | Apparatus for Multiple Sample Analysis | ESSENLIX CORPORATION (US) | 2024-05-09 | — | — | US | disclosed |
| CN-117999035-A | Treatment of atopic dermatitis | 高德美控股有限公司 | 2024-05-07 | — | — | CN | disclosed |
| US-20240141413-A1 | AMPLICON-FREE CRISPR-BASED ONE-POT DETECTION WITH LOOP-MEDIATED ISOTHERMAL AMPLIFICATION FOR POINT-OF-CARE DIAGNOSIS OF VIRAL PATHOGENS | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-05-02 | — | — | US | disclosed |
| CN-117947211-A | One-pot detection based on amplicon-free CRISPR using loop-mediated isothermal amplification for immediate diagnosis of viral pathogens | 香港科技大学 | 2024-04-30 | — | — | CN | disclosed |
| CN-117940580-A | Detection of genetic variants | 生物辐射实验室股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20240132948-A1 | Cyanine Dyes | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2024-04-25 | — | — | US | disclosed |
| US-20240132752-A1 | COMPOSITIONS CONTAINING A FREE RADICAL POLYMERIZATION INITIATOR | PRC-DESOTO INTERNATIONAL, INC. (US) | 2024-04-25 | — | — | US | disclosed |
| US-20240132939-A1 | DIGITAL ANALYTE ANALYSIS | BIO-RAD LABORATORIES, INC. | 2024-04-25 | — | — | US | disclosed |
| US-20240131193-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS | ARES CAPITAL CORPORATION, AS AGENT | 2024-04-25 | — | — | US | disclosed |
| US-20240132961-A1 | Oligonucleotide-Comprising Cellular Component-Binding Reagents and Methods of Using the Same | BECTON DICKINSON CO (US) | 2024-04-25 | — | — | US | disclosed |
| WO-2024086770-A2 | COMPOSITIONS AND METHODS FOR ASSESSING NEUROINFLAMMATION USING SOMATIC MUTATIONS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2024-04-25 | — | — | WO | disclosed |
| EP-4355908-A1 | A METHOD TO AMPLIFY AND DETECT TARGET NUCLEIC ACIDS WITH VERY HIGH SPECIFICITY AND SENSITIVITY | Obront Biotech Private Limited (IN) | 2024-04-24 | — | — | EP | disclosed |
| US-11965204-B2 | Detection of analytes by enzyme-mediated strand displacement reactions | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-04-23 | — | — | US | disclosed |
| US-11965877-B2 | Compositions and methods for molecular labeling | BIO-RAD LABORATORIES, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| US-11965208-B2 | Methods of associating phenotypical data and single cell sequencing data | BECTON, DICKINSON AND COMPANY (US) | 2024-04-23 | — | — | US | disclosed |
| US-11965212-B2 | Nucleic acid detection combining amplification with fragmentation | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-04-23 | — | — | US | disclosed |
| CN-117917998-A | Method for determining a photo-detector gain correction factor for an optical signal in a flow cytometer | 贝克顿·迪金森公司 | 2024-04-23 | — | — | CN | disclosed |
| US-20240123035-A1 | MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS | ARES CAPITAL CORPORATION, AS AGENT | 2024-04-18 | — | — | US | disclosed |
| US-20240123054-A1 | CORONAVIRUS ANTIGENS AND EPITOPES AND PROTEINS THAT BIND THERETO | COTROPIA JOSEPH (US) | 2024-04-18 | — | — | US | disclosed |
| US-20240123091-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES, INC. | 2024-04-18 | — | — | US | disclosed |
| CN-117897613-A | Multiplex proteomic analysis using oligonucleotide conjugated antibodies | 贝克顿迪金森公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11959838-B2 | Representative diagnostics | VENTANA MEDICAL SYSTEMS, INC. (US) | 2024-04-16 | — | — | US | disclosed |
| US-11952373-B2 | Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) interaction inhibitor maraviroc | INCELLDX, INC. (US) | 2024-04-09 | — | — | US | disclosed |
| EP-3420102-B1 | METHODS FOR IDENTIFYING AND MODULATING IMMUNE PHENOTYPES | MASSACHUSETTS INST TECHNOLOGY (US) | 2024-04-03 | — | — | EP | disclosed |
| US-11946929-B2 | Sandwich assays in droplets | BIO-RAD LABORATORIES, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| US-11944706-B2 | Hybridosomes, compositions comprising the same, processes for their production and uses thereof | ANJARIUM BIOSCIENCES AG (CH) | 2024-04-02 | — | — | US | disclosed |
| US-20240102996-A1 | Methods and Systems for Providing Labelled Biomolecules | BECTON, DICKINSON AND COMPANY | 2024-03-28 | — | — | US | disclosed |
| WO-2024064766-A2 | METHODS FOR TREATMENT SELECTION FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | THE BROAD INSTITUTE, INC. (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024061930-A1 | NEW METHOD TO TREAT AND DIAGNOSE PERIPHERAL T-CELL LYMPHOMA (PTCL) | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-03-28 | — | — | WO | disclosed |
| EP-4341428-A1 | METHODS FOR PERFORMING DIGITAL PCR | Fluent Biosciences Inc. (US) | 2024-03-27 | — | — | EP | disclosed |
| US-11940382-B2 | Assay with amplification | ESSENLIX CORPORATION (US) | 2024-03-26 | — | — | US | disclosed |
| CN-117769643-A | Rapid pathological or cytological examinations, in particular without flushing | 上海宜晟生物科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20240093272-A1 | CAS12 DETECTION METHODS AND COMPOSITIONS | THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) | 2024-03-21 | — | — | US | disclosed |
| US-20240093271-A1 | DIGITAL ANALYTE ANALYSIS | BIO-RAD LABORATORIES, INC. | 2024-03-21 | — | — | US | disclosed |
| EP-4337932-A1 | SYSTEMS FOR DETECTING LIGHT BY BIREFRINGENT FOURIER TRANSFORM INTERFEROMETRY AND METHODS FOR USING SAME | Becton, Dickinson and Company (US) | 2024-03-20 | — | — | EP | disclosed |
| EP-4337933-A1 | SYSTEMS FOR DETECTING LIGHT BY SPECTRAL DISCRIMINATION AND METHODS FOR USING SAME | Becton, Dickinson and Company (US) | 2024-03-20 | — | — | EP | disclosed |
| US-11935629-B2 | Methods for flow cytometry panel design based on modeling and minimizing spillover spreading, and systems for practicing the same | BECTON, DICKINSON AND COMPANY (US) | 2024-03-19 | — | — | US | disclosed |
| US-20240083953-A1 | Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION | 2024-03-14 | — | — | US | disclosed |
| US-20240084395-A1 | SINGLE-STRANDED OLIGONUCLEOTIDE PROBES FOR CHROMOSOME OR GENE COPY ENUMERATION | VENTANA MED SYST INC (US) | 2024-03-14 | — | — | US | disclosed |
| US-11927533-B2 | Multi-mode illumination system | ESSENLIX CORPORATION (US) | 2024-03-12 | — | — | US | disclosed |
| US-20240076654-A1 | AUTOMATED METHODS FOR SCALABLE, PARALLELIZED ENZYMATIC BIOPOLYMER SYNTHESIS AND MODIFICATION USING MICROFLUIDIC DEVICES | U.S. DEPARTMENT OF ENERGY | 2024-03-07 | — | — | US | disclosed |
| US-20240077485-A1 | Methods of Assaying Neoplastic and Neoplasia-Related Cells and Uses Thereof | INCELLDX, INC. | 2024-03-07 | — | — | US | disclosed |
| US-20240076736-A1 | COMPOSITIONS AND METHODS FOR CHARACTERIZING POLYNUCLEOTIDE SEQUENCE ALTERATIONS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2024-03-07 | — | — | US | disclosed |
| EP-4330421-A1 | COMPOSITIONS AND METHODS FOR CHARACTERIZING POLYNUCLEOTIDE SEQUENCE ALTERATIONS | The Brigham and Women's Hospital, Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-117642619-A | System for detecting light by adopting spectrum identification method and using method thereof | 贝克顿·迪金森公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-110913903-B | Glycan interaction compounds and methods of use | 思进股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-20240069019-A1 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | BECTON, DICKINSON AND COMPANY | 2024-02-29 | — | — | US | disclosed |
| EP-4326903-A1 | METHODS AND COMPOSITIONS FOR TREATING CELL SENESCENCE ACCUMULATION RELATED DISEASE | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2024-02-28 | — | — | EP | disclosed |
| US-11913954-B2 | Combination treponemal and non-treponemal syphilis test | BIO-RAD LABORATORIES, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11913079-B2 | Detection of gene fusions by intragenic differential expression (ide) using average cycle thresholds | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-02-27 | — | — | US | disclosed |
| CN-117616265-A | System for detecting light by adopting double refraction Fourier transform interferometry and using method thereof | 贝克顿·迪金森公司 | 2024-02-27 | — | — | CN | disclosed |
| US-11904310-B2 | High-throughput dynamic reagent delivery system | THE BROAD INSTITUTE, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| US-11906530-B2 | Methods for the detection of tau protein aggregates | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-02-20 | — | — | US | disclosed |
| EP-4320439-A1 | IMMUNOASSAY FOR SARS-COV-2 AND MATERIALS THEREFOR | Bio-Rad Laboratories, Inc. (US) | 2024-02-14 | — | — | EP | disclosed |
| US-11901041-B2 | Digital analysis of nucleic acid modification | BIO-RAD LABORATORIES, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| US-11898193-B2 | Manipulating droplet size | BIO-RAD LABORATORIES, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| US-20240044901-A1 | NEW METHOD TO PRONOSTIC LUNG CANCER | SORBONNE UNIVERSITE (FR) | 2024-02-08 | — | — | US | disclosed |
| US-20240041998-A1 | METHODS AND COMPOSITIONS FOR SENSITIZING PRC2 MUTANT TUMORS TO IMMUNE CHECKPOINT BLOCKADE THERAPY | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-02-08 | — | — | US | disclosed |
| WO-2024030288-A1 | METHODS FOR DETERMINING PARTICLE POSITIONAL INFORMATION IN A FLOW CYTOMETER CORE STREAM AND SYSTEMS FOR SAME | BECTON, DICKINSON AND COMPANY (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20240044769-A1 | METHODS FOR DETERMINING PARTICLE POSITIONAL INFORMATION IN A FLOW CYTOMETER CORE STREAM AND SYSTEMS FOR SAME | BECTON, DICKINSON AND COMPANY | 2024-02-08 | — | — | US | disclosed |
| EP-4314115-A1 | HYBRID DUAL CURE COMPOSITIONS | PRC-Desoto International, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117512080-A | Multiplexing using microparticles in dispensing | 生物-拉德实验室公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117487811-A | Compositions and methods for treating complications and diseases associated with von willebrand factor | 邦德治疗有限公司 | 2024-02-02 | — | — | CN | disclosed |
| US-20240035953-A1 | MULTILAYER ANALYSIS OF SINGLE CELLS | Teracyte Ltd. (IL) | 2024-02-01 | — | — | US | disclosed |
| US-20240035092-A1 | METHODS, KITS, AND SYSTEMS FOR PREDICTING PATIENT OUTCOMES | SAPERE BIO, INC. | 2024-02-01 | — | — | US | disclosed |
| US-11883824-B2 | Assay using different spacing heights | ESSENLIX CORPORATION (US) | 2024-01-30 | — | — | US | disclosed |
| US-11885952-B2 | Optics, device, and system for assaying and imaging | ESSENLIX CORPORATION (US) | 2024-01-30 | — | — | US | disclosed |
| EP-3446118-B1 | MULTIPLEX POLYMERIC DYE DEVICES AND METHODS FOR USING THE SAME | BECTON DICKINSON CO (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-4308934-A1 | METHOD FOR DIAGNOSING PANCREATIC CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2024-01-24 | — | — | EP | disclosed |
| EP-4308588-A1 | HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIGENS AND EPITOPES AND PROTEINS THAT BIND THERETO | Cotropia, Joseph (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-4308121-A1 | THERAPEUTIC CONJUGATES | Totus Medicines Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20240019447-A1 | Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19 | INCELLDX, INC. | 2024-01-18 | — | — | US | disclosed |
| US-20240019434-A1 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | CELLULAR RESEARCH, INC. | 2024-01-18 | — | — | US | disclosed |
| US-20240011977-A1 | TISSUE PROCESSING | APPLIKATE TECHNOLOGIES, INC. | 2024-01-11 | — | — | US | disclosed |
| US-20240011094-A1 | METHODS FOR DIAGNOSIS AND TREATING POLYCYSTIC OVARY SYNDROME (PCOS) | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE (FR) | 2024-01-11 | — | — | US | disclosed |
| US-20240011091-A1 | METHODS FOR PREVENTING OR REDUCING ACUTE KIDNEY INJURY | SAPERE BIO INC (US) | 2024-01-11 | — | — | US | disclosed |
| US-20240009306-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2024-01-11 | — | — | US | disclosed |
| US-20240011908-A1 | Rapid Pathology or Cytology, Particularly Without Wash | ESSENLIX CORPORATION (US) | 2024-01-11 | — | — | US | disclosed |
| US-20240011974-A1 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | BIO-RAD LABORATORIES, INC. | 2024-01-11 | — | — | US | disclosed |
| WO-2024011121-A2 | TISSUE PROCESSING | APPLIKATE TECHNOLOGIES, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| EP-3500686-B1 | METHODS FOR DETECTING CRANIOPHARYNGIOMA AND FOR SELECTING MEDICAMENTS AND PATIENTS FOR TREATMENT | QUEST DIAGNOSTICS INVEST LLC (US) | 2024-01-10 | — | — | EP | disclosed |
| US-11865192-B2 | Modified wound dressings | CONVATEC TECHNOLOGIES, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| US-11866506-B2 | Anti-CD59 antibodies | MELLITUS, LLC (US) | 2024-01-09 | — | — | US | disclosed |
| WO-2024006762-A1 | NUCLEIC ACID PROBES AND THEIR USES FOR THE DETECTION OF PREVOTELLA BIVIA | THE UAB RESEARCH FOUNDATION (US) | 2024-01-04 | — | — | WO | disclosed |
| US-20240003889-A1 | Compositions and Methods for Targeting Cancer Stem Cells | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20240000962-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20240002422-A1 | Glycan Analysis and Profiling | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20240002537-A1 | Compositions and Methods for Targeting Cancer Stem Cells | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20240002910-A1 | DIGITAL ANALYTE ANALYSIS | BIO-RAD LABORATORIES, INC. | 2024-01-04 | — | — | US | disclosed |
| WO-2024003311-A1 | METHOD FOR ADHERING A POLY(DA/DT) TAIL TO A DNA BACKBONE | QUANTOOM BIOSCIENCES FRANCE SAS (FR) | 2024-01-04 | — | — | WO | disclosed |
| EP-4300099-A2 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | Becton, Dickinson and Company (US) | 2024-01-03 | — | — | EP | disclosed |
| US-11860159-B2 | Methods and systems for providing labelled biomolecules | BECTON, DICKINSON AND COMPANY (US) | 2024-01-02 | — | — | US | disclosed |
| WO-2023249714-A1 | THERAPEUTIC COMPOSITIONS AND METHODS FOR ACTIVATING DOUBLE STRANDED RNA RESPONSE IN CANCER PATIENTS VIA DNMT1 TARGETED THERAPY | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023247567-A1 | NEW BIOMARKERS OF ALCOHOL USE DISORDERS | Institut National de la Santé et de la Recherche Médicale (FR) | 2023-12-28 | — | — | WO | disclosed |
| EP-4296370-A2 | METHOD TO DETECT REPEAT SEQUENCE MOTIFS IN NUCLEIC ACID | Quest Diagnostics Investments Incorporated (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-4294856-A1 | COMPOSITIONS CONTAINING A FREE RADICAL POLYMERIZATION INITIATOR | PRC-Desoto International, Inc. (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-4294833-A2 | CORONA VIRUS ANTIGENS AND EPITOPES AND PROTEINS THAT BIND THERETO | Cotropia, Joseph (US) | 2023-12-27 | — | — | EP | disclosed |
| US-11851651-B2 | Automated methods for scalable, parallelized enzymatic biopolymer synthesis and modification using microfluidic devices | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-12-26 | — | — | US | disclosed |
| US-20230405135-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC (US) | 2023-12-21 | — | — | US | disclosed |
| US-20230408505-A1 | SANDWICH ASSAYS IN DROPLETS | BIO-RAD LABORATORIES, INC. | 2023-12-21 | — | — | US | disclosed |
| EP-4291685-A1 | ASSAYS FOR THE DETECTION OF SARS-COV-2 MUTANTS | Procomcure Biotech GmbH (AT) | 2023-12-20 | — | — | EP | disclosed |
| EP-4291897-A1 | NEW METHOD TO PRONOSTIC LUNG CANCER | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2023-12-20 | — | — | EP | disclosed |
| EP-4291901-A1 | USE OF MARKERS FOUND ON LYMPH NODE METASTATIC SAMPLES FOR THE PROGNOSIS OF BREAST CANCER | Universität Zürich (CH) | 2023-12-20 | — | — | EP | disclosed |
| US-11846582-B2 | Optical transmission sample holder and analysis, particularly for hemoglobin | ESSENLIX CORPORATION (US) | 2023-12-19 | — | — | US | disclosed |
| CN-112272556-B | Phospholipid-flavagline conjugates and methods for their use in targeted cancer therapy | 塞勒科塔生物科学公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-117243963-A | Application of Remodelin and Venetoclax in treating cancer | 深圳大学总医院 | 2023-12-19 | — | — | CN | disclosed |
| WO-2023239730-A1 | SYSTEMS FOR RECONSTITUTING DRIED REAGENT COMPOSITIONS AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2023-12-14 | — | — | WO | disclosed |
| US-20230398546-A1 | SYSTEMS FOR RECONSTITUTING DRIED REAGENT COMPOSITIONS AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY | 2023-12-14 | — | — | US | disclosed |
| EP-3359558-B1 | BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR | BIO RAD LABORATORIES INC (US) | 2023-12-13 | — | — | EP | disclosed |
| CN-117222692-A | Mixed dual cure composition | PRC-迪索托国际公司 | 2023-12-12 | — | — | CN | disclosed |
| US-11840726-B2 | MLH1 methylation assay | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2023-12-12 | — | — | US | disclosed |
| CN-117180836-A | Dry reagent filter screens and methods of making and using the same | 贝克顿·迪金森公司 | 2023-12-08 | — | — | CN | disclosed |
| WO-2023235392-A1 | ELECTROPHORESIS-MEDIATED CHARACTERIZATION OF DNA CONTENT OF ADENO-ASSOCIATED VIRUS CAPSIDS | PERKINELMER HEALTH SCIENCES, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| US-20230392213-A1 | COMPOSITIONS AND METHODS FOR TUMOR CHARACTERIZATION | THE GENERAL HOSPITAL CORPORATION (US) | 2023-12-07 | — | — | US | disclosed |
| US-20230392188-A1 | ELECTROPHORESIS-MEDIATED CHARACTERIZATION OF DNA CONTENT OF ADENO-ASSOCIATED VIRUS CAPSIDS | REVVITY HEALTH SCIENCES, INC. | 2023-12-07 | — | — | US | disclosed |
| EP-4284554-A1 | CONTAINER WITH DRIED REAGENT COMPOSITION AND METHODS FOR USING THE SAME | Becton, Dickinson and Company (US) | 2023-12-06 | — | — | EP | disclosed |
| US-11834715-B2 | Oligonucleotide-comprising cellular component-binding reagents and methods of using the same | BECTON, DICKINSON AND COMPANY (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230383350-A1 | METHOD FOR PREDICTING THE RESPONSE TO TNF INHIBITORS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2023-11-30 | — | — | US | disclosed |
| WO-2023229811-A1 | LINEAR VARIABLE OPTICAL FILTER SYSTEMS FOR FLOW CYTOMETRY AND METHODS FOR USING SAME | BECTON, DICKINSON AND COMPANY (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20230384204-A1 | Linear Variable Optical Filter Systems for Flow Cytometry and Methods for Using the Same | BECTON, DICKINSON AND COMPANY | 2023-11-30 | — | — | US | disclosed |
| EP-4281751-A1 | METHOD AND SYSTEMS FOR DETERMING DROP DELAY USING SCATTER SIGNALS ACROSS SPATIALLY SEPARATED LASERS | Becton, Dickinson and Company (US) | 2023-11-29 | — | — | EP | disclosed |
| US-11827698-B2 | Compositions and methods for growth factor modulation | SCHOLAR ROCK, INC. (US) | 2023-11-28 | — | — | US | disclosed |
| CN-117120824-A | Method and system for determining drop delay using scattered signals of spatially separated lasers | 贝克顿·迪金森公司 | 2023-11-24 | — | — | CN | disclosed |
| WO-2023224949-A1 | COMPOSITIONS AND METHODS RELATING TO LOOP MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) | PERKINELMER U.S. LLC (US) | 2023-11-23 | — | — | WO | disclosed |
| US-11820795-B2 | Desmoglein 2 (DSG2) binding proteins and uses therefor | UNIVERSITY OF WASHINGTON (US) | 2023-11-21 | — | — | US | disclosed |
| US-20230364018-A1 | SYSTEMS FOR VACUUM MEDIATED LIPOSOME PREPARATION, AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY | 2023-11-16 | — | — | US | disclosed |
| WO-2023219758-A1 | SYSTEMS FOR VACUUM MEDIATED LIPOSOME PREPARATION, AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2023-11-16 | — | — | WO | disclosed |
| US-20230366038-A1 | COMPOSITIONS AND METHODS RELATING TO LOOP MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) | PERKINELMER U.S. LLC | 2023-11-16 | — | — | US | disclosed |
| CN-110520128-B | Compositions and methods for treating complications and diseases associated with von Willebrand Factor | 邦德治疗有限公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-117043234-A | Composition containing radical polymerization initiator | PRC-迪索托国际公司 | 2023-11-10 | — | — | CN | disclosed |
| US-20230357860-A1 | METHOD TO TREAT AND STRATIFICATE A PATIENT SUFFERING FROM A CANCER | INST NAT SANTE RECH MED (FR) | 2023-11-09 | — | — | US | disclosed |
| WO-2023215278-A1 | MODIFIED IMMUNE CELLS AND METHODS FOR USE THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| US-20230356211-A1 | DEVICES FOR SAMPLE ANALYSIS USING EPITACHOPHORESIS | Roche Sequencing Solutions, Inc. | 2023-11-09 | — | — | US | disclosed |
| US-11807877-B1 | CRISPR/Cas activity assays and compositions thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2023-11-07 | — | — | US | disclosed |
| CN-111656179-B | Device for sample analysis using epitope electrophoresis | 豪夫迈·罗氏有限公司 | 2023-11-03 | — | — | CN | disclosed |
| US-20230348899-A1 | SINGLE CELL SEQUENCING LIBRARIES OF GENOMIC TRANSCRIPT REGIONS OF INTEREST IN PROXIMITY TO BARCODES, AND GENOTYPING OF SAID LIBRARIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-11-02 | — | — | US | disclosed |
| EP-3415641-B1 | METHOD FOR ANALYSIS OF MOLECULES | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2023-11-01 | — | — | EP | disclosed |
| US-11802317-B2 | Kits for detecting Mycobacterium avium/intracellulare nucleic acid | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2023-10-31 | — | — | US | disclosed |
| WO-2023202612-A1 | THE IDENTIFICATION OF ENDOMETRIAL IMMUNE CELL DENSITIES AND CLUSTERING ANALYSIS IN THE MID-LUTEAL PHASE AS PREDICTOR FOR PREGNANCY OUTCOMES | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023205018-A1 | HIGH-THROUGHPUT FLOW CYTOMETRY ANALYSIS OF HIGHLY MULTIPLEXED SAMPLES USING SAMPLE INDEXING WITH SPECIFIC BINDING MEMBER-FLUOR CONJUGATES | BECTON, DICKINSON AND COMPANY (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20230338493-A1 | DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING BETA-GLUCAN AS A VACCINE ADJUVANT | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230340559-A1 | DEVICES AND METHODS FOR EXAMINING DRUG EFFECTS ON MICROORGANISMS | ESSENLIX CORPORATION (US) | 2023-10-26 | — | — | US | disclosed |
| EP-4264280-A1 | METHODS OF ASSIGNING A COVID PATHOLOGICAL TYPE AND COMPOSITIONS FOR PRACTICING THE SAME, AND METHODS OF TREATING A SUBJECT FOR CHRONIC COVID-19 | IncellDx, Inc. (US) | 2023-10-25 | — | — | EP | disclosed |
| US-11796538-B2 | Sample collection, holding and assaying | ESSENLIX CORPORATION (US) | 2023-10-24 | — | — | US | disclosed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | disclosed |
| US-20230331868-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230332209-A1 | QUENCHER AND USE THEREOF | SFC CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230332246-A1 | METHODS FOR CHARACTERIZING BIOLOGICAL SAMPLES | THE GENERAL HOSPITAL CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230333105-A1 | HIGH-THROUGHPUT FLOW CYTOMETRY ANALYSIS OF HIGHLY MULTIPLEXED SAMPLES USING SAMPLE INDEXING WITH SPECIFIC BINDING MEMBER-FLUOR CONJUGATES | BECTON, DICKINSON AND COMPANY | 2023-10-19 | — | — | US | disclosed |
| EP-4260063-A1 | MULTIPLEXED SINGLE CELL IMMUNOASSAY | Becton, Dickinson and Company (US) | 2023-10-18 | — | — | EP | disclosed |
| US-11788149-B2 | Single-stranded oligonucleotide probes for chromosome or gene copy enumeration | VENTANA MEDICAL SYSTEMS, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230323344-A1 | POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER | ARES CAPITAL CORPORATION, AS AGENT | 2023-10-12 | — | — | US | disclosed |
| EP-4256043-A1 | CAS12 DETECTION METHODS AND COMPOSITIONS | The New Zealand Institute for Plant and Food Research Limited (NZ) | 2023-10-11 | — | — | EP | disclosed |
| CN-116868045-A | Integrated flow cytometry data quality control | 贝克顿·迪金森公司 | 2023-10-10 | — | — | CN | disclosed |
| US-11782059-B2 | Measurement of protein expression using reagents with barcoded oligonucleotide sequences | BECTON, DICKINSON AND COMPANY (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230313277-A1 | QUENCHER AND USE THEREOF | SFC CO., LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| EP-3341724-B1 | DEVICE AND SYSTEM FOR COLLECTING AND ANALYZING VAPOR CONDENSATE, PARTICULARLY EXHALED BREATH CONDENSATE, AS WELL AS METHOD OF USING THE SAME | ESSENLIX CORP (US) | 2023-10-04 | — | — | EP | disclosed |
| US-11771769-B2 | Ocular applications of silk-based products | COCOON BIOTECH INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-11768198-B2 | Compositions and methods for molecular labeling | BIO-RAD LABORATORIES, INC. (US) | 2023-09-26 | — | — | US | disclosed |
| CN-116801983-A | Container with dry reagent composition and method of use thereof | 贝克顿·迪金森公司 | 2023-09-22 | — | — | CN | disclosed |
| US-20230296595-A1 | Homogenous Assay Device and Apparatus | ESSENLIX CORPORATION (US) | 2023-09-21 | — | — | US | disclosed |
| EP-3436012-B1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC (US) | 2023-09-20 | — | — | EP | disclosed |
| US-11761031-B2 | Method for real time monitoring of nucleic acid amplicons mediated by loop oligonucleotide probes | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-09-19 | — | — | US | disclosed |
| US-20230287510-A1 | COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA | THE BROAD INSTITUTE, INC. (US) | 2023-09-14 | — | — | US | disclosed |
| WO-2023172977-A1 | MODIFIED FLOW PROXY ASSAY PRIOR TO SINGLE-CELL CITE-SEQ | BECTON, DICKINSON AND COMPANY (US) | 2023-09-14 | — | — | WO | disclosed |
| US-20230288314-A1 | APPARATUS AND METHODS FOR RAPID DETECTION OF ACUTE PHASE REACTANTS AND WHITE BLOOD CELLS | ESSENLIX CORPORATION (US) | 2023-09-14 | — | — | US | disclosed |
| EP-4240874-A1 | METHODS FOR DIAGNOSIS AND TREATING POLYCYSTIC OVARY SYNDROME (PCOS) | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2023-09-13 | — | — | EP | disclosed |
| CN-113477149-B | Microfluidic devices and methods of making and using the same | 贝克顿·迪金森公司 | 2023-09-12 | — | — | CN | disclosed |
| US-20230280337-A1 | SANDWICH ASSAYS IN DROPLETS | BIO-RAD LABORATORIES, INC. | 2023-09-07 | — | — | US | disclosed |
| US-20230279513-A1 | METHODS FOR DETECTING NOROVIRUS | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2023-09-07 | — | — | US | disclosed |
| EP-3822363-B1 | METHOD TO DETECT REPEAT SEQUENCE MOTIFS IN NUCLEIC ACID | QUEST DIAGNOSTICS INVEST INC (US) | 2023-09-06 | — | — | EP | disclosed |
| US-11747327-B2 | Compositions and methods for molecular labeling | BIO-RAD LABORATORIES, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| EP-4232603-A1 | METHOD FOR PREDICTING THE RESPONSE TO TNF INHIBITORS | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2023-08-30 | — | — | EP | disclosed |
| US-11740238-B2 | Compositions and methods of detecting a substance of interest | PIONEER HI-BRED INTERNATIONAL, INC. | 2023-08-29 | — | — | US | disclosed |
| US-11740240-B2 | Immunoassay for SARS-CoV-2 neutralizing antibodies and materials therefor | BIO-RAD LABORATORIES, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-20230265510-A1 | METHOD TO DETECT REPEAT SEQUENCE MOTIFS IN NUCLEIC ACID | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2023-08-24 | — | — | US | disclosed |
| US-20230263859-A1 | SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE | COCOON BIOTECH, INC. | 2023-08-24 | — | — | US | disclosed |
| US-20230266321-A1 | LIVE CELL ENGAGEMENT ASSAY | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-08-24 | — | — | US | disclosed |
| US-20230266306-A1 | ENHANCED CHEMILUMINESCENT ENZYME-LINKED IMMUNOSORBENT ASSAY FOR DETECTION OF ANTIBODIES AGAINST BABESIA MICROTI | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-08-24 | — | — | US | disclosed |
| US-11732257-B2 | Single cell sequencing libraries of genomic transcript regions of interest in proximity to barcodes, and genotyping of said libraries | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-08-22 | — | — | US | disclosed |
| WO-2023154694-A1 | REFERENCE BEADS FOR LINKING IMAGING AND SEQUENCING READOUTS WITH SINGLE-CELL RESOLUTION | BECTON, DICKINSON AND COMPANY (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20230257587-A1 | FLUORENYL CYANINE DYES | BIOTIUM, INC. | 2023-08-17 | — | — | US | disclosed |
| WO-2023152133-A1 | METHOD FOR DIAGNOSING COLORECTAL CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-08-17 | — | — | WO | disclosed |
| WO-2023154936-A2 | SIMULTANEOUS CELL TAGGING METHODS | NARWHAL BIO, INC. (US) | 2023-08-17 | — | — | WO | disclosed |
| EP-3516400-B1 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | BECTON DICKINSON CO (US) | 2023-08-16 | — | — | EP | disclosed |
| EP-4226142-A1 | METHODS FOR FLOW CYTOMETRY PANEL DESIGN BASED ON MODELING AND MINIMIZING SPILLOVER SPREADING, AND SYSTEMS FOR PRACTICING THE SAME | Becton, Dickinson and Company (US) | 2023-08-16 | — | — | EP | disclosed |
| US-11723948-B2 | Method for treating and prognosing cancer | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2023-08-15 | — | — | US | disclosed |
| US-11725227-B2 | Devices and methods for examining drug effects on microorganisms | ESSENLIX CORPORATION (US) | 2023-08-15 | — | — | US | disclosed |
| US-11726089-B2 | Methods of assaying neoplastic and neoplasia-related cells and uses thereof | INCELLDX, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| WO-2023150764-A1 | SORTING OF MRNA AND ABSEQ CONTAINING BARCODED BEADS BY FLOW | BECTON, DICKINSON AND COMPANY (US) | 2023-08-10 | — | — | WO | disclosed |
| US-20230250426-A1 | METHOD FOR TREATING AND PROGNOSING CANCER LIKE GLIOBLASTOMA | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2023-08-10 | — | — | US | disclosed |
| US-11719607-B2 | Method of partial lysis and assay | HOLOGIC, INC. (US) | 2023-08-08 | — | — | US | disclosed |
| CN-116569042-A | Multiplexed single cell immunoassays | 贝克顿迪金森公司 | 2023-08-08 | — | — | CN | disclosed |
| US-20230243734-A1 | Methods for Array Binning Flow Cytometry Data and Systems for Same | BECTON, DICKINSON AND COMPANY | 2023-08-03 | — | — | US | disclosed |
| US-20230242710-A1 | Dual Cure Sealants | PRC-DESOTO INTERNATIONAL, INC. (US) | 2023-08-03 | — | — | US | disclosed |
| WO-2023144303-A1 | CD38 AS A BIOMARKER AND BIOTARGET IN T-CELL LYMPHOMAS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146623-A1 | METHODS FOR ARRAY BINNING FLOW CYTOMETRY DATA AND SYSTEMS FOR SAME | BECTON, DICKINSON AND COMPANY (US) | 2023-08-03 | — | — | WO | disclosed |
| US-20230242652-A1 | TREATMENTS FOR ATOPIC DERMATITIS | GALDERMA HOLDING S.A. (CH) | 2023-08-03 | — | — | US | disclosed |
| CN-108779460-B | Multiplexing using microparticles in dispensing | 睿恩达思技术公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-116509869-A | Treatment of extrapyramidal syndrome with trapidil | 希诺皮亚生物科学公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-116529391-A | CAS12 detection methods and compositions | 新西兰植物与食品研究所 | 2023-08-01 | — | — | CN | disclosed |
| US-20230235412-A1 | BORDETELLA DETECTION ASSAY | QUEST DIAGNOSTICS INVESTMENTS LLC | 2023-07-27 | — | — | US | disclosed |
| US-20230233608-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. (US) | 2023-07-27 | — | — | US | disclosed |
| US-20230235400-A1 | METHODS OF DETECTING MITOCHONDRIAL DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-27 | — | — | US | disclosed |
| US-11708396-B2 | Signal-sensor polynucleotides for the alteration of cellular phenotypes | MODERNATX, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| EP-4211273-A1 | METHOD TO TREAT AND STRATIFICATE A PATIENT SUFFERING FROM A CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-07-19 | — | — | EP | disclosed |
| EP-4210766-A1 | THERAPEUTIC CONJUGATES | Totus Medicines Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| CN-116430055-A | T cell immunological state marker combination for evaluating chronic pathological state of T lymphocyte of disease and application thereof | 中南大学湘雅二医院 | 2023-07-14 | — | — | CN | disclosed |
| US-20230219084-A1 | SAMPLE MANIPULATION AND ASSAY WITH RAPID TEMPERATURE CHANGE | ESSENLIX CORPORATION (US) | 2023-07-13 | — | — | US | disclosed |
| US-20230220447-A1 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | BIO-RAD LABORATORIES, INC. | 2023-07-13 | — | — | US | disclosed |
| WO-2023129460-A2 | TUMOR MHC CLASS I EXPRESSION IS ASSOCIATED WITH INTERLEUKIN-2 RESPONSE IN MELANOMA | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2023-07-06 | — | — | WO | disclosed |
| EP-2850086-B1 | HETEROARYLCYANINE DYES | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-11691141-B2 | Devices for sample analysis using epitachophoresis | Roche Sequencing Solutions, Inc. (US) | 2023-07-04 | — | — | US | disclosed |
| US-11692927-B2 | Apparatus and methods for rapid detection of acute phase reactants and white blood cells | ESSENLIX CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| CN-116373056-A | Flexible intelligent wood with responsiveness function, actuator and preparation method | 南京林业大学 | 2023-07-04 | — | — | CN | disclosed |
| US-20230201205-A1 | TREATING EXTRAPYRAMIDAL SYNDROME USING TRAPIDIL | SINOPIA BIOSCIENCES, INC. | 2023-06-29 | — | — | US | disclosed |
| WO-2023122723-A1 | PANELS AND METHODS FOR DIAGNOSING AND TREATING LUNG CANCER | THE BROAD INSTITUTE, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| US-20230194508-A1 | THERMODYNAMICALLY STABILIZED ANTIBODIES FOR DEEP IMMUNOLABELING AND TISSUE IMAGING | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2023-06-22 | — | — | US | disclosed |
| WO-2023114723-A2 | BIOMARKERS FOR DENDRITIC CELLS | PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023114231-A1 | CLUSTERED MUTATIONS FOR THE TREATMENT OF CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20230193371-A1 | QUANTITATIVE PCR-BASED ENVIRONMENTAL DNA ASSAYS | UVIC INDUSTRY PARTNERSHIPS INC. (CA) | 2023-06-22 | — | — | US | disclosed |
| US-20230181467-A1 | HYBRIDOSOMES, COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THEIR PRODUCTION AND USES THEREOF | ANJARIUM BIOSCIENCES AG (CH) | 2023-06-15 | — | — | US | disclosed |
| US-20230183786-A1 | METHODS FOR IDENTIFYING AND MODULATING CO-OCCURANT CELLULAR PHENOTYPES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-06-15 | — | — | US | disclosed |
| CN-116249902-A | SARS-CoV-2 immunoassay and material thereof | 生物辐射实验室股份有限公司 | 2023-06-09 | — | — | CN | disclosed |
| WO-2023102459-A1 | PSILOCYBE ASSAY | Medicinal Genomics Corporation (US) | 2023-06-08 | — | — | WO | disclosed |
| EP-3420348-B1 | METHOD OF DETERMINING THE RISK OF DEVELOPING ACUTE KIDNEY INJURY | SAPERE BIO INC (US) | 2023-06-07 | — | — | EP | disclosed |
| CN-116217729-A | Glycan interaction compounds and methods of use | 思进公司 | 2023-06-06 | — | — | CN | disclosed |
| WO-2023096906-A1 | INTEGRATED FLOW CYTOMETRY DATA QUALITY CONTROL | BECTON, DICKINSON AND COMPANY (US) | 2023-06-01 | — | — | WO | disclosed |
| US-20230167513-A1 | METHOS FOR RAPID DETECTION AND IDENTIFICATION OF VIRAL NUCLEIC ACIDS | NYAN DOUGBEH CHRIS (US) | 2023-06-01 | — | — | US | disclosed |
| EP-3555630-B1 | METHODS AND COMPOSITIONS FOR OBTAINING A TUBERCULOSIS ASSESSMENT IN A SUBJECT | BECTON DICKINSON CO (US) | 2023-05-31 | — | — | EP | disclosed |
| US-20230158030-A1 | METHODS AND COMPOSITION FOR TREATMENT OF COVID-19 ILLNESS REQUIRING HOSPITALIZATION | OHIO STATE INNOVATION FOUNDATION (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230160807-A1 | Integrated Flow Cytometry Data Quality Control | BECTON, DICKINSON AND COMPANY | 2023-05-25 | — | — | US | disclosed |
| WO-2023089159-A1 | NEW STRATEGY TARGETING STROMA/TUMOR CELL CROSSTALK TO TREAT A CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-05-25 | — | — | WO | disclosed |
| EP-4182687-A2 | IMMUNOASSAY FOR SARS-COV-2 NEUTRALIZING ANTIBODIES AND MATERIALS THEREFOR | Bio-Rad Laboratories, Inc. (US) | 2023-05-24 | — | — | EP | disclosed |
| EP-4183806-A2 | GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE | Seagen Inc. (US) | 2023-05-24 | — | — | EP | disclosed |
| US-11655340-B2 | Dual cure sealants | PRC-DESOTO INTERNATIONAL, INC. (US) | 2023-05-23 | — | — | US | disclosed |
| US-11648551-B2 | Sample manipulation and assay with rapid temperature change | ESSENLIX CORPORATION (US) | 2023-05-16 | — | — | US | disclosed |
| US-20230140976-A1 | MONOCLONAL ANTIBODIES FOR INTRACELLULAR DELIVERY OF PAYLOADS | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2023-05-11 | — | — | US | disclosed |
| EP-3194563-B1 | METHOD OF PARTIAL LYSIS AND ASSAY | HOLOGIC INC (US) | 2023-05-10 | — | — | EP | disclosed |
| US-20230134425-A1 | METHODS OF TREATING GLIOBLASTOMA | TRIACT THERAPEUTICS, INC. | 2023-05-04 | — | — | US | disclosed |
| US-20230138400-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REPROGRAMING IMMUNE ENVIRONMENT IN A SUBJECT IN NEED THEREOF | INST NAT SANTE RECH MED (FR) | 2023-05-04 | — | — | US | disclosed |
| US-11639930-B2 | Enhanced chemiluminescent enzyme-linked immunosorbent assay for detection of antibodies against Babesia microti | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-05-02 | — | — | US | disclosed |
| US-20230125113-A1 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | CELLULAR RESEARCH, INC. | 2023-04-27 | — | — | US | disclosed |
| EP-4168006-A1 | NEW STRATEGY FOR TREATING PANCREATIC CANCER | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2023-04-26 | — | — | EP | disclosed |
| US-11635427-B2 | Sandwich assays in droplets | BIO-RAD LABORATORIES, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| US-11634766-B2 | Methods and compositions for analyzing nucleic acids | THE BROAD INSTITUTE, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| US-11634757-B2 | Emulsions with improved stability | STILLA TECHNOLOGIES (FR) | 2023-04-25 | — | — | US | disclosed |
| US-11633455-B2 | Silk-based product formulations and methods of use | COCOON BIOTECH INC. (US) | 2023-04-25 | — | — | US | disclosed |
| WO-2023064319-A1 | CONSUMABLE FOR ANALYTE DETECTION | BIO-RAD LABORATORIES, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| US-20230121541-A1 | MULTIPLEX PCR DETECTION OF ALK, RET, AND ROS FUSIONS | ROCHE MOLECULAR SYSTEMS INC (US) | 2023-04-20 | — | — | US | disclosed |
| EP-4165214-A1 | METHOD FOR TREATING AND PROGNOSING CANCER LIKE GLIOBLASTOMA | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2023-04-19 | — | — | EP | disclosed |
| EP-4164680-A1 | DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING BETA-GLUCAN AS A VACCINE ADJUVANT | Memorial Sloan Kettering Cancer Center (US) | 2023-04-19 | — | — | EP | disclosed |
| US-11629196-B2 | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions | INCELLDX, INC. (US) | 2023-04-18 | — | — | US | disclosed |
| US-11628170-B2 | Treating extrapyramtdal syndrome using trapidil | SINOPIA BIOSCIENCES, INC. (US) | 2023-04-18 | — | — | US | disclosed |
| US-20230113705-A1 | METHODS FOR DIAGNOSING, PROGNOSING AND MANAGING TREATMENT OF BREAST CANCER | ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (FR) | 2023-04-13 | — | — | US | disclosed |
| US-20230111586-A1 | CONSUMABLE FOR ANALYTE DETECTION | ALIGHT SCIENCES INC. | 2023-04-13 | — | — | US | disclosed |
| US-11624089-B2 | Cyanine dyes | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-04-11 | — | — | US | disclosed |
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-04-06 | — | — | US | disclosed |
| EP-4159741-A1 | METHOD FOR PRODUCING A CHIMERIC POLYNUCLEOTIDE ENCODING A POLYPEPTIDE HAVING A TRIAZOLE-CONTAINING INTERNUCLEOTIDE LINKAGE | ModernaTX, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| US-11618923-B2 | Methods of determining multiple interactions between nucleic acids in a cell | THE BROAD INSTITUTE, INC. (US) | 2023-04-04 | — | — | US | disclosed |
| US-20230096658-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2023-03-30 | — | — | US | disclosed |
| WO-2023048903-A1 | BASELINE RESTORATION CIRCUIT | BECTON, DICKINSON AND COMPANY (US) | 2023-03-30 | — | — | WO | disclosed |
| EP-4154002-A1 | THERMODYNAMICALLY STABILIZED ANTIBODIES FOR DEEP IMMUNOLABELING AND TISSUE IMAGING | The Chinese University Of Hong Kong (CN) | 2023-03-29 | — | — | EP | disclosed |
| US-11614443-B2 | Multiplex polymeric dye devices and methods for using the same | BECTON, DICKINSON AND COMPANY (US) | 2023-03-28 | — | — | US | disclosed |
| US-11613774-B2 | Quencher and use thereof | SFC CO., LTD. (KR) | 2023-03-28 | — | — | US | disclosed |
| CN-115867311-A | Polynucleotides comprising antigen cargo | 纳特科瑞克股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20230086845-A1 | DIGITAL ANALYTE ANALYSIS | BIO-RAD LABORATORIES | 2023-03-23 | — | — | US | disclosed |
| US-20230087228-A1 | NOVEL TYPE IV AND TYPE I CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-03-23 | — | — | US | disclosed |
| US-20230086718-A1 | METHOD FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM A CANCER | INST NAT SANTE RECH MED (FR) | 2023-03-23 | — | — | US | disclosed |
| US-20230090672-A1 | RAPID AND SAMPLE-SPECIFIC DETECTION OF VIRAL PATHOGEN FOR POOLED TESTING IN LARGE-POPULATION SCREENING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-03-23 | — | — | US | disclosed |
| US-20230089230-A1 | BaseLine Restoration Circuit | BECTON, DICKINSON AND COMPANY | 2023-03-23 | — | — | US | disclosed |
| WO-2023043914-A1 | DIAGNOSIS AND PROGNOSIS OF RICHTER'S SYNDROME | THE BROAD INSTITUTE, INC. (US) | 2023-03-23 | — | — | WO | disclosed |
| EP-4149506-A1 | POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOAD | Nutcracker Therapeutics, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| EP-4150335-A1 | BLOOD BASED CONTROLS FOR COMPLEX PANEL | Becton, Dickinson and Company (US) | 2023-03-22 | — | — | EP | disclosed |
| CN-110234600-B | Molecular nanotags | 美国政府(由卫生和人类服务部的部长所代表) | 2023-03-21 | — | — | CN | disclosed |
| US-11608458-B2 | Adhesion-promoting interlayer compositions containing organic titanates/zirconates and methods of use | PRC-DESOTO INTERNATIONAL, INC. (US) | 2023-03-21 | — | — | US | disclosed |
| US-11609224-B2 | Devices and methods for white blood cell analyses | ESSENLIX CORPORATION (US) | 2023-03-21 | — | — | US | disclosed |
| US-11608533-B1 | Compositions and methods for classifying tumors with microsatellite instability | THE GENERAL HOSPITAL CORPORATION (US) | 2023-03-21 | — | — | US | disclosed |
| WO-2023039433-A1 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | BECTON, DICKINSON AND COMPANY (US) | 2023-03-16 | — | — | WO | disclosed |
| US-20230078084-A1 | MULTI-MODE ILLUMINATION SYSTEM | ESSENLIX CORPORATION (US) | 2023-03-16 | — | — | US | disclosed |
| US-20230078489-A1 | Device and system for analyzing a sample, particularly blood, as well as methods of using the same | ESSENLIX CORPORATION (US) | 2023-03-16 | — | — | US | disclosed |
| EP-4146343-A1 | SARS-COV-2 IMMUNOASSAY AND MATERIALS THEREFOR | Bio-Rad Laboratories, Inc. (US) | 2023-03-15 | — | — | EP | disclosed |
| US-11603399-B2 | Long-lived polynucleotide molecules | MODERNATX, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| WO-2023031770-A1 | TREATMENTS FOR ATOPIC DERMATITIS | Galderma Holding SA (CH) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023034789-A1 | MULTIPLEXED PROTEOMICS ANALYSIS USING OLIGONUCLEOTIDE-CONJUGATED ANTIBODIES | BECTON, DICKINSON AND COMPANY (US) | 2023-03-09 | — | — | WO | disclosed |
| EP-4143235-A1 | METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM INFECTIONS, INCLUDING COVID-19, BY INHIBITING CCR5/CCL5 INTERACTION | IncellDx, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| EP-4144378-A1 | MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS | ModernaTX, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| EP-4144867-A1 | METHODS FOR DETECTING BORDETELLA | Quest Diagnostics Investments LLC (US) | 2023-03-08 | — | — | EP | disclosed |
| US-11597964-B2 | Droplet-based method and apparatus for composite single-cell nucleic acid analysis | THE BROAD INSTITUTE, INC. (US) | 2023-03-07 | — | — | US | disclosed |
| US-20230068000-A1 | COLORIMETRIC SENSOR FOR DETECTION OF A CONTAMINANT IN THE INDOOR ENVIRONMENT AND RELATED SYSTEMS | OHIO STATE INNOVATION FOUNDATION | 2023-03-02 | — | — | US | disclosed |
| US-RE49435-E1 | Glycan-interacting compounds and methods of use | SEAGEN INC. (US) | 2023-02-28 | — | — | US | disclosed |
| US-20230059390-A1 | METHODS AND SYSTEMS FOR MULTIPLEX ALLELE DETECTION | GENOMIND INC (US) | 2023-02-23 | — | — | US | disclosed |
| US-20230058329-A1 | BCR-ABL TRUNCATION MUTATIONS | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2023-02-23 | — | — | US | disclosed |
| US-11579147-B2 | Use of VNN1 as a biomarker and a therapeutic target in sarcomas | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-02-14 | — | — | US | disclosed |
| US-11578103-B2 | Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-02-14 | — | — | US | disclosed |
| US-20230043703-A1 | DETECTION OF GENETIC VARIANTS | BIO-RAD LABORATORIES, INC. | 2023-02-09 | — | — | US | disclosed |
| WO-2023009961-A2 | DETECTION OF GENETIC VARIANTS | BIO-RAD LABORATORIES, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| US-11566279-B2 | Droplet-based method and apparatus for composite single-cell nucleic acid analysis | THE BROAD INSTITUTE, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| US-11567066-B2 | Homogenous assay (II) | ESSENLIX CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
| CN-115667923-A | Blood-based complex group controls | 贝克顿·迪金森公司 | 2023-01-31 | — | — | CN | disclosed |
| US-20230029085-A1 | Compositions and Methods for Targeting Cancer Stem Cells | SEAGEN INC. (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2023002325-A1 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A COMPLEX BIOLOGICAL SAMPLE | THE BROAD INSTITUTE, INC. (US) | 2023-01-26 | — | — | WO | disclosed |
| US-20230022846-A1 | Methods For Determining A Photodetector Gain Correction Factor For Optical Signals In A Flow Cytometer | BECTON, DICKINSON AND COMPANY | 2023-01-26 | — | — | US | disclosed |
| US-20230022411-A1 | Compositions and Methods for Targeting Cancer Stem Cells | SEAGEN INC. (US) | 2023-01-26 | — | — | US | disclosed |
| US-20230025039-A1 | NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS | THE BROAD INSTITUTE, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| EP-4121768-A1 | METHOD FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM A CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-01-25 | — | — | EP | disclosed |
| US-20230013771-A1 | Method of Detecting an Analyte in a Sample | ESSENLIX CORP. | 2023-01-19 | — | — | US | disclosed |
| US-20230014031-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING | ESSENLIX CORPORATION (US) | 2023-01-19 | — | — | US | disclosed |
| WO-2023287568-A1 | METHODS FOR DETERMINING A PHOTODETECTOR GAIN CORRECTION FACTOR FOR OPTICAL SIGNALS IN A FLOW CYTOMETER | BECTON, DICKINSON AND COMPANY (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2023287831-A2 | APPARATUS FOR MULTIPLE SAMPLE ANALYSIS | ESSENLIX CORPORATION (US) | 2023-01-19 | — | — | WO | disclosed |
| US-20230013773-A1 | SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES | ARES CAPITAL CORPORATION, AS AGENT | 2023-01-19 | — | — | US | disclosed |
| EP-4119675-A1 | METHODS FOR DETECTING GENE DYSREGULATIONS | Quest Diagnostics Investments Incorporated (US) | 2023-01-18 | — | — | EP | disclosed |
| US-11555223-B2 | Methods for detecting Norovirus | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2023-01-17 | — | — | US | disclosed |
| WO-2023280790-A1 | GENE SIGNATURES FOR PREDICTING SURVIVAL TIME IN PATIENTS SUFFERING FROM RENAL CELL CARCINOMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-01-12 | — | — | WO | disclosed |
| EP-4116431-A1 | DETECTION OF ATYPICAL PNEUMONIA | Quest Diagnostics Investments Incorporated (US) | 2023-01-11 | — | — | EP | disclosed |
| US-20230001007-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2023-01-05 | — | — | US | disclosed |
| WO-2023278826-A2 | METHODS FOR SELECTING LUNG CANCER PATIENTS FOR TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2023-01-05 | — | — | WO | disclosed |
| EP-3218005-B1 | GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE | SEAGEN INC (US) | 2023-01-04 | — | — | EP | disclosed |
| EP-4110955-A1 | METHODS FOR DIAGNOSING, PROGNOSING AND MANAGING TREATMENT OF BREAST CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-01-04 | — | — | EP | disclosed |
| US-11543408-B2 | Device and system for analyzing a sample, particularly blood, as well as methods of using the same | ESSENLIX CORPORATION (US) | 2023-01-03 | — | — | US | disclosed |
| US-11543353-B2 | Multi-mode illumination system | ESSENLIX CORPORATION (US) | 2023-01-03 | — | — | US | disclosed |
| US-20220411783-A1 | METHOD FOR EXTRACTING NUCLEI OR WHOLE CELLS FROM FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUES | THE BROAD INSTITUTE, INC. | 2022-12-29 | — | — | US | disclosed |
| US-11536719-B2 | Molecular nanotags | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-27 | — | — | US | disclosed |
| US-11536941-B2 | Planar area light source | ESSENLIX CORPORATION (US) | 2022-12-27 | — | — | US | disclosed |
| US-20220401959-A1 | Dried Dye Reagent Devices and Methods for Making and Using The Same | BECTON, DICKINSON AND COMPANY | 2022-12-22 | — | — | US | disclosed |
| WO-2022264174-A1 | A METHOD TO AMPLIFY AND DETECT TARGET NUCLEIC ACIDS WITH VERY HIGH SPECIFICITY AND SENSITIVITY | ISLAM AMIRUL (IN) | 2022-12-22 | — | — | WO | disclosed |
| US-20220403357-A1 | SMALL TYPE II CAS PROTEINS AND METHODS OF USE THEREOF | THE BROAD INSTITUTE, INC. (US) | 2022-12-22 | — | — | US | disclosed |
| WO-2022265856-A1 | DRIED DYE REAGENT DEVICES AND METHODS FOR MAKING AND USING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2022-12-22 | — | — | WO | disclosed |
| EP-4105337-A1 | A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS | The Broad Institute, Inc. (US) | 2022-12-21 | — | — | EP | disclosed |
| CN-115491435-A | Rapid and sample-specific mixing and detection methods for screening of viral pathogens in large-scale populations | 香港科技大学 | 2022-12-20 | — | — | CN | disclosed |
| US-11530440-B2 | Methods for quantitating DNA using digital multiple displacement amplification | THE BROAD INSTITUTE, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| US-20220395562-A1 | TERMINALLY MODIFIED RNA | ARES CAPITAL CORPORATION, AS AGENT | 2022-12-15 | — | — | US | disclosed |
| EP-4101930-A1 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | ModernaTX, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| CN-111426822-B | Device and system for collecting and analyzing steam condensate, in particular exhaled gas condensate, and method of use | 艾森利克斯公司 | 2022-12-13 | — | — | CN | disclosed |
| WO-2022164709-A9 | CONTAINER WITH DRIED REAGENT COMPOSITION AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2022-12-08 | — | — | WO | disclosed |
| US-20220387603-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2022-12-08 | — | — | US | disclosed |
| WO-2022256371-A1 | METHODS FOR PREDICTING AND TREATING CHEMORESISTANCE IN SMALL CELL LUNG CANCER PATIENTS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-12-08 | — | — | WO | disclosed |
| US-20220380443-A1 | TARGETING NAPA-LINKED PEPTIDOGLYCAN FOR TREATING LYME DISEASE | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2022-12-01 | — | — | US | disclosed |
| US-11512313-B2 | Functionally-interdependent shape switching nucleic acid nanoparticles | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-11-29 | — | — | US | disclosed |
| WO-2022245830-A1 | METHODS FOR PERFORMING DIGITAL PCR | FLUENT BIOSCIENCES INC. (US) | 2022-11-24 | — | — | WO | disclosed |
| US-20220372561-A1 | METHODS FOR PERFORMING DIGITAL PCR | FLUENT BIOSCIENCES INC. (US) | 2022-11-24 | — | — | US | disclosed |
| US-20220370644-A1 | MYELOID CELL-TARGETED NANOPARTICLES AND RELATED COMPOSITIONS AND METHODS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2022-11-24 | — | — | US | disclosed |
| US-20220370625-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2022-11-24 | — | — | US | disclosed |
| EP-4090762-A1 | METHODS AND COMPOSITIONS FOR SINGLE CELL SECRETOMICS | Becton, Dickinson and Company (US) | 2022-11-23 | — | — | EP | disclosed |
| US-11505830-B2 | Multiplex PCR detection of ALK, RET, and ROS fusions | ROCHE MOLECULAR SYSTEMS, INC. (US) | 2022-11-22 | — | — | US | disclosed |
| CN-115354086-A | Compositions and methods for detecting human papillomavirus | 杭州诺辉健康科技有限公司 | 2022-11-18 | — | — | CN | disclosed |
| CN-115354076-A | Detection of Gene fusions by Intragenic Differential Expression (IDE) Using average cycle threshold | 奎斯特诊断投资股份有限公司 | 2022-11-18 | — | — | CN | disclosed |
| US-20220364071-A1 | NOVEL CRISPR ENZYMES AND SYSTEMS | THE BROAD INSTITUTE, INC. (US) | 2022-11-17 | — | — | US | disclosed |
| US-20220364987-A1 | SYSTEMS FOR DETECTING LIGHT BY SPECTRAL DISCRIMINATION AND METHODS FOR USING SAME | BECTON DICKINSON CO (US) | 2022-11-17 | — | — | US | disclosed |
| WO-2022240492-A1 | SYSTEMS FOR DETECTING LIGHT BY BIREFRINGENT FOURIER TRANSFORM INTERFEROMETRY AND METHODS FOR USING SAME | BECTON, DICKINSON AND COMPANY (US) | 2022-11-17 | — | — | WO | disclosed |
| WO-2022240552-A1 | SYSTEMS FOR DETECTING LIGHT BY SPECTRAL DISCRIMINATION AND METHODS FOR USING SAME | BECTON, DICKINSON AND COMPANY (US) | 2022-11-17 | — | — | WO | disclosed |
| US-20220364978-A1 | SYSTEMS FOR DETECTING LIGHT BY BIREFRINGENT FOURIER TRANSFORM INTERFEROMETRY AND METHODS FOR USING SAME | BECTON, DICKINSON AND COMPANY | 2022-11-17 | — | — | US | disclosed |
| US-11499199-B2 | Bordetella detection assay | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2022-11-15 | — | — | US | disclosed |
| WO-2022235901-A1 | METHODS, KITS, AND SYSTEMS FOR MODULATING AND PREDICTING CHANGES IN P16, SENESCENCE, AND PHYSIOLOGICAL RESERVE | SAPERE BIO, INC. (US) | 2022-11-10 | — | — | WO | disclosed |
| CN-115315515-A | Engineered GYRI-like mutein aptamers and related methods | 跨界科技公司 | 2022-11-08 | — | — | CN | disclosed |
| CN-115298322-A | Methods and compositions for single cell secretogomics | 贝克顿迪金森公司 | 2022-11-04 | — | — | CN | disclosed |
| WO-2022232050-A1 | COMPOSITIONS AND METHODS FOR CHARACTERIZING POLYNUCLEOTIDE SEQUENCE ALTERATIONS | THE BROAD INSTITUTE, INC. (US) | 2022-11-03 | — | — | WO | disclosed |
| US-11484500-B2 | Hybridosomes, compositions comprising the same, processes for their production and uses thereof | ANJARIUM BIOSCIENCES AG (CH) | 2022-11-01 | — | — | US | disclosed |
| US-11484597-B2 | Therapeutic conjugates | TOTUS MEDICINES INC. (US) | 2022-11-01 | — | — | US | disclosed |
| US-20220340975-A1 | METHOD OF TREATMENT AND PRONOSTIC OF ACUTE MYELOID LEUKEMIA | UNIVERSITÉ D'AIX MARSEILLE (FR) | 2022-10-27 | — | — | US | disclosed |
| WO-2022223791-A1 | METHODS AND COMPOSITIONS FOR TREATING CELL SENESCENCE ACCUMULATION RELATED DISEASE | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-10-27 | — | — | WO | disclosed |
| US-20220341842-A1 | OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN | ESSENLIX CORPORATION (US) | 2022-10-27 | — | — | US | disclosed |
| US-20220340936-A1 | PROGRAMMABLE POLYNUCLEOTIDE EDITORS FOR ENHANCED HOMOLOGOUS RECOMBINATION | THE BROAD INSTITUTE, INC. (US) | 2022-10-27 | — | — | US | disclosed |
| EP-3374769-B1 | ASSAYS USING AVIDIN AND BIOTIN | BIO RAD LABORATORIES INC (US) | 2022-10-26 | — | — | EP | disclosed |
| EP-4078184-A1 | METHODS FOR QUANTITATING EXTRA-CELLULAR VESICLE SURFACE MARKERS, AND COMPOSITIONS FOR PRACTICING THE SAME | Becton, Dickinson and Company (US) | 2022-10-26 | — | — | EP | disclosed |
| EP-4077464-A2 | FREE RADICAL POLYMERIZABLE ADHESION-PROMOTING INTERLAYER COMPOSITIONS AND METHODS OF USE | PRC-Desoto International, Inc. (US) | 2022-10-26 | — | — | EP | disclosed |
| CN-115244102-A | Free radical polymerizable adhesion promoting interlayer compositions and methods of use | PRC-迪索托国际公司 | 2022-10-25 | — | — | CN | disclosed |
| US-11479813-B2 | Quantitative PCR-based environmental DNA assays | UVIC INDUSTRY PARTNERSHIPS INC. (CA) | 2022-10-25 | — | — | US | disclosed |
| WO-2022219632-A1 | MULTILAYER ANALYSIS OF SINGLE CELLS | TERACYTE LTD (IL) | 2022-10-20 | — | — | WO | disclosed |
| EP-4074834-A1 | TERMINALLY MODIFIED RNA | ModernaTX, Inc. (US) | 2022-10-19 | — | — | EP | disclosed |
| US-11473141-B2 | Endpoint detection of amplified nucleic acids | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2022-10-18 | — | — | US | disclosed |
| WO-2022217073-A1 | METHODS FOR INHIBITING KRAS ONCOPROTEIN THROUGH ENHANCED GTPASE ACTIVITY | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-10-13 | — | — | WO | disclosed |
| US-20220323588-A1 | OCULAR APPLICATIONS OF SILK-BASED PRODUCTS | COCOON BIOTECH INC. | 2022-10-13 | — | — | US | disclosed |
| US-20220326240-A1 | IMMUNOASSAY FOR SARS-COV-2 AND MATERIALS THEREFOR | BIO-RAD LABORATORIES, INC. | 2022-10-13 | — | — | US | disclosed |
| US-20220325268-A1 | DEVICES AND METHODS FOR SAMPLE ANALYSIS | Roche Sequencing Solutions, Inc. | 2022-10-13 | — | — | US | disclosed |
| WO-2022217007-A1 | IMMUNOASSAY FOR SARS-COV-2 AND MATERIALS THEREFOR | BIO-RAD LABORATORIES, INC. (US) | 2022-10-13 | — | — | WO | disclosed |
| US-11466329-B2 | Detection of blaIMP antibacterial resistance genes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-10-11 | — | — | US | disclosed |
| CN-115175996-A | Novel type VI CRISPR enzymes and systems | 博德研究所 | 2022-10-11 | — | — | CN | disclosed |
| US-11466325-B2 | Method to detect repeat sequence motifs in nucleic acid | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2022-10-11 | — | — | US | disclosed |
| US-11467157-B2 | Measurement of protein expression using reagents with barcoded oligonucleotide sequences | BECTON, DICKINSON AND COMPANY (US) | 2022-10-11 | — | — | US | disclosed |
| US-20220317134-A1 | Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19 | INCELLDX, INC. | 2022-10-06 | — | — | US | disclosed |
| WO-2022207566-A1 | NEW METHOD TO EVALUATE PANCREATIC CANCER PROGNOSIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-10-06 | — | — | WO | disclosed |
| US-11460468-B2 | Measurement of protein expression using reagents with barcoded oligonucleotide sequences | BECTON, DICKINSON AND COMPANY (US) | 2022-10-04 | — | — | US | disclosed |
| CN-115141789-A | Luterion and isolation and culture method thereof | 株式会社露太利温 | 2022-10-04 | — | — | CN | disclosed |
| CN-107850526-B | Methods of evaluating a cellular breast sample and compositions for practicing the methods | 茵赛德斯有限公司 | 2022-09-30 | — | — | CN | disclosed |
| US-20220307073-A1 | DIGITAL ANALYTE ANALYSIS | BIO-RAD LABORATORIES, INC. | 2022-09-29 | — | — | US | disclosed |
| US-20220298234-A1 | MACROPHAGE DIVERSITY IN REGENERATIVE, FIBROTIC BIOMATERIAL ENVIRONMENTS | THE JOHNS HOPKINS UNIVERSITY | 2022-09-22 | — | — | US | disclosed |
| WO-2022198024-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. (US) | 2022-09-22 | — | — | WO | disclosed |
| WO-2022194949-A1 | METHOD FOR DIAGNOSING PANCREATIC CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-09-22 | — | — | WO | disclosed |
| WO-2022197770-A1 | METHODS FOR TAILORING ANALGESIC REGIMEN IN LUNG OR COLON CANCER PATIENTS BASED ON TUMOR GENOMICS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-09-22 | — | — | WO | disclosed |
| US-20220298516-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | ARES CAPITAL CORPORATION, AS AGENT | 2022-09-22 | — | — | US | disclosed |
| WO-2022197882-A1 | HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIGENS AND EPITOPES AND PROTEINS THAT BIND THERETO | COTROPIA JOSEPH (US) | 2022-09-22 | — | — | WO | disclosed |
| EP-4058580-A1 | ENGINEERED GYRI-LIKE MUTEIN APTAMERS, AND RELATED METHODS | Crosslife Technologies Inc. (US) | 2022-09-21 | — | — | EP | disclosed |
| EP-4059569-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2022-09-21 | — | — | EP | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-115087711-A | Adhesion promoting compositions containing organotitanates/zirconates and methods of use | PRC-迪索托国际公司 | 2022-09-20 | — | — | CN | disclosed |
| US-11446356-B2 | Peptides and related compositions and methods | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-09-20 | — | — | US | disclosed |
| CN-115060911-A | Measurement of protein expression using reagents with barcoded oligonucleotide sequences | 贝克顿迪金森公司 | 2022-09-16 | — | — | CN | disclosed |
| US-20220290237-A1 | METHOD FOR PREDICTING THE RESPONSE OF ANTIPSYCHOTIC DRUGS | UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (FR) | 2022-09-15 | — | — | US | disclosed |
| US-20220291093-A1 | Rapid Bio/Chemical Assay | ESSENLIX CORPORATION (US) | 2022-09-15 | — | — | US | disclosed |
| US-20220291241-A1 | ASSAY FOR THE DETECTION OF ALPHA-SYNUCLEIN SEEDING ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-09-15 | — | — | US | disclosed |
| US-20220290224-A1 | METHOD FOR IN SITU DETERMINATION OF NUCLEIC ACID PROXIMITY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-09-15 | — | — | US | disclosed |
| US-11441196-B2 | Ribosomal ribonucleic acid hybridization for organism identification | THE BROAD INSTITUTE, INC. (US) | 2022-09-13 | — | — | US | disclosed |
| CN-115053135-A | Method for quantifying extracellular vesicle surface markers and composition for carrying out the method | 贝克顿·迪金森公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-4051385-A1 | METHODS FOR PREDICTING RESPONSIVENESS OF PROSTATE CANCER PATIENTS TO PARP INHIBITORS | Memorial Sloan Kettering Cancer Center (US) | 2022-09-07 | — | — | EP | disclosed |
| US-11433075-B2 | Methods of treating glioblastoma | TRIACT THERAPEUTICS, INC. (US) | 2022-09-06 | — | — | US | disclosed |
| US-11434486-B2 | Polynucleotides containing a morpholino linker | MODERNATX, INC. (US) | 2022-09-06 | — | — | US | disclosed |
| US-11433074-B2 | Methods of treating glioblastoma | TRIACT THERAPEUTICS, INC. (US) | 2022-09-06 | — | — | US | disclosed |
| US-11435358-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-09-06 | — | — | US | disclosed |
| US-20220273555-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS | ARES CAPITAL CORPORATION, AS AGENT | 2022-09-01 | — | — | US | disclosed |
| US-20220274960-A1 | QUENCHER AND USES THEREOF | SFC CO., LTD. (KR) | 2022-09-01 | — | — | US | disclosed |
| US-20220276235-A1 | IMAGING BASED HOMOGENEOUS ASSAY | ESSENLIX CORPORATION (US) | 2022-09-01 | — | — | US | disclosed |
| US-11427869-B2 | T cell balance gene expression, compositions of matters and methods of use thereof | THE BROAD INSTITUTE, INC. (US) | 2022-08-30 | — | — | US | disclosed |
| US-11427861-B2 | Methods for identifying and modulating co-occurant cellular phenotypes | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-08-30 | — | — | US | disclosed |
| WO-2022178216-A2 | CORONA VIRUS ANTIGENS AND EPITOPES AND PROTEINS THAT BIND THERETO | COTROPIA JOSEPH (US) | 2022-08-25 | — | — | WO | disclosed |
| WO-2022177989-A1 | MODELS FOR PREDICTING MUTANT P53 FITNESS AND THEIR IMPLICATIONS IN CANCER THERAPY | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-08-25 | — | — | WO | disclosed |
| WO-2022177863-A1 | COMPOSITIONS CONTAINING A FREE RADICAL POLYMERIZATION INITIATOR | PRC-DESOTO INTERNATIONAL, INC. (US) | 2022-08-25 | — | — | WO | disclosed |
| EP-4045686-A1 | METHODS FOR DIAGNOSING NASAL INTESTINAL TYPE ADENOCARCINOMAS | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2022-08-24 | — | — | EP | disclosed |
| EP-4047057-A1 | QUENCHER AND USES THEREOF | SFC Co., Ltd. (KR) | 2022-08-24 | — | — | EP | disclosed |
| WO-2022171584-A1 | ASSAYS FOR THE DETECTION OF SARS-COV-2 MUTANTS | PROCOMCURE BIOTECH GMBH (AT) | 2022-08-18 | — | — | WO | disclosed |
| WO-2022171831-A1 | USE OF MARKERS FOUND ON LYMPH NODE METASTATIC SAMPLES FOR THE PROGNOSIS OF BREAST CANCER | Universität Zürich (CH) | 2022-08-18 | — | — | WO | disclosed |
| US-20220259323-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2022-08-18 | — | — | US | disclosed |
| US-20220259665-A1 | METHODS FOR PREDICTING THE SURVIVAL TIME AND TREATMENT RESPONSIVENESS OF A PATIENT SUFFERING FROM A SOLID CANCER WITH A SIGNATURE OF AT LEAST 7 GENES | UNIVERSITÉ PARIS CITÉ (FR) | 2022-08-18 | — | — | US | disclosed |
| US-20220259679-A1 | Assays for the Detection of SARS-CoV2 Mutants | PROCOMCURE BIOTECH GMBH (AT) | 2022-08-18 | — | — | US | disclosed |
| WO-2022171611-A1 | NEW METHOD TO PRONOSTIC LUNG CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-08-18 | — | — | WO | disclosed |
| EP-4043588-A1 | ASSAYS FOR THE DETECTION OF SARS-COV-2 MUTANTS | Procomcure Biotech GmbH (AT) | 2022-08-17 | — | — | EP | disclosed |
| EP-4041718-A1 | PHOSPHOLIPID-FLAVAGLINE CONJUGATES AND METHODS OF USING THE SAME FOR TARGETED CANCER THERAPY | Cellectar Biosciences, Inc. (US) | 2022-08-17 | — | — | EP | disclosed |
| US-11415504-B2 | Optical transmission sample holder and analysis, particularly for hemoglobin | ESSENLIX CORPORATION (US) | 2022-08-16 | — | — | US | disclosed |
| US-11415570-B2 | Rapid vapor condensate collection and analysis | ESSENLIX CORPORATION (US) | 2022-08-16 | — | — | US | disclosed |
| CN-110719928-B | Dual cure sealant | PRC-迪索托国际公司 | 2022-08-12 | — | — | CN | disclosed |
| US-20220249484-A1 | METHODS FOR PREDICTING RESPONSIVENESS OF CANCER TO FERROPTOSIS-INDUCING THERAPIES | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-08-11 | — | — | US | disclosed |
| US-20220249701-A1 | COMPOSITIONS AND METHODS FOR TARGETING MULTINUCLEATED CELLS | THE BROAD INSTITUTE, INC. | 2022-08-11 | — | — | US | disclosed |
| US-20220250308-A1 | METHODS FOR MANUFACTURING WIND TURBINE BLADES AND LEADING EDGE PROTECTION SURFACES | PPG COATINGS EUROPE B.V. (NL) | 2022-08-11 | — | — | US | disclosed |
| US-20220251628-A1 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | BIO-RAD LABORATORIES, INC. | 2022-08-11 | — | — | US | disclosed |
| EP-2971278-B1 | METHODS FOR DETERMINING MULTIPLE INTERACTIONS BETWEEN NUCLEIC ACIDS IN A CELL | BROAD INST INC (US) | 2022-08-10 | — | — | EP | disclosed |
| EP-3442984-B1 | METHODS FOR DETECTING BORDETELLA | QUEST DIAGNOSTICS INVEST LLC (US) | 2022-08-10 | — | — | EP | disclosed |
| WO-2022164709-A1 | CONTAINER WITH DRIED REAGENT COMPOSITION AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2022-08-04 | — | — | WO | disclosed |
| US-20220241203-A1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIVERSIDADE DO MINHO (PT) | 2022-08-04 | — | — | US | disclosed |
| US-20220244245-A1 | A METHOD OF PROFILING THE ENERGETIC METABOLISM OF A POPULATION OF CELLS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2022-08-04 | — | — | US | disclosed |
| US-20220241789-A1 | CONTAINER WITH DRIED REAGENT COMPOSITION AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY | 2022-08-04 | — | — | US | disclosed |
| EP-4034659-A2 | PROGRAMMABLE POLYNUCLEOTIDE EDITORS FOR ENHANCED HOMOLOGOUS RECOMBINATION | The Broad Institute, Inc. (US) | 2022-08-03 | — | — | EP | disclosed |
| CN-112592494-B | Preparation method of targeted colon part antibacterial imaging nano material based on dendritic cationic polyamide and tetraphenylethylene | 天津理工大学 | 2022-08-02 | — | — | CN | disclosed |
| US-11402391-B2 | Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist | INCELLDX, INC. (US) | 2022-08-02 | — | — | US | disclosed |
| WO-2022159190-A1 | METHOD AND SYSTEMS FOR DETERMING DROP DELAY USING SCATTER SIGNALS ACROSS SPATIALLY SEPARATED LASERS | BECTON, DICKINSON AND COMPANY (US) | 2022-07-28 | — | — | WO | disclosed |
| US-20220236164-A1 | METHOD AND SYSTEMS FOR DETERMING DROP DELAY USING SCATTER SIGNALS ACROSS SPATIALLY SEPARATED LASERS | BECTON, DICKINSON AND COMPANY | 2022-07-28 | — | — | US | disclosed |
| US-20220237930-A1 | CELL AGE CLASSIFICATION AND DRUG SCREENING | FOUNTAIN THERAPEUTICS INC (US) | 2022-07-28 | — | — | US | disclosed |
| EP-3697531-B1 | EMULSIONS WITH IMPROVED STABILITY | STILLA TECH (FR) | 2022-07-27 | — | — | EP | disclosed |
| EP-4031660-A1 | NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS | The Broad Institute, Inc. (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4031143-A1 | THERAPEUTIC CONJUGATES | Totus Medicines Inc. (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-3191605-B1 | A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS | BROAD INST INC (US) | 2022-07-27 | — | — | EP | disclosed |
| WO-2022152698-A1 | USE OF NPDK-D TO EVALUATE CANCER PROGNOSIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-07-21 | — | — | WO | disclosed |
| US-11390917-B2 | Digital analyte analysis | BIO-RAD LABORATORIES, INC. (US) | 2022-07-19 | — | — | US | disclosed |
| US-11393561-B2 | Devices and methods for authenticating a medical test and use of the same | ESSENLIX CORPORATION (US) | 2022-07-19 | — | — | US | disclosed |
| CN-114761389-A | phospholipid-FLAVAGLINE conjugates and methods of using the same for targeted cancer therapy | 塞勒科塔生物科学公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-111936641-B | Compositions and methods for detecting human papillomavirus | 杭州诺辉健康科技有限公司 | 2022-07-15 | — | — | CN | disclosed |
| US-20220220532-A1 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | BIO-RAD LABORATORIES, INC. | 2022-07-14 | — | — | US | disclosed |
| EP-4025712-A1 | METHOD OF TREATMENT AND PRONOSTIC OF ACUTE MYELOID LEUKEMIA | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2022-07-13 | — | — | EP | disclosed |
| CN-107873054-B | Droplet-based methods and apparatus for multiplexed single-cell nucleic acid analysis | 博德研究所 | 2022-07-12 | — | — | CN | disclosed |
| US-11385143-B2 | Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use | ESSENLIX CORPORATION (US) | 2022-07-12 | — | — | US | disclosed |
| CN-110268247-B | Measurement of protein-protein interactions at the Single molecule level | 生物辐射实验室股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20220213530-A1 | DIGITAL ANALYTE ANALYSIS | BIO-RAD LABORATORIES, INC. | 2022-07-07 | — | — | US | disclosed |
| US-20220214354-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | VIB VZW (BE) | 2022-07-07 | — | — | US | disclosed |
| US-20220211855-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. | 2022-07-07 | — | — | US | disclosed |
| US-20220211741-A1 | METHODS FOR THE TREATMENT AND PROGNOSIS OF CANCER | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2022-07-07 | — | — | US | disclosed |
| EP-3283499-B1 | DUAL QUENCHER PROBES | BIOSEARCH TECH INC (US) | 2022-07-06 | — | — | EP | disclosed |
| EP-4023249-A1 | NUCLEIC ACID VACCINES | ModernaTX, Inc. (US) | 2022-07-06 | — | — | EP | disclosed |
| US-20220202837-A1 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-30 | — | — | US | disclosed |
| WO-2022136252-A1 | METHODS FOR PROGNOSIS THE HUMORAL RESPONSE OF A SUBJECT PRIOR TO VACCINATION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022135753-A1 | METHODS FOR PROGNOSIS THE HUMORAL RESPONSE OF A SUBJECT PRIOR TO VACCINATION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022140299-A1 | METHODS OF ASSIGNING A COVID PATHOLOGICAL TYPE AND COMPOSITIONS FOR PRACTICING THE SAME, AND METHODS OF TREATING A SUBJECT FOR CHRONIC COVID-19 | INCELLDX, INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| US-20220196665-A1 | BCR-ABL VARIANTS | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2022-06-23 | — | — | US | disclosed |
| US-20220193223-A1 | NUCLEIC ACID VACCINES | MODERNATX, INC. (US) | 2022-06-23 | — | — | US | disclosed |
| EP-4015005-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | ModernaTX, Inc. (US) | 2022-06-22 | — | — | EP | disclosed |
| EP-3825421-B1 | DETECTION OF GENE FUSIONS BY INTRAGENIC DIFFERENTIAL EXPRESSION (IDE) USING AVERAGE CYCLE THRESHOLDS | QUEST DIAGNOSTICS INVEST INC (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11366116-B1 | Real time autonomous surveillance of pathogens | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2022-06-21 | — | — | US | disclosed |
| WO-2022125871-A1 | METHODS FOR TAILORING ANALGESIC REGIMEN IN CANCER PATIENT'S BASED ON TUMOR TRANSCRIPTOMICS | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022124789-A1 | QUENCHER AND USE THEREOF | 에스에프씨 주식회사 | 2022-06-16 | — | — | WO | disclosed |
| WO-2022125701-A1 | MULTIPLEXED SINGLE CELL IMMUNOASSAY | BECTON, DICKINSON AND COMPANY (US) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022124663-A1 | QUENCHER AND USES THEREOF | 에스에프씨 주식회사 | 2022-06-16 | — | — | WO | disclosed |
| WO-2022125857-A1 | METHODS, KITS, AND SYSTEMS FOR PREDICTING PATIENT OUTCOMES | SAPERE BIO, INC. (US) | 2022-06-16 | — | — | WO | disclosed |
| EP-3529205-B1 | MOLECULAR NANOTAGS | US HEALTH (US) | 2022-06-15 | — | — | EP | disclosed |
| US-11359136-B2 | Colorimetric indicators for photocurable sealants | THE BOEING COMPANY (US) | 2022-06-14 | — | — | US | disclosed |
| US-20220180975-A1 | METHODS AND SYSTEMS FOR DETERMINING GENE EXPRESSION PROFILES AND CELL IDENTITIES FROM MULTI-OMIC IMAGING DATA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2022-06-09 | — | — | US | disclosed |
| WO-2022118200-A1 | CAS12 DETECTION METHODS AND COMPOSITIONS | THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) | 2022-06-09 | — | — | WO | disclosed |
| US-20220178909-A1 | MULTIPLEXED SINGLE CELL IMMUNOASSAY | BECTON, DICKINSON AND COMPANY | 2022-06-09 | — | — | US | disclosed |
| US-20220177978-A1 | METHODS OF PREDICTING AND PREVENTING CANCER IN PATIENTS HAVING PREMALIGNANT LESIONS | TRUSTEES OF BOSTON UNIVERSITY | 2022-06-09 | — | — | US | disclosed |
| WO-2021263188-A9 | LIVE CELL ENGAGEMENT ASSAY | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2022-06-09 | — | — | WO | disclosed |
| CN-109791157-B | Measuring protein expression using reagents with barcoded oligonucleotide sequences | 贝克顿迪金森公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114599366-A | Therapeutic conjugates | 托特斯医药公司 | 2022-06-07 | — | — | CN | disclosed |
| US-11345964-B2 | BCR-ABL truncation mutations | Quest Diagnostics Investments, LLC (US) | 2022-05-31 | — | — | US | disclosed |
| US-11339390-B2 | DNA microscopy methods | THE BROAD INSTITUTE, INC. (US) | 2022-05-24 | — | — | US | disclosed |
| EP-3997435-A1 | RAPID PATHOLOGY/CYTOLOGY WITHOUT WASH | Essenlix Corporation (US) | 2022-05-18 | — | — | EP | disclosed |
| US-11332736-B2 | Methods and compositions for multiplexing single cell and single nuclei sequencing | THE BROAD INSTITUTE, INC. (US) | 2022-05-17 | — | — | US | disclosed |
| US-11332783-B2 | Sample analysis, presence determination of a target sequence | THE BROAD INSTITUTE, INC. (US) | 2022-05-17 | — | — | US | disclosed |
| CN-114480574-A | Representative diagnosis | 文塔纳医疗系统公司 | 2022-05-13 | — | — | CN | disclosed |
| WO-2022099004-A1 | METHODS FOR CHARACTERIZING BIOLOGICAL SAMPLES | THE GENERAL HOSPITAL CORPORATION (US) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022098997-A1 | COMPOSITIONS AND METHODS FOR TUMOR CHARACTERIZATION | THE GENERAL HOSPITAL CORPORATION (US) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022096633-A1 | METHODS FOR DIAGNOSIS AND TREATING POLYCYSTIC OVARY SYNDROME (PCOS) | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-05-12 | — | — | WO | disclosed |
| US-20220145367-A1 | METHODS FOR DETECTING LEGIONELLA | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2022-05-12 | — | — | US | disclosed |
| US-20220146511-A1 | ELECTROPHORETIC BAR CODE ASSAY DEVICES AND METHODS FOR MAKING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-05-12 | — | — | US | disclosed |
| US-20220148177-A1 | FAST STAINING OF BIOMATERIALS ENHANCED BY IMAGE PROCESSING AND ARTIFICIAL INTELLIGENCE | ESSENLIX CORPORATION (US) | 2022-05-12 | — | — | US | disclosed |
| EP-3572526-B1 | DETECTION OF ATYPICAL PNEUMONIA | QUEST DIAGNOSTICS INVEST INC (US) | 2022-05-11 | — | — | EP | disclosed |
| EP-3546596-B1 | USE OF A KIT FOR DETECTING GENE DYSREGULATIONS | QUEST DIAGNOSTICS INVEST INC (US) | 2022-05-11 | — | — | EP | disclosed |
| US-11326989-B2 | Devices and methods for tissue and cell staining | ESSENLIX CORPORATION (US) | 2022-05-10 | — | — | US | disclosed |
| US-20220136969-A1 | RAPID PATHOLOGY/CYTOLOGY WITHOUT WASH | ESSENLIX CORPORATION (US) | 2022-05-05 | — | — | US | disclosed |
| US-20220137038-A1 | ASSAYS WITH REDUCED INTERFERENCE (III) | ESSENLIX CORPORATION (US) | 2022-05-05 | — | — | US | disclosed |
| US-20220133914-A1 | OPTICALLY HEAT-GENERATING COMPOSITE MATERIAL, NANOCLUSTER, SUBSTANCE DELIVERY CARRIER AND PHARMACEUTICAL COMPOSITION | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2022-05-05 | — | — | US | disclosed |
| US-20220137047-A1 | BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR | BIO-RAD LABORATORIES, INC. | 2022-05-05 | — | — | US | disclosed |
| WO-2022094346-A1 | RAPID PATHOLOGY OR CYTOLOGY, PARTICULARLY WITHOUT WASH | ESSENLIX CORPORATION (US) | 2022-05-05 | — | — | WO | disclosed |
| EP-3990265-A1 | METHODS FOR MANUFACTURING WIND TURBINE BLADES AND LEADING EDGE PROTECTION SURFACES | PPG Coatings Europe B.V. (NL) | 2022-05-04 | — | — | EP | disclosed |
| US-11320437-B2 | Dried dye reagent devices and methods for making and using the same | BECTON, DICKINSON AND COMPANY (US) | 2022-05-03 | — | — | US | disclosed |
| CN-114410830-A | Method for partial lysis and assay | 豪洛捷公司 | 2022-04-29 | — | — | CN | disclosed |
| US-20220127308-A1 | Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION | 2022-04-28 | — | — | US | disclosed |
| WO-2022084327-A1 | METHOD FOR PREDICTING THE RESPONSE TO TNF INHIBITORS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-04-28 | — | — | WO | disclosed |
| CN-110337331-B | Dry dye reagent devices and methods of making and using the same | 贝克顿·迪金森公司 | 2022-04-26 | — | — | CN | disclosed |
| US-11313867-B2 | Assay for the detection of alpha-synuclein seeding activity associated with synucleinopathies | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-04-26 | — | — | US | disclosed |
| US-20220119871-A1 | IN-SITU SPATIAL TRANSCRIPTOMICS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2022-04-21 | — | — | US | disclosed |
| US-20220120740-A1 | Sample Collection, holding and assaying | ESSENLIX CORPORATION (US) | 2022-04-21 | — | — | US | disclosed |
| US-20220119898-A1 | METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2022-04-21 | — | — | US | disclosed |
| US-20220119516-A1 | VARIANTS OF ERYTHROFERRONE AND THEIR USE | UNIVERSITÉ PARIS CITÉ (FR) | 2022-04-21 | — | — | US | disclosed |
| US-11306367-B1 | Methods for rapid detection and identification of viral nucleic acids | NYAN DOUGBEH CHRIS (US) | 2022-04-19 | — | — | US | disclosed |
| CN-114364308-A | Rapid staining of biological material enhanced by image processing and artificial intelligence | ESSENLIX 公司 | 2022-04-15 | — | — | CN | disclosed |
| US-20220111079-A1 | COMPOSITIONS COMPRISING SYNTHETIC POLYNUCLEOTIDES ENCODING CRISPR RELATED PROTEINS AND SYNTHETIC SGRNAs AND METHODS OF USE | MODERNATX, INC. | 2022-04-14 | — | — | US | disclosed |
| US-20220112567-A1 | METHODS AND COMPOSITIONS FOR INFLUENZA A VIRUS SUBTYPING | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2022-04-14 | — | — | US | disclosed |
| WO-2022076088-A1 | METHODS FOR FLOW CYTOMETRY PANEL DESIGN BASED ON MODELING AND MINIMIZING SPILLOVER SPREADING, AND SYSTEMS FOR PRACTICING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2022-04-14 | — | — | WO | disclosed |
| EP-3981437-A1 | NUCLEIC ACID VACCINES | ModernaTX, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-114341614-A | Rapid pathology/cytology without wash-out | ESSENLIX 公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20220108774-A1 | METHODS FOR FLOW CYTOMETRY PANEL DESIGN BASED ON MODELING AND MINIMIZING SPILLOVER SPREADING, AND SYSTEMS FOR PRACTICING THE SAME | BECTON, DICKINSON AND COMPANY | 2022-04-07 | — | — | US | disclosed |
| US-20220107320-A1 | Assaying Bladder-Associated Samples, Identifying and Treating Bladder-Associated Neoplasia, and Kits for Use Therein | INCELLDX, INC. | 2022-04-07 | — | — | US | disclosed |
| EP-3975833-A1 | FAST STAINING OF BIOMATERIALS ENHANCED BY IMAGE PROCESSING AND ARTIFICIAL INTELLIGENCE | Essenlix Corporation (US) | 2022-04-06 | — | — | EP | disclosed |
| EP-3978030-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE | ModernaTX, Inc. (US) | 2022-04-06 | — | — | EP | disclosed |
| CN-114269916-A | Device and method for sample analysis | 豪夫迈·罗氏有限公司 | 2022-04-01 | — | — | CN | disclosed |
| US-20220098674-A1 | METHODS AND COMPOSITIONS FOR SELECTING A CANCER TREATMENT IN A SUBJECT SUFFERING FROM CANCER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - (FR) | 2022-03-31 | — | — | US | disclosed |
| US-20220098665-A1 | METHODS FOR PREDICTING ACUTE SEVERE COLITIS TREATMENT RESPONSE | Universite De Paris (FR) | 2022-03-31 | — | — | US | disclosed |
| US-20220098676-A1 | SINGLE-STRANDED OLIGONUCLEOTIDE PROBES FOR CHROMOSOME OR GENE COPY ENUMERATION | VENTANA MEDICAL SYSTEMS, INC. | 2022-03-31 | — | — | US | disclosed |
| US-20220098679-A1 | NUCLEIC ACID DETECTION COMBINING AMPLIFICATION WITH FRAGMENTATION | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2022-03-31 | — | — | US | disclosed |
| WO-2022064049-A1 | METHOD FOR DIAGNOSING BRUCELLA INFECTION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-03-31 | — | — | WO | disclosed |
| US-20220090089-A1 | ENGINEERED MULTI-OMIC DISPLAY CONSTRUCTS AND DISPLAY SYSTEMS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-03-24 | — | — | US | disclosed |
| US-20220090070-A1 | METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS | THE BROAD INSTITUTE, INC. | 2022-03-24 | — | — | US | disclosed |
| US-20220091130-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2022-03-24 | — | — | US | disclosed |
| US-20220090218-A1 | COMPOSITIONS AND METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS | HANGZHOU NEW HORIZON HEALTH TECHNOLOGY CO. LTD. (CN) | 2022-03-24 | — | — | US | disclosed |
| US-20220090164-A1 | METHODS FOR THE DETECTION OF DNA-RNA PROXIMITY IN VIVO | THE BROAD INSTITUTE, INC. | 2022-03-24 | — | — | US | disclosed |
| EP-3969881-A1 | PHASE-CALIBRATION FOR IMAGING FLOW CYTOMETRY | Becton, Dickinson and Company (US) | 2022-03-23 | — | — | EP | disclosed |
| EP-3971287-A1 | COMPOSITIONS COMPRISING SYNTHETIC POLYNUCLEOTIDES ENCODING CRISPR RELATED PROTEINS AND SYNTHETIC SGRNAS AND METHODS OF USE | ModernaTX, Inc. (US) | 2022-03-23 | — | — | EP | disclosed |
| US-11278554-B2 | Compositions and methods for modification of biomolecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-03-22 | — | — | US | disclosed |
| US-11279974-B2 | Method for in situ determination of nucleic acid proximity | THE BROAD INSTITUTE, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| US-11278495-B2 | Liposomes and methods of production thereof | BECTON, DICKINSON AND COMPANY (US) | 2022-03-22 | — | — | US | disclosed |
| US-11280706-B2 | Dilution calibration | ESSENLIX CORPORATION (US) | 2022-03-22 | — | — | US | disclosed |
| WO-2022056078-A1 | RNASE H-ASSISTED DETECTION ASSAY FOR RNA (RADAR) | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022053691-A1 | METHOD TO TREAT AND STRATIFICATE A PATIENT SUFFERING FROM A CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022056453-A1 | THERAPEUTIC CONJUGATES | TOTUS MEDICINES INC. (US) | 2022-03-17 | — | — | WO | disclosed |
| US-11275088-B2 | BCR-ABL variants | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2022-03-15 | — | — | US | disclosed |
| US-11275026-B2 | Phase-calibration for imaging flow cytometry | BECTON, DICKINSON AND COMPANY (US) | 2022-03-15 | — | — | US | disclosed |
| CN-114173880-A | Methods of predicting cancer responsiveness to iron death induction therapy | 纪念斯隆凯特琳癌症中心 | 2022-03-11 | — | — | CN | disclosed |
| CN-114174824-A | Determination of interference reduction (III) | ESSENLIX 公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20220073626-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER | Universite Paris-Saclay (FR) | 2022-03-10 | — | — | US | disclosed |
| US-20220074944-A1 | DETECTION OF BCL-2 FAMILY HETERODIMER COMPLEXES AND USE THEREOF | The United States of America, as represented by the Secretary,Department of Health and Human Service (US) | 2022-03-10 | — | — | US | disclosed |
| EP-3169693-B1 | CHIMERIC POLYNUCLEOTIDES | MODERNATX INC (US) | 2022-03-09 | — | — | EP | disclosed |
| US-11268136-B2 | Allergen detection | DOTS TECHNOLOGY CORP. (US) | 2022-03-08 | — | — | US | disclosed |
| EP-3959340-A1 | METHOD FOR PREDICTING THE RESPONSE OF ANTIPSYCHOTIC DRUGS | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2022-03-02 | — | — | EP | disclosed |
| CN-114127536-A | Phase correction for imaging flow cytometry | 贝克顿·迪金森公司 | 2022-03-01 | — | — | CN | disclosed |
| EP-3956663-A1 | A METHOD OF PROFILING THE ENERGETIC METABOLISM OF A POPULATION OF CELLS | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2022-02-23 | — | — | EP | disclosed |
| EP-3956474-A1 | METHODS FOR THE TREATMENT AND PROGNOSIS OF CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-02-23 | — | — | EP | disclosed |
| US-20220050097-A1 | Methods and Systems for Providing Labelled Biomolecules | BECTON, DICKINSON AND COMPANY | 2022-02-17 | — | — | US | disclosed |
| WO-2022035723-A1 | COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA | THE BROAD INSTITUTE, INC. (US) | 2022-02-17 | — | — | WO | disclosed |
| EP-2699679-B1 | COMPOSITIONS FOR ISOLATING A TARGET ANALYTE FROM A HETEROGENEOUS SAMPLE | DNAE GROUP HOLDINGS LTD (GB) | 2022-02-16 | — | — | EP | disclosed |
| US-11248028-B2 | Desmoglein 2 (DSG2) binding proteins and uses therefor | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2022-02-15 | — | — | US | disclosed |
| US-20220043249-A1 | PLANAR AREA LIGHT SOURCE | ESSENLIX CORPORATION (US) | 2022-02-10 | — | — | US | disclosed |
| US-20220042910-A1 | MULTI-MODE ILLUMINATION SYSTEM | ESSENLIX CORPORATION (US) | 2022-02-10 | — | — | US | disclosed |
| US-20220042110-A1 | DETECTION OF GENE FUSIONS BY INTRAGENIC DIFFERENTIAL EXPRESSION (IDE) USING AVERAGE CYCLE THRESHOLDS | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2022-02-10 | — | — | US | disclosed |
| US-20220042097-A1 | IN-SITU SPATIAL TRANSCRIPTOMICS AND PROTEOMICS | THE BROAD INSTITUTE, INC. | 2022-02-10 | — | — | US | disclosed |
| EP-3947726-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND CHARACTERIZING GENE TRANSLOCATIONS, REARRANGEMENTS AND INVERSIONS | Agilent Technologies, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| US-11242564-B2 | Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2022-02-08 | — | — | US | disclosed |
| CN-114026422-A | Apparatus and method for rapid detection of acute phase reactants and leukocytes | ESSENLIX 公司 | 2022-02-08 | — | — | CN | disclosed |
| US-20220034869-A1 | MULTI-STAGE, MULTIPLEXED TARGET ISOLATION AND PROCESSING FROM HETEROGENEOUS POPULATIONS | THE BROAD INSTITUTE, INC. (US) | 2022-02-03 | — | — | US | disclosed |
| CN-108449995-B | Representative diagnosis | 文塔纳医疗系统公司 | 2022-02-01 | — | — | CN | disclosed |
| US-11237113-B2 | Rapid pH measurement | ESSENLIX CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
| WO-2022020234-A2 | IMMUNOASSAY FOR SARS-COV-2 NEUTRALIZING ANTIBODIES AND MATERIALS THEREFOR | BIO-RAD LABORATORIES, INC. (US) | 2022-01-27 | — | — | WO | disclosed |
| US-11230736-B2 | Methods for assessing pregnancy outcome | INSERM (INSTITUT NATIONAL DE LA SANTÉ DE LA RECHERCHE MÉDICALE) (FR) | 2022-01-25 | — | — | US | disclosed |
| CN-113959928-A | Immunomodulatory potential of pluripotent stromal cell (MSC) populations | 贝克顿·迪金森公司 | 2022-01-21 | — | — | CN | disclosed |
| US-20210402748-A1 | FREE RADICAL POLYMERIZABLE ADHESION-PROMOTING INTERLAYER COMPOSITIONS AND METHODS OF USE | PRC DESOTO INT INC (US) | 2021-12-30 | — | — | US | disclosed |
| US-11173692-B2 | Free radical polymerizable adhesion-promoting interlayer compositions and methods of use | PRC-DESOTO INTERNATIONAL, INC. (US) | 2021-11-16 | — | — | US | disclosed |
| US-11162952-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-11-02 | — | — | US | disclosed |
| CN-113396006-A | Dry reagent screen and methods of making and using same | 贝克顿·迪金森公司 | 2021-09-14 | — | — | CN | disclosed |
| EP-3635032-B1 | DUAL CURE SEALANTS | PRC DESOTO INT INC (US) | 2021-08-04 | — | — | EP | disclosed |
| EP-3852814-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | ModernaTX, Inc. (US) | 2021-07-28 | — | — | EP | disclosed |
| WO-2021127292-A2 | FREE RADICAL POLYMERIZABLE ADHESION-PROMOTING INTERLAYER COMPOSITIONS AND METHODS OF USE | PRC-DESOTO INTERNATIONAL, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| US-20210187922-A1 | FREE RADICAL POLYMERIZABLE ADHESION-PROMOTING INTERLAYER COMPOSITIONS AND METHODS OF USE | PRC-DESOTO INTERNATIONAL, INC. (US) | 2021-06-24 | — | — | US | disclosed |
| US-20210115489-A1 | NOVEL MEDIATOR | KIKKOMAN CORPORATION (JP) | 2021-04-22 | — | — | US | disclosed |
| CN-112639137-A | Methods for detecting cancer-associated cell populations, screening for metastatic cancer and treating same | 茵赛德斯有限公司 | 2021-04-09 | — | — | CN | disclosed |
| EP-3797112-A1 | THE KIT FOR SCREENING COLORECTAL CANCER AND ADVANCED ADENOMA AND ITS APPLICATION | Hangzhou New Horizon Health Technology Co., Ltd. (CN) | 2021-03-31 | — | — | EP | disclosed |
| US-20210072251-A9 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2021-03-11 | — | — | US | disclosed |
| WO-2021035211-A1 | TISSUE PROCESSING | APPLIKATE TECHNOLOGIES LLC (US) | 2021-02-25 | — | — | WO | disclosed |
| US-20210018407-A1 | SAMPLE COLLECTION AND HANDLING FOR DELAYED ANALYSIS | ESSENLIX CORPORATION (US) | 2021-01-21 | — | — | US | disclosed |
| WO-2020264115-A1 | METHODS FOR MANUFACTURING WIND TURBINE BLADES AND LEADING EDGE PROTECTION SURFACES | PPG COATINGS EUROPE B.V. (NL) | 2020-12-30 | — | — | WO | disclosed |
| US-10823645-B2 | Sample collection and handling for delayed analysis | ESSENLIX CORPORATION (US) | 2020-11-03 | — | — | US | disclosed |
| CN-111656155-A | Sample collection and manipulation for delayed analysis | ESSENLIX公司 | 2020-09-11 | — | — | CN | disclosed |
| CN-111492222-A | Sample collection, retention and assay | ESSENLIX公司 | 2020-08-04 | — | — | CN | disclosed |
| US-20200199300-A1 | Dual Cure Sealants | PRC-DESOTO INTERNATIONAL, INC. (US) | 2020-06-25 | — | — | US | disclosed |
| US-20200124613-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | UNIV TEXAS (US) | 2020-04-23 | — | — | US | disclosed |
| EP-3635032-A1 | DUAL CURE SEALANTS | PRC-Desoto International, Inc. (US) | 2020-04-15 | — | — | EP | disclosed |
| WO-2020061397-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | MODERNATX, INC. (US) | 2020-03-26 | — | — | WO | disclosed |
| US-10545153-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-01-28 | — | — | US | disclosed |
| EP-3543703-A1 | IMPROVED SINGLE MOLECULE PEPTIDE SEQUENCING | Board of Regents, The University of Texas System (US) | 2019-09-25 | — | — | EP | disclosed |
| WO-2018227149-A1 | DUAL CURE SEALANTS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2018-12-13 | — | — | WO | disclosed |
| WO-2018148470-A1 | SAMPLE COLLECTION AND HANDLING FOR DELAYED ANALYSIS | ESSENLIX CORPORATION (US) | 2018-08-16 | — | — | WO | disclosed |
| EP-3350333-A2 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | ModernaTX, Inc. (US) | 2018-07-25 | — | — | EP | disclosed |
| US-20180057542-A1 | THERAGNOSTIC PARTICLES | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2018-03-01 | — | — | US | disclosed |
| EP-3283499-A1 | DUAL QUENCHER PROBES | Biosearch Technologies, Inc. (US) | 2018-02-21 | — | — | EP | disclosed |
| US-20170292068-A1 | Colorimetric Indicators for Photocurable Sealants | THE BOEING COMPANY | 2017-10-12 | — | — | US | disclosed |
| US-20170276686-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2017-09-28 | — | — | US | disclosed |
| EP-3194980-A1 | IMPROVED SINGLE MOLECULE PEPTIDE SEQUENCING | Board of Regents, The University of Texas System (US) | 2017-07-26 | — | — | EP | disclosed |
| EP-3157572-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| WO-2017049275-A2 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | MODERNA THERAPEUTICS, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| WO-2017049286-A1 | POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER | MODERNA THERAPEUTICS, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| WO-2017048982-A1 | OLIGOPHOSPHATE DARK QUENCHERS AND USES | BIOSEARCH TECHNOLOGIES, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| WO-2016168750-A1 | DUAL QUENCHER PROBES | BIOSEARCH TECHNOLOGIES, INC. (US) | 2016-10-20 | — | — | WO | disclosed |
| EP-3052479-A2 | POLYNUCLEOTIDE MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2016-08-10 | — | — | EP | disclosed |
| EP-3053585-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2016-08-10 | — | — | EP | disclosed |
| WO-2016069124-A1 | IMPROVED SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-05-06 | — | — | WO | disclosed |
| EP-2989463-A1 | MULTIPLEX HEPATITIS B ASSAY | Bio-Rad Laboratories, Inc. (US) | 2016-03-02 | — | — | EP | disclosed |
| EP-2968397-A1 | DIAGNOSIS AND TREATMENT OF FIBROSIS | Moderna Therapeutics, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2964234-A1 | HETEROLOGOUS UNTRANSLATED REGIONS FOR MRNA | Moderna Therapeutics, Inc. (US) | 2016-01-13 | — | — | EP | disclosed |
| WO-2015196118-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| WO-2015196130-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| EP-2931319-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2015-10-21 | — | — | EP | disclosed |
| EP-2922554-A1 | TERMINALLY MODIFIED RNA | Moderna Therapeutics, Inc. (US) | 2015-09-30 | — | — | EP | disclosed |
| WO-2015051173-A2 | POLYNUCLEOTIDE MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC (US) | 2015-04-09 | — | — | WO | disclosed |
| EP-2044090-B1 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | UNIV CALIFORNIA (US) | 2015-04-08 | — | — | EP | disclosed |
| US-8974768-B2 | Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates | MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN (DE) | 2015-03-10 | — | — | US | disclosed |
| EP-2797634-A1 | MODIFIED MRNAS ENCODING CELL-PENETRATING POLYPEPTIDES | Moderna Therapeutics, Inc. (US) | 2014-11-05 | — | — | EP | disclosed |
| WO-2014176535-A1 | MULTIPLEX HEPATITIS B ASSAY | BIO-RAD LABORATORIES, INC. (US) | 2014-10-30 | — | — | WO | disclosed |
| EP-2791159-A1 | MODIFIED NUCLEIC ACIDS, AND ACUTE CARE USES THEREOF | Moderna Therapeutics, Inc. (US) | 2014-10-22 | — | — | EP | disclosed |
| WO-2014164253-A1 | HETEROLOGOUS UNTRANSLATED REGIONS FOR MRNA | MODERNA THERAPEUTICS, INC. (US) | 2014-10-09 | — | — | WO | disclosed |
| WO-2014158795-A1 | DIAGNOSIS AND TREATMENT OF FIBROSIS | MODERNA THERAPEUTICS, INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| CN-104040358-A | Microfluidic devices and methods for assaying a fluid sample using the same | UNIV CALIFORNIA | 2014-09-10 | — | — | CN | disclosed |
| CN-104024396-A | AFFINITY METHODS AND COMPOSITIONS EMPLOYING ELECTRONIC CONTROL OF PH | BIO RAD LABORATORIES | 2014-09-03 | — | — | CN | disclosed |
| WO-2014093924-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2014-06-19 | — | — | WO | disclosed |
| WO-2014081507-A1 | TERMINALLY MODIFIED RNA | MODERNA THERAPEUTICS, INC. (US) | 2014-05-30 | — | — | WO | disclosed |
| CN-101946171-B | Fluorescent compounds | BIOTIUM INC | 2014-03-12 | — | — | CN | disclosed |
| CN-101914620-B | Method for analysis of molecules | PACIFIC BIOSCIENCES CALIFORNIA | 2014-02-12 | — | — | CN | disclosed |
| WO-2013101690-A1 | MODIFIED MRNAS ENCODING CELL-PENETRATING POLYPEPTIDES | modeRNA Therapeutics (US) | 2013-07-04 | — | — | WO | disclosed |
| EP-2606150-A1 | QUANTITATIVE REAL-TIME PCR ASSAY USING FRET DUAL-LABELED PRIMERS | Life Technologies Corporation (US) | 2013-06-26 | — | — | EP | disclosed |
| WO-2013090186-A1 | MODIFIED NUCLEIC ACIDS, AND ACUTE CARE USES THEREOF | modeRNA Therapeutics (US) | 2013-06-20 | — | — | WO | disclosed |
| US-20130078186-A1 | AZO COMPOUNDS REDUCING FORMATION AND TOXICITY OF AMYLOID BETA AGGREGATION INTERMEDIATES | MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN (DE) | 2013-03-28 | — | — | US | disclosed |
| CN-101321878-B | Non-fluorescent energy transfer | HOFFMANN LA ROCHE | 2013-03-27 | — | — | CN | disclosed |
| CN-102712614-A | Heterocycle-substituted xanthene dyes | BIOTIUM INC | 2012-10-03 | — | — | CN | disclosed |
| US-8242062-B2 | IMS detection of chemical markers in petroleum products | AUTHENTIX, INC. (US) | 2012-08-14 | — | — | US | disclosed |
| WO-2012027625-A9 | SCAFFOLD-BASED POLYMERASE ENZYME SUBSTRATES | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-08-02 | — | — | WO | disclosed |
| CN-102439460-A | Multi-directional microfluidic devices and methods | UNIV CALIFORNIA | 2012-05-02 | — | — | CN | disclosed |
| WO-2012027625-A2 | SCAFFOLD-BASED POLYMERASE ENZYME SUBSTRATES | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012024642-A1 | QUANTITATIVE REAL-TIME PCR ASSAY USING FRET DUAL-LABELED PRIMERS | Life Technologies Corporation (US) | 2012-02-23 | — | — | WO | disclosed |
| CN-101199241-B | Apparatus and method for molecular analysis | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-02-22 | — | — | CN | disclosed |
| EP-2380025-A2 | RATIO BASED BIOMARKERS AND METHODS OF USE THEREOF | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) | 2011-10-26 | — | — | EP | disclosed |
| EP-2368558-A1 | Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates | Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch (DE) | 2011-09-28 | — | — | EP | disclosed |
| CN-101946171-A | Fluorescent compounds | BIOTIUM INC | 2011-01-12 | — | — | CN | disclosed |
| EP-2264130-A2 | Ims detection of chemical markers in petroleum products | Authentix, Inc. (US) | 2010-12-22 | — | — | EP | disclosed |
| CN-101914620-A | The apparatus and method of analysis of molecules | PACIFIC BIOSCIENCES CALIFORNIA | 2010-12-15 | — | — | CN | disclosed |
| US-20100255464-A1 | Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis | Life Technologies Corporation | 2010-10-07 | — | — | US | disclosed |
| CN-101855362-A | Primers and probes for the detection of streptococcus pneumoniae | US GOV HEALTH & HUMAN SERV (US) | 2010-10-06 | — | — | CN | disclosed |
| WO-2010083252-A2 | RATIO BASED BIOMARKERS AND METHODS OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2010-07-22 | — | — | WO | disclosed |
| US-7718437-B2 | Method for analyzing N-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2010-05-18 | — | — | US | disclosed |
| WO-2010021989-A1 | MULTIPLEX ASSAY FOR RHEUMATOID ARTHRITIS | BIO-RAD LABORATORIES, INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| WO-2009085328-A1 | MOLECULES AND METHODS FOR NUCLEIC ACID SEQUENCING | HELICOS BIOSCIENCES CORPORATION (US) | 2009-07-09 | — | — | WO | disclosed |
| EP-2057175-A2 | NUCLEOTIDE ANALOGS | Helicos Biosciences Corporation (US) | 2009-05-13 | — | — | EP | disclosed |
| EP-1738177-B1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2009-02-11 | — | — | EP | disclosed |
| CN-101321878-A | Non-fluorescent energy transfer | ROCHE MOLECULAR SYSTEMS INC (CH) | 2008-12-10 | — | — | CN | disclosed |
| WO-2008144315-A1 | METHODS AND COMPOSITIONS FOR SEQUENCING A NUCLEIC ACID | HELICOS BIOSCIENCES CORPORATION (US) | 2008-11-27 | — | — | WO | disclosed |
| EP-1973926-A2 | METHODS AND COMPOSITIONS FOR SEQUENCING A NUCLEIC ACID | Helicos Biosciences Corporation (US) | 2008-10-01 | — | — | EP | disclosed |
| EP-1948824-A2 | FLUOROGENIC PROBES FOR REACTIVE OXYGEN SPECIES | The Regents of the University of California Office of Technology Transfer (US) | 2008-07-30 | — | — | EP | disclosed |
| CN-101199241-A | Apparatus and method for molecular analysis | PACIFIC BIOSCIENCES CALIFORNIA (US) | 2008-06-11 | — | — | CN | disclosed |
| US-7374950-B2 | Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients | PRINCETON BIOMEDITECH CORPORATION (US) | 2008-05-20 | — | — | US | disclosed |
| EP-1917346-A2 | SIGNAL PATTERN COMPOSITIONS AND METHODS | Helicos Biosciences Corporation (US) | 2008-05-07 | — | — | EP | disclosed |
| WO-2008016906-A2 | 3'-PHOSPHATE-LABELED NUCLEOTIDE ANALOGS AND THEIR USE FOR SEQUENCING A NUCLEIC ACID | HELICOS BIOSCIENCES CORPORATION (US) | 2008-02-07 | — | — | WO | disclosed |
| WO-2008016909-A2 | NUCLEOTIDE ANALOGS | HELICOS BIOSCIENCES CORPORATION (US) | 2008-02-07 | — | — | WO | disclosed |
| US-20080026379-A1 | Nucleotide analogs | FLUIDIGM CORPORATION | 2008-01-31 | — | — | US | disclosed |
| WO-2007121453-A2 | 2-HYDROXY-1-OXO 1,2 DIHYDRO ISOQUINOLINE CHELATING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-10-25 | — | — | WO | disclosed |
| WO-2007120859-A2 | METHODS FOR INCREASING ACCURACY OF NUCLEIC ACID SEQUENCING | HELICOS BIOSCIENCES CORPORATION (US) | 2007-10-25 | — | — | WO | disclosed |
| EP-1844328-A2 | USE OF REVERSIBLE EXTENSION TERMINATOR IN NUCLEIC ACID SEQUENCING | Pacific Biosciences of California, Inc. (US) | 2007-10-17 | — | — | EP | disclosed |
| US-20070212785-A1 | IMS DETECTION OF CHEMICAL MARKERS IN PETROLEUM PRODUCTS | AUTHENTIX, INC. (US) | 2007-09-13 | — | — | US | disclosed |
| CN-101023187-A | KSV-2 type specific immunoassays using glycoprotein G2 peptides | BIO RAD LABORATORIES (US) | 2007-08-22 | — | — | CN | disclosed |
| US-20070190659-A1 | Method for analyzing n-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2007-08-16 | — | — | US | disclosed |
| EP-1368497-A4 | METHODS AND APPARATUS FOR ANALYZING POLYNUCLEOTIDE SEQUENCES BY ASYNCHRONOUS BASE EXTENSION | CALIFORNIA INST OF TECHN (US) | 2007-08-15 | — | — | EP | disclosed |
| WO-2007070642-A2 | METHODS FOR INCREASING ACCURACY OF NUCLEIC ACID SEQUENCING | HELICOS BIOSCIENCES CORPORATION (US) | 2007-06-21 | — | — | WO | disclosed |
| WO-2007062160-A2 | METHODS AND COMPOSITIONS FOR SEQUENCING A NUCLEIC ACID | HELICOS BIOSCIENCES CORPORATION (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007019422-A9 | SIGNAL PATTERN COMPOSITIONS AND METHODS | HELICOS BIOSCIENCES CORP (US) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007050810-A2 | FLUOROGENIC PROBES FOR REACTIVE OXYGEN SPECIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-05-03 | — | — | WO | disclosed |
| US-7208451-B2 | IMS detection of chemical markers in petroleum products | AUTHENTIC INC. (US) | 2007-04-24 | — | — | US | disclosed |
| WO-2007019422-A2 | SIGNAL PATTERN COMPOSITIONS AND METHODS | HELICOS BIOSCIENCES CORPORATION (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20070020769-A1 | Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients | PRINCETON BIOMEDITECH CORPORATION (US) | 2007-01-25 | — | — | US | disclosed |
| EP-1706452-A4 | AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES | UNIV CALIFORNIA OFFICE OF THE (US) | 2007-01-10 | — | — | EP | disclosed |
| EP-1738177-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | Adduct Analys AB (SE) | 2007-01-03 | — | — | EP | disclosed |
| EP-1706452-A2 | AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES | The Regents of the University of California, Office of the President (US) | 2006-10-04 | — | — | EP | disclosed |
| US-7109023-B2 | Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients | PRINCETON BIOMEDITECH CORPORATION (US) | 2006-09-19 | — | — | US | disclosed |
| WO-2006083751-A2 | USE OF REVERSIBLE EXTENSION TERMINATOR IN NUCLEIC ACID SEQUENCING | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2006-08-10 | — | — | WO | disclosed |
| US-7022331-B2 | Thermochromic/photochromic cosmetic compositions | Theisen, Lyle (US) | 2006-04-04 | — | — | US | disclosed |
| WO-2006001835-A2 | AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-05 | — | — | WO | disclosed |
| WO-2005101020-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2005-10-27 | — | — | WO | disclosed |
| US-20050239209-A1 | Method for peptide and polypeptide purification and differential analysis | KRAKOVER JONATHAN | 2005-10-27 | — | — | US | disclosed |
| WO-2005007663-A9 | FLUOROGENIC ENZYME SUBSTRATES AND USES THEREOF | IRM LLC (US) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005007663-A2 | FLUOROGENIC ENZYME SUBSTRATES AND USES THEREOF | IRM LLC (BM) | 2005-01-27 | — | — | WO | disclosed |
| EP-1154990-B1 | PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS | UNIV CALIFORNIA (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2004106890-A2 | TRACE INCORPORATION OF FLUORESCENT MONOMER FACILITATING QUALITY CONTROL OF POLYMERIZATION REACTIONS | CIPHERGEN BIOSYSTEMS, INC. (US) | 2004-12-09 | — | — | WO | disclosed |
| US-20040147413-A1 | IMS detection of chemical markers in petroleum products | AUTHENTIX, INC. | 2004-07-29 | — | — | US | disclosed |
| US-20040096988-A1 | IMMUNOSSAY DEVICE FOR DIAGNOSING CONGESTIVE HEART FAILURE AND PREDICTING MORTALITY IN CONGESTIVE HEART FAILURE PATIENTS | PRINCETON BIOMEDITECH CORPORATION | 2004-05-20 | — | — | US | disclosed |
| US-6737277-B1 | COMPRISING A BASE MEMBER, AN ARRAY DISPOSED ON THE BASE MEMBER, AND ASSAY INDICIA ZONE; INCREASED SENSITIVITY COMPARED TO PREVIOUS MIGRATION TYPE ASSAYS DUE TO FILTER ELEMENT BEFORE ASSAY INDICIAZONE | PMB-SELFCARE LLC | 2004-05-18 | — | — | US | disclosed |
| EP-1368497-A1 | METHODS AND APPARATUS FOR ANALYZING POLYNUCLEOTIDE SEQUENCES BY ASYNCHRONOUS BASE EXTENSION | California Institute of Technology (US) | 2003-12-10 | — | — | EP | disclosed |
| EP-1305445-A4 | DARK QUENCHERS FOR DONOR-ACCEPTOR ENERGY TRANSFER | BIOSEARCH TECHNOLOGIES INC (US) | 2003-08-13 | — | — | EP | disclosed |
| US-20030138374-A1 | Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same | BF RESEARCH INSTITUTE, INC. (JP) | 2003-07-24 | — | — | US | disclosed |
| EP-1305445-A1 | DARK QUENCHERS FOR DONOR-ACCEPTOR ENERGY TRANSFER | Biosearch Technologies, Inc. (US) | 2003-05-02 | — | — | EP | disclosed |
| US-6541277-B1 | Reservoir pad; wicking membrane; filter membrane | PRINCETON BIOMEDITECH CORPORATION | 2003-04-01 | — | — | US | disclosed |
| US-6506612-B2 | For detection of the presence of an analyte in a sample of biological fluid through the use of immunochemical ligand-receptor reactions and specially selected, treated, and arranged filter materials | PRINCETON BIOMEDITECH CORPORATION | 2003-01-14 | — | — | US | disclosed |
| US-20020192247-A1 | Thermochromic/photochromic cosmetic compositions | THEISEN LYLE (US) | 2002-12-19 | — | — | US | disclosed |
| EP-1266884-A1 | IMAGE DIAGNOSIS PROBE BASED ON SUBSTITUTED AZOBENZENE OR ANALOGUE THEREOF FOR DISEASE ATTRIBUTABLE TO AMYLOID ACCUMULATION AND COMPOSITION FOR IMAGE DIAGNOSIS CONTAINING THE SAME | BF Research Institute, Inc. (JP) | 2002-12-18 | — | — | EP | disclosed |
| US-20020160525-A1 | IMMUNOASSAY DEVICES AND MATERIALS | PRINCETON BIOMEDITECH CORPORATION | 2002-10-31 | — | — | US | disclosed |
| WO-2002072892-A1 | METHODS AND APPARATUS FOR ANALYZING POLYNUCLEOTIDE SEQUENCES BY ASYNCHRONOUS BASE EXTENSION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-09-19 | — | — | WO | disclosed |
| WO-2002026867-A2 | DENDRIMERIC SUPPORT OR CARRIER MACROMOLECULE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-04-04 | — | — | WO | disclosed |
| WO-2001086001-A1 | DARK QUENCHERS FOR DONOR-ACCEPTOR ENERGY TRANSFER | BIOSEARCH TECHNOLOGIES, INC. (US) | 2001-11-15 | — | — | WO | disclosed |
| EP-0912597-A4 | NUCLEIC ACID AMPLIFICATION OLIGONUCLEOTIDES WITH MOLECULAR ENERGY TRANSFER LABELS AND METHODS BASED THEREON | INTERGEN COMPANY (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-2000075378-A1 | FLUORESCENCE ENERGY TRANSFER PROBES WITH STABILIZED CONFORMATIONS | BIOSEARCH TECHNOLOGIES, INC. (US) | 2000-12-14 | — | — | WO | disclosed |
| US-6027943-A | A BASE, AN ASSAY INDICIA ZONE, A RESERVOIR PAD TO RECEIVE LIQUID SAMPLE, A WICKING MEMBRANE, AND A FILTER ZONE IN BETWEEN THE WICK AND THE PAD | PRINCETON BIOMEDITECH CORPORATION (US) | 2000-02-22 | — | — | US | disclosed |
| US-5965699-A | SUBSTRATE PEPTIDE MODIFIED BY ACETYLATING N-TERMINAL AND ELIMINATING NEGATIVE CHARGE AT C-TERMINAL; FOR RAPID DETECTION WITHOUT SEPARATING PRODUCTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0912597-A1 | NUCLEIC ACID AMPLIFICATION OLIGONUCLEOTIDES WITH MOLECULAR ENERGY TRANSFER LABELS AND METHODS BASED THEREON | ONCOR, INC. (US) | 1999-05-06 | — | — | EP | disclosed |
| EP-0587008-B1 | Surface-enhanced raman spectroscopy immunoassy | ABBOTT LAB (US) | 1999-02-10 | — | — | EP | disclosed |
| WO-1998002449-A9 | NUCLEIC ACID AMPLIFICATION OLIGONUCLEOTIDES WITH MOLECULAR ENERGY TRANSFER LABELS AND METHODS BASED THEREON | — | 1998-04-30 | — | — | WO | disclosed |
| US-5728587-A | Immunoassay devices and materials | PMB-SELFCARE, LLC (US) | 1998-03-17 | — | — | US | disclosed |
| WO-1998002449-A1 | NUCLEIC ACID AMPLIFICATION OLIGONUCLEOTIDES WITH MOLECULAR ENERGY TRANSFER LABELS AND METHODS BASED THEREON | ONCOR, INC. (US) | 1998-01-22 | — | — | WO | disclosed |
| US-5567628-A | Surface-enhanced raman spectroscopy immunoassay method, composition and kit | ABBOTT LABORATORIES (US) | 1996-10-22 | — | — | US | disclosed |
| US-5559041-A | SUPPORTS WITH RESERVOIR PADS, WICKING MEMBRANES AND FILTER ZONES FOR IMMUNOASSAY | PRINCETON BIOMEDITECH CORPORATION (US) | 1996-09-24 | — | — | US | disclosed |
| EP-0620822-A4 | HYBRIDIZATION OF POLYNUCLEOTIDES CONJUGATED WITH CHROMOPHORES AND FLUOROPHORES TO GENERATE DONOR-TO-DONOR ENERGY TRANSFER SYSTEM. | NANOTRONICS INC (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5445972-A | Raman label and its conjugate in a ligand-binding assay for a test sample analyte | ABBOTT LABORATORIES (US) | 1995-08-29 | — | — | US | disclosed |
| EP-0389437-B1 | Luciferin derivatives | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1995-05-24 | — | — | EP | disclosed |
| EP-0547142-A4 | — | MICROPROBE CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| US-5376556-A | Surface-enhanced Raman spectroscopy immunoassay | ABBOTT LABORATORIES (US) | 1994-12-27 | — | — | US | disclosed |
| EP-0620822-A1 | HYBRIDIZATION OF POLYNUCLEOTIDES CONJUGATED WITH CHROMOPHORES AND FLUOROPHORES TO GENERATE DONOR-TO-DONOR ENERGY TRANSFER SYSTEM | NANOTRONICS, INC. (US) | 1994-10-26 | — | — | EP | disclosed |
| EP-0587008-A1 | Surface-enhanced raman spectroscopy immunoassy | ABBOTT LABORATORIES (US) | 1994-03-16 | — | — | EP | disclosed |
| US-5266498-A | Ligand binding assay for an analyte using surface-enhanced scattering (SERS) signal | ABBOTT LABORATORIES (US) | 1993-11-30 | — | — | US | disclosed |
| US-5252496-A | Treated with dextran and fluorescein isothiocyanate | PRINCETON BIOMEDITECH CORPORATION (US) | 1993-10-12 | — | — | US | disclosed |
| EP-0547142-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | EPOCH PHARMACEUTICALS, INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| WO-1993009128-A1 | HYBRIDIZATION OF POLYNUCLEOTIDES CONJUGATED WITH CHROMOPHORES AND FLUOROPHORES TO GENERATE DONOR-TO-DONOR ENERGY TRANSFER SYSTEM | NANOTRONICS, INC. (US) | 1993-05-13 | — | — | WO | disclosed |
| US-5128069-A | Luciferin derivatives | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1992-07-07 | — | — | US | disclosed |
| WO-1992003464-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | MICROPROBE CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
| US-4975418-A | Therapeutically active compositions of pseudo-peptide of glutamyl-aspartic acid | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC (CNRS) (FR) | 1990-12-04 | — | — | US | disclosed |
| EP-0135514-B1 | CROSS LINKED POROUS MEMBRANES | MEMTEC LIMITED (AU) | 1990-11-07 | — | — | EP | disclosed |
| EP-0266385-A1 | THERAPEUTICALLY ACTIVE PSEUDO-PEPTIDE OF GLUTAMYL-ASPARTIC ACID | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1988-05-11 | — | — | EP | disclosed |
| WO-1987006931-A1 | THERAPEUTICALLY ACTIVE PSEUDO-PEPTIDE OF GLUTAMYL-ASPARTIC ACID | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) | 1987-11-19 | — | — | WO | disclosed |
| US-4661526-A | THERMOPLASTIC POLYAMIDES OR POLYAMIDEIMIDE COPOLYMERS | MEMTEC LIMITED (AU) | 1987-04-28 | — | — | US | disclosed |
| EP-0135514-A4 | CROSS LINKED POROUS MEMBRANES. | MEMTEC LTD (AU) | 1987-01-20 | — | — | EP | disclosed |
| EP-0135514-A1 | CROSS LINKED POROUS MEMBRANES. | MEMTEC LTD (AU) | 1985-04-03 | — | — | EP | disclosed |
| WO-1984003054-A1 | CROSS LINKED POROUS MEMBRANES | MEMTEC LTD (AU) | 1984-08-16 | — | — | WO | disclosed |
| WO-1984003054-A1 | CROSS LINKED POROUS MEMBRANES | MEMTEC LTD (AU) | 1984-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240123091-A1 | MODIFIED WOUND DRESSINGS | MMP8, CD68, ELANE | ALDH1A1 393/4885TSHR 4883/4885MAPK1 2180/4885 |
| US-20240132948-A1 | Cyanine Dyes | ABCG2, IK, ACR | ALDH1A1 1447/4885TSHR 3235/4885MAPK1 1978/4885 |
| US-20230332209-A1 | QUENCHER AND USE THEREOF | SQOR, NQO1, GPX4 | ALDH1A1 1639/4885TSHR 4498/4885MAPK1 4684/4885 |
| US-12595517-B2 | Method to treat and stratify a patient suffering from a cancer | PDCD1, CD274, PDCD4 | ALDH1A1 3221/4885TSHR 1712/4885MAPK1 928/4885 |
| US-20220364071-A1 | NOVEL CRISPR ENZYMES AND SYSTEMS | DCLRE1B, FEN1, APOBEC3C | ALDH1A1 4483/4885TSHR 4005/4885MAPK1 4113/4885 |
| US-12048710-B2 | Compositions and methods for modification of biomolecules | PTMS, QPCT, ANPEP | ALDH1A1 3718/4885TSHR 1564/4885MAPK1 4072/4885 |
| US-20230266321-A1 | LIVE CELL ENGAGEMENT ASSAY | KSR1, KSR2, ARAF | ALDH1A1 4413/4885TSHR 207/4885MAPK1 80/4885 |
| US-11628170-B2 | Treating extrapyramtdal syndrome using trapidil | SLC6A3, PARK7, DCTD | ALDH1A1 1153/4885TSHR 197/4885MAPK1 1838/4885 |
| US-20240409597-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS | MSH2, POLRMT, SARNP | ALDH1A1 4456/4885TSHR 1159/4885MAPK1 3915/4885 |
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | QPCTL, ANPEP, VIP | ALDH1A1 3926/4885TSHR 3578/4885MAPK1 2810/4885 |
| US-20230134425-A1 | METHODS OF TREATING GLIOBLASTOMA | MGMT, IDH3B, IDH3A | ALDH1A1 1863/4885TSHR 2546/4885MAPK1 4579/4885 |
| US-20250387396-A1 | TREATING EXTRAPYRAMIDAL SYNDROME USING TRAPIDIL | MAP2K3, JUND, BCL2L13 | ALDH1A1 3514/4885TSHR 552/4885MAPK1 64/4885 |
| US-20230338493-A1 | DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING BETA-GLUCAN AS A VACCINE ADJUVANT | CLEC4M, LGALS7; LGALS7B, CHIT1 | ALDH1A1 2858/4885TSHR 4266/4885MAPK1 943/4885 |
| US-12529092-B2 | In-situ spatial transcriptomics | MKI67, CTCF, CD68 | ALDH1A1 4221/4885TSHR 1332/4885MAPK1 3466/4885 |
| US-11484597-B2 | Therapeutic conjugates | CD47, CD44, EPCAM | ALDH1A1 1307/4885TSHR 1880/4885MAPK1 4779/4885 |
| US-20250255889-A1 | METHODS FOR TREATMENT SELECTION FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | BCL6B, BCL9, BCL9L | ALDH1A1 1771/4885TSHR 2698/4885MAPK1 4405/4885 |
| US-20260108464-A1 | Systems for Vacuum Mediated Liposome Preparation, and Methods for Using the Same | VMP1, LIPA, LIPG | ALDH1A1 4753/4885TSHR 4329/4885MAPK1 3983/4885 |
| US-12631645-B2 | Detection of BCL-2 family heterodimer complexes and use thereof | BCL2L10, BCL2L1, BCL2L2 | ALDH1A1 4550/4885TSHR 1453/4885MAPK1 2057/4885 |
| US-12029791-B2 | Therapeutic conjugates | CD47, CD44, EPCAM | ALDH1A1 1307/4885TSHR 1880/4885MAPK1 4779/4885 |
| US-20210115489-A1 | NOVEL MEDIATOR | MPO, EPX, LPO | ALDH1A1 1833/4885TSHR 4574/4885MAPK1 2739/4885 |
| US-20260085366-A1 | PSILOCYBE ASSAY | RNGTT, MYCBP, SLTM | ALDH1A1 3161/4885TSHR 4373/4885MAPK1 4437/4885 |
| US-20220202837-A1 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | PTMS, QPCT, ANPEP | ALDH1A1 3718/4885TSHR 1564/4885MAPK1 4072/4885 |
| US-12631545-B2 | Method and systems for determining drop delay using scatter signals across spatially separated lasers | PDE6C, TRPC6, DYNC1LI2 | ALDH1A1 3159/4885TSHR 2430/4885MAPK1 2921/4885 |
| US-20240228500-A1 | THERAPEUTIC CONJUGATES | CD47, CD44, EPCAM | ALDH1A1 1307/4885TSHR 1880/4885MAPK1 4779/4885 |
| US-12109274-B2 | Polynucleotides containing a stabilizing tail region | POLR2E, POLN, PHAX | ALDH1A1 4559/4885TSHR 3704/4885MAPK1 4686/4885 |
| US-11613774-B2 | Quencher and use thereof | GPX4, NQO1, SQOR | ALDH1A1 1838/4885TSHR 4585/4885MAPK1 4668/4885 |
| US-20240410892-A1 | PHOTOSTABLE DETECTABLE COMPOUNDS | DDT, ANXA6, ANXA4 | ALDH1A1 738/4885TSHR 4476/4885MAPK1 4503/4885 |
| US-11460468-B2 | Measurement of protein expression using reagents with barcoded oligonucleotide sequences | HSPBP1, CD2BP2, RRBP1 | ALDH1A1 3639/4885TSHR 3165/4885MAPK1 4024/4885 |
| US-20260092336-A1 | AMPLICON-DEPLETED CRISPR/CAS-REGULATED ISOTHERMAL MOLECULAR ASSAY AT SKIN TEMPERATURE ENABLING MULTI-LEVEL, EQUIPMENT-FREE, HOME-BASED SELF-TESTING OF VIRAL INFECTIONS | CUTA, LRBA, CTSL | ALDH1A1 3602/4885TSHR 2429/4885MAPK1 4292/4885 |
| US-20250170228-A1 | TERMINALLY MODIFIED RNA | RNGTT, NSUN3, RNMT | ALDH1A1 4235/4885TSHR 1251/4885MAPK1 4721/4885 |
| US-20240408191-A1 | NUCLEIC ACID VACCINES | POLRMT, NSUN3, RNGTT | ALDH1A1 4523/4885TSHR 3347/4885MAPK1 3280/4885 |
| US-20240325545-A1 | Phospholipid-Flavagline Conjugates and Methods of Using the Same for Targeted Cancer Therapy | PHOSPHO1, PLEC, PEBP1 | ALDH1A1 1686/4885TSHR 2345/4885MAPK1 2583/4885 |
| US-20260140039-A1 | METHODS FOR MONITORING FLOW RATE OF A FLOW STREAM AND SYSTEMS FOR SAME | CD69, SELL, CD47 | ALDH1A1 2056/4885TSHR 1220/4885MAPK1 1821/4885 |
| US-20080026379-A1 | Nucleotide analogs | NT5C2, NT5C3B, NUDT1 | ALDH1A1 2887/4885TSHR 2431/4885MAPK1 4091/4885 |
| US-11435358-B2 | Single molecule peptide sequencing | QPCTL, ANPEP, VIP | ALDH1A1 3945/4885TSHR 3565/4885MAPK1 2798/4885 |
| US-12274743-B2 | Nucleic acid vaccines | POLRMT, NSUN3, RNGTT | ALDH1A1 4523/4885TSHR 3347/4885MAPK1 3280/4885 |
| US-11603399-B2 | Long-lived polynucleotide molecules | POLN, MSH2, POLRMT | ALDH1A1 3159/4885TSHR 2399/4885MAPK1 4248/4885 |
| US-20260091104-A1 | NUCLEIC ACID VACCINES | RNMT, NSUN2, AMPD1 | ALDH1A1 3617/4885TSHR 720/4885MAPK1 2352/4885 |
| US-20260036574-A1 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | MERTK, RNMT, RBM14 | ALDH1A1 4455/4885TSHR 3151/4885MAPK1 2632/4885 |
| US-11624089-B2 | Cyanine dyes | ABCG2, IK, ACR | ALDH1A1 1447/4885TSHR 3235/4885MAPK1 1978/4885 |
| US-20260063530-A1 | METHODS AND COMPOSITIONS FOR FLOW CYTOMETER CALIBRATION | CD47, CACNG6, CACNA1F | ALDH1A1 2464/4885TSHR 1762/4885MAPK1 3561/4885 |
| US-20220387603-A1 | THERAPEUTIC CONJUGATES | CD47, CD44, EPCAM | ALDH1A1 1307/4885TSHR 1880/4885MAPK1 4779/4885 |
| US-11782059-B2 | Measurement of protein expression using reagents with barcoded oligonucleotide sequences | HSPBP1, CD2BP2, RRBP1 | ALDH1A1 3639/4885TSHR 3165/4885MAPK1 4024/4885 |
| US-20240165267-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | NSUN2, ADAR, NSUN3 | ALDH1A1 1969/4885TSHR 2428/4885MAPK1 4733/4885 |
| US-12527743-B2 | Systems for vacuum mediated liposome preparation, and methods for using the same | VMP1, LIPA, NSF | ALDH1A1 4737/4885TSHR 4042/4885MAPK1 4160/4885 |
| US-20260118250-A1 | METHODS FOR ASSESSING COLLINEARITY OF MULTI-AUTOFLUORESCENCE SPECTRA OF A SAMPLE AND SYSTEMS FOR SAME | CD40, PF4, CD47 | ALDH1A1 769/4885TSHR 1242/4885MAPK1 3804/4885 |
| US-20220133914-A1 | OPTICALLY HEAT-GENERATING COMPOSITE MATERIAL, NANOCLUSTER, SUBSTANCE DELIVERY CARRIER AND PHARMACEUTICAL COMPOSITION | CHRM1, NPY1R, C1R | ALDH1A1 122/4885TSHR 1478/4885MAPK1 2346/4885 |
| US-12577296-B2 | Compositions and methods for growth factor modulation | TGFB1, TGFBR1, TGFBR2 | ALDH1A1 4150/4885TSHR 1534/4885MAPK1 1713/4885 |
| US-11162952-B2 | Single molecule peptide sequencing | MICA, ANPEP, VIP | ALDH1A1 4699/4885TSHR 4070/4885MAPK1 2096/4885 |
| US-20260002864-A1 | METHODS FOR DETERMINING POSITIONAL FLOW STREAM VELOCITY AND SYSTEMS FOR SAME | PF4, SELL, PLK1 | ALDH1A1 4187/4885TSHR 2587/4885MAPK1 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.